GNF SymAtlas + NCI-60 cancer cell lines, human (Su, 2004; Ross, 2000)
Gene Symbol | Gene ID | Gene Info |
---|---|---|
RCOR1
|
ENSG00000089902.8 | REST corepressor 1 |
MTA3
|
ENSG00000057935.9 | metastasis associated 1 family member 3 |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
RCOR1 | hg19_v2_chr14_+_103058948_103059005 | 0.44 | 1.1e-11 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr3_-_185542761 | 114.50 |
ENST00000457616.2
ENST00000346192.3 |
IGF2BP2
|
insulin-like growth factor 2 mRNA binding protein 2 |
chr15_-_72523454 | 109.85 |
ENST00000565154.1
ENST00000565184.1 ENST00000389093.3 ENST00000449901.2 ENST00000335181.5 ENST00000319622.6 |
PKM
|
pyruvate kinase, muscle |
chr19_+_35645817 | 105.99 |
ENST00000423817.3
|
FXYD5
|
FXYD domain containing ion transport regulator 5 |
chr3_-_185542817 | 103.46 |
ENST00000382199.2
|
IGF2BP2
|
insulin-like growth factor 2 mRNA binding protein 2 |
chr19_+_35645618 | 102.58 |
ENST00000392218.2
ENST00000543307.1 ENST00000392219.2 ENST00000541435.2 ENST00000590686.1 ENST00000342879.3 ENST00000588699.1 |
FXYD5
|
FXYD domain containing ion transport regulator 5 |
chr9_-_113018746 | 100.75 |
ENST00000374515.5
|
TXN
|
thioredoxin |
chr19_+_6361754 | 91.13 |
ENST00000597326.1
|
CLPP
|
caseinolytic mitochondrial matrix peptidase proteolytic subunit |
chrX_+_118602363 | 86.58 |
ENST00000317881.8
|
SLC25A5
|
solute carrier family 25 (mitochondrial carrier; adenine nucleotide translocator), member 5 |
chr5_+_167913450 | 86.50 |
ENST00000231572.3
ENST00000538719.1 |
RARS
|
arginyl-tRNA synthetase |
chr18_+_657733 | 86.00 |
ENST00000323250.5
ENST00000323224.7 |
TYMS
|
thymidylate synthetase |
chr2_+_120125245 | 85.81 |
ENST00000393103.2
|
DBI
|
diazepam binding inhibitor (GABA receptor modulator, acyl-CoA binding protein) |
chr13_+_28194873 | 80.51 |
ENST00000302979.3
|
POLR1D
|
polymerase (RNA) I polypeptide D, 16kDa |
chr14_-_105420241 | 79.56 |
ENST00000557457.1
|
AHNAK2
|
AHNAK nucleoprotein 2 |
chr19_-_1095330 | 79.13 |
ENST00000586746.1
|
POLR2E
|
polymerase (RNA) II (DNA directed) polypeptide E, 25kDa |
chr1_-_8939265 | 79.07 |
ENST00000489867.1
|
ENO1
|
enolase 1, (alpha) |
chr19_-_55919087 | 78.61 |
ENST00000587845.1
ENST00000589978.1 ENST00000264552.9 |
UBE2S
|
ubiquitin-conjugating enzyme E2S |
chr8_+_26149007 | 77.43 |
ENST00000380737.3
ENST00000524169.1 |
PPP2R2A
|
protein phosphatase 2, regulatory subunit B, alpha |
chr11_-_2950642 | 76.27 |
ENST00000314222.4
|
PHLDA2
|
pleckstrin homology-like domain, family A, member 2 |
chr17_-_4852332 | 75.94 |
ENST00000572383.1
|
PFN1
|
profilin 1 |
chr2_-_106015491 | 75.82 |
ENST00000408995.1
ENST00000393353.3 ENST00000322142.8 |
FHL2
|
four and a half LIM domains 2 |
chr2_-_234763147 | 73.03 |
ENST00000411486.2
ENST00000432087.1 ENST00000441687.1 ENST00000414924.1 |
HJURP
|
Holliday junction recognition protein |
chr9_-_113018835 | 72.05 |
ENST00000374517.5
|
TXN
|
thioredoxin |
chr19_-_48894762 | 70.43 |
ENST00000600980.1
ENST00000330720.2 |
KDELR1
|
KDEL (Lys-Asp-Glu-Leu) endoplasmic reticulum protein retention receptor 1 |
chr2_+_235860616 | 69.34 |
ENST00000392011.2
|
SH3BP4
|
SH3-domain binding protein 4 |
chr11_-_14665163 | 69.01 |
ENST00000418988.2
|
PSMA1
|
proteasome (prosome, macropain) subunit, alpha type, 1 |
chr18_+_657578 | 68.85 |
ENST00000323274.10
|
TYMS
|
thymidylate synthetase |
chr7_+_30634297 | 68.78 |
ENST00000389266.3
|
GARS
|
glycyl-tRNA synthetase |
chr4_+_174089904 | 68.31 |
ENST00000265000.4
|
GALNT7
|
UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 7 (GalNAc-T7) |
chr7_-_93519471 | 68.11 |
ENST00000451238.1
|
TFPI2
|
tissue factor pathway inhibitor 2 |
chr20_+_43514320 | 67.30 |
ENST00000372839.3
ENST00000428262.1 ENST00000445830.1 |
YWHAB
|
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, beta |
chrX_+_154444643 | 66.51 |
ENST00000286428.5
|
VBP1
|
von Hippel-Lindau binding protein 1 |
chr8_+_145149930 | 66.44 |
ENST00000318911.4
|
CYC1
|
cytochrome c-1 |
chr1_+_100731749 | 66.33 |
ENST00000370128.4
ENST00000260563.4 |
RTCA
|
RNA 3'-terminal phosphate cyclase |
chr16_-_29466285 | 65.76 |
ENST00000330978.3
|
BOLA2
|
bolA family member 2 |
chr10_+_95256356 | 64.77 |
ENST00000371485.3
|
CEP55
|
centrosomal protein 55kDa |
chr1_-_153599426 | 64.65 |
ENST00000392622.1
|
S100A13
|
S100 calcium binding protein A13 |
chr17_+_1944790 | 64.36 |
ENST00000575162.1
|
DPH1
|
diphthamide biosynthesis 1 |
chr2_-_106015527 | 64.33 |
ENST00000344213.4
ENST00000358129.4 |
FHL2
|
four and a half LIM domains 2 |
chr7_+_16685756 | 63.53 |
ENST00000415365.1
ENST00000258761.3 ENST00000433922.2 ENST00000452975.2 ENST00000405202.1 |
BZW2
|
basic leucine zipper and W2 domains 2 |
chr1_+_43824577 | 63.17 |
ENST00000310955.6
|
CDC20
|
cell division cycle 20 |
chr20_-_33872518 | 62.62 |
ENST00000374436.3
|
EIF6
|
eukaryotic translation initiation factor 6 |
chr1_+_236558694 | 62.18 |
ENST00000359362.5
|
EDARADD
|
EDAR-associated death domain |
chr1_+_32687971 | 62.15 |
ENST00000373586.1
|
EIF3I
|
eukaryotic translation initiation factor 3, subunit I |
chr12_-_118498958 | 61.47 |
ENST00000315436.3
|
WSB2
|
WD repeat and SOCS box containing 2 |
chr15_-_91537723 | 61.17 |
ENST00000394249.3
ENST00000559811.1 ENST00000442656.2 ENST00000557905.1 ENST00000361919.3 |
PRC1
|
protein regulator of cytokinesis 1 |
chr20_-_60718430 | 61.14 |
ENST00000370873.4
ENST00000370858.3 |
PSMA7
|
proteasome (prosome, macropain) subunit, alpha type, 7 |
chr8_-_121457332 | 61.07 |
ENST00000518918.1
|
MRPL13
|
mitochondrial ribosomal protein L13 |
chr20_-_33872548 | 60.63 |
ENST00000374443.3
|
EIF6
|
eukaryotic translation initiation factor 6 |
chr17_+_73257742 | 59.59 |
ENST00000579761.1
ENST00000245539.6 |
MRPS7
|
mitochondrial ribosomal protein S7 |
chr17_-_47492164 | 59.59 |
ENST00000512041.2
ENST00000446735.1 ENST00000504124.1 |
PHB
|
prohibitin |
chr7_+_116165754 | 59.54 |
ENST00000405348.1
|
CAV1
|
caveolin 1, caveolae protein, 22kDa |
chr14_+_54863739 | 59.52 |
ENST00000541304.1
|
CDKN3
|
cyclin-dependent kinase inhibitor 3 |
chr7_+_116139744 | 59.21 |
ENST00000343213.2
|
CAV2
|
caveolin 2 |
chr16_-_69760409 | 59.17 |
ENST00000561500.1
ENST00000439109.2 ENST00000564043.1 ENST00000379046.2 ENST00000379047.3 |
NQO1
|
NAD(P)H dehydrogenase, quinone 1 |
chr12_+_6309517 | 58.66 |
ENST00000382519.4
ENST00000009180.4 |
CD9
|
CD9 molecule |
chr8_-_121457608 | 58.47 |
ENST00000306185.3
|
MRPL13
|
mitochondrial ribosomal protein L13 |
chr17_+_73257945 | 58.02 |
ENST00000579002.1
|
MRPS7
|
mitochondrial ribosomal protein S7 |
chr19_-_291365 | 57.91 |
ENST00000591572.1
ENST00000269812.3 ENST00000434325.2 |
PPAP2C
|
phosphatidic acid phosphatase type 2C |
chr11_-_64014379 | 57.64 |
ENST00000309318.3
|
PPP1R14B
|
protein phosphatase 1, regulatory (inhibitor) subunit 14B |
chr22_+_21921994 | 57.62 |
ENST00000545681.1
|
UBE2L3
|
ubiquitin-conjugating enzyme E2L 3 |
chr11_-_88070920 | 56.94 |
ENST00000524463.1
ENST00000227266.5 |
CTSC
|
cathepsin C |
chr3_+_23847432 | 56.81 |
ENST00000346855.3
|
UBE2E1
|
ubiquitin-conjugating enzyme E2E 1 |
chr1_+_40723779 | 56.74 |
ENST00000372759.3
|
ZMPSTE24
|
zinc metallopeptidase STE24 |
chr12_+_96252706 | 56.57 |
ENST00000266735.5
ENST00000553192.1 ENST00000552085.1 |
SNRPF
|
small nuclear ribonucleoprotein polypeptide F |
chr15_+_22892663 | 56.27 |
ENST00000313077.7
ENST00000561274.1 ENST00000560848.1 |
CYFIP1
|
cytoplasmic FMR1 interacting protein 1 |
chr1_-_212004090 | 56.23 |
ENST00000366997.4
|
LPGAT1
|
lysophosphatidylglycerol acyltransferase 1 |
chr10_+_81107271 | 55.93 |
ENST00000448165.1
|
PPIF
|
peptidylprolyl isomerase F |
chr2_-_174828892 | 55.78 |
ENST00000418194.2
|
SP3
|
Sp3 transcription factor |
chr4_-_7069760 | 55.65 |
ENST00000264954.4
|
GRPEL1
|
GrpE-like 1, mitochondrial (E. coli) |
chr7_+_116166331 | 55.64 |
ENST00000393468.1
ENST00000393467.1 |
CAV1
|
caveolin 1, caveolae protein, 22kDa |
chr17_-_79481666 | 55.63 |
ENST00000575659.1
|
ACTG1
|
actin, gamma 1 |
chr2_-_44223138 | 55.60 |
ENST00000260665.7
|
LRPPRC
|
leucine-rich pentatricopeptide repeat containing |
chr13_+_28195988 | 55.47 |
ENST00000399697.3
ENST00000399696.1 |
POLR1D
|
polymerase (RNA) I polypeptide D, 16kDa |
chr17_-_73150599 | 55.31 |
ENST00000392566.2
ENST00000581874.1 |
HN1
|
hematological and neurological expressed 1 |
chr17_+_1733276 | 55.19 |
ENST00000254719.5
|
RPA1
|
replication protein A1, 70kDa |
chr6_+_34204642 | 54.88 |
ENST00000347617.6
ENST00000401473.3 ENST00000311487.5 ENST00000447654.1 ENST00000395004.3 |
HMGA1
|
high mobility group AT-hook 1 |
chrX_-_153285395 | 54.81 |
ENST00000369980.3
|
IRAK1
|
interleukin-1 receptor-associated kinase 1 |
chr11_+_1968508 | 54.77 |
ENST00000397298.3
ENST00000381519.1 ENST00000397297.3 ENST00000381514.3 ENST00000397294.3 |
MRPL23
|
mitochondrial ribosomal protein L23 |
chr3_+_49711777 | 54.76 |
ENST00000442186.1
ENST00000438011.1 ENST00000457042.1 |
APEH
|
acylaminoacyl-peptide hydrolase |
chr22_-_24322660 | 54.42 |
ENST00000404092.1
|
DDT
|
D-dopachrome tautomerase |
chr1_+_110163202 | 54.36 |
ENST00000531203.1
ENST00000256578.3 |
AMPD2
|
adenosine monophosphate deaminase 2 |
chr12_-_112856623 | 54.33 |
ENST00000551291.2
|
RPL6
|
ribosomal protein L6 |
chr4_+_57302297 | 54.24 |
ENST00000399688.3
ENST00000512576.1 |
PAICS
|
phosphoribosylaminoimidazole carboxylase, phosphoribosylaminoimidazole succinocarboxamide synthetase |
chr2_+_10262442 | 54.17 |
ENST00000360566.2
|
RRM2
|
ribonucleotide reductase M2 |
chr18_+_12308231 | 53.99 |
ENST00000590103.1
ENST00000591909.1 ENST00000586653.1 ENST00000592683.1 ENST00000590967.1 ENST00000591208.1 ENST00000591463.1 |
TUBB6
|
tubulin, beta 6 class V |
chr19_+_49496705 | 53.97 |
ENST00000595090.1
|
RUVBL2
|
RuvB-like AAA ATPase 2 |
chr12_+_69979210 | 53.60 |
ENST00000544368.2
|
CCT2
|
chaperonin containing TCP1, subunit 2 (beta) |
chr8_-_80942061 | 53.43 |
ENST00000519386.1
|
MRPS28
|
mitochondrial ribosomal protein S28 |
chr19_+_6361795 | 53.42 |
ENST00000596149.1
|
CLPP
|
caseinolytic mitochondrial matrix peptidase proteolytic subunit |
chr1_-_8938736 | 53.28 |
ENST00000234590.4
|
ENO1
|
enolase 1, (alpha) |
chr11_-_14541872 | 53.12 |
ENST00000419365.2
ENST00000530457.1 ENST00000532256.1 ENST00000533068.1 |
PSMA1
|
proteasome (prosome, macropain) subunit, alpha type, 1 |
chr11_+_65687158 | 53.07 |
ENST00000532933.1
|
DRAP1
|
DR1-associated protein 1 (negative cofactor 2 alpha) |
chr12_+_108079664 | 53.05 |
ENST00000541166.1
|
PWP1
|
PWP1 homolog (S. cerevisiae) |
chr11_+_747329 | 52.98 |
ENST00000319006.3
ENST00000528097.1 |
TALDO1
|
transaldolase 1 |
chr8_+_97274119 | 52.96 |
ENST00000455950.2
|
PTDSS1
|
phosphatidylserine synthase 1 |
chr1_+_155178481 | 52.91 |
ENST00000368376.3
|
MTX1
|
metaxin 1 |
chr3_-_149688655 | 52.88 |
ENST00000461930.1
ENST00000423691.2 ENST00000490975.1 ENST00000461868.1 ENST00000452853.2 |
PFN2
|
profilin 2 |
chr2_+_201171372 | 52.85 |
ENST00000409140.3
|
SPATS2L
|
spermatogenesis associated, serine-rich 2-like |
chr3_-_149688502 | 52.78 |
ENST00000481767.1
ENST00000475518.1 |
PFN2
|
profilin 2 |
chr9_-_130635741 | 52.75 |
ENST00000223836.10
|
AK1
|
adenylate kinase 1 |
chr11_-_535515 | 52.71 |
ENST00000311189.7
ENST00000451590.1 ENST00000417302.1 |
HRAS
|
Harvey rat sarcoma viral oncogene homolog |
chrX_-_153707246 | 52.66 |
ENST00000407062.1
|
LAGE3
|
L antigen family, member 3 |
chr14_+_54863682 | 52.51 |
ENST00000543789.2
ENST00000442975.2 ENST00000458126.2 ENST00000556102.2 |
CDKN3
|
cyclin-dependent kinase inhibitor 3 |
chr1_-_24126023 | 52.47 |
ENST00000429356.1
|
GALE
|
UDP-galactose-4-epimerase |
chr11_+_69455855 | 52.00 |
ENST00000227507.2
ENST00000536559.1 |
CCND1
|
cyclin D1 |
chr17_-_46178527 | 51.94 |
ENST00000393408.3
|
CBX1
|
chromobox homolog 1 |
chr8_-_101965559 | 51.84 |
ENST00000353245.3
|
YWHAZ
|
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, zeta |
chrX_+_77359671 | 51.68 |
ENST00000373316.4
|
PGK1
|
phosphoglycerate kinase 1 |
chr3_+_23847394 | 51.39 |
ENST00000306627.3
|
UBE2E1
|
ubiquitin-conjugating enzyme E2E 1 |
chr19_+_47634039 | 51.37 |
ENST00000597808.1
ENST00000413379.3 ENST00000600706.1 ENST00000540850.1 ENST00000598840.1 ENST00000600753.1 ENST00000270225.7 ENST00000392776.3 |
SAE1
|
SUMO1 activating enzyme subunit 1 |
chr14_+_53173910 | 51.33 |
ENST00000606149.1
ENST00000555339.1 ENST00000556813.1 |
PSMC6
|
proteasome (prosome, macropain) 26S subunit, ATPase, 6 |
chr1_-_24126892 | 51.13 |
ENST00000374497.3
ENST00000425913.1 |
GALE
|
UDP-galactose-4-epimerase |
chr5_+_68462837 | 51.05 |
ENST00000256442.5
|
CCNB1
|
cyclin B1 |
chr17_+_66508154 | 51.02 |
ENST00000358598.2
|
PRKAR1A
|
protein kinase, cAMP-dependent, regulatory, type I, alpha |
chr1_-_75198681 | 50.97 |
ENST00000370872.3
ENST00000370871.3 ENST00000340866.5 ENST00000370870.1 |
CRYZ
|
crystallin, zeta (quinone reductase) |
chrX_-_153285251 | 50.96 |
ENST00000444230.1
ENST00000393682.1 ENST00000393687.2 ENST00000429936.2 ENST00000369974.2 |
IRAK1
|
interleukin-1 receptor-associated kinase 1 |
chr1_-_43638168 | 50.86 |
ENST00000431635.2
|
EBNA1BP2
|
EBNA1 binding protein 2 |
chr11_+_35160709 | 50.77 |
ENST00000415148.2
ENST00000433354.2 ENST00000449691.2 ENST00000437706.2 ENST00000360158.4 ENST00000428726.2 ENST00000526669.2 ENST00000433892.2 ENST00000278386.6 ENST00000434472.2 ENST00000352818.4 ENST00000442151.2 |
CD44
|
CD44 molecule (Indian blood group) |
chr3_+_105086056 | 50.65 |
ENST00000472644.2
|
ALCAM
|
activated leukocyte cell adhesion molecule |
chr11_-_65667884 | 50.48 |
ENST00000448083.2
ENST00000531493.1 ENST00000532401.1 |
FOSL1
|
FOS-like antigen 1 |
chrX_-_149106653 | 50.43 |
ENST00000462691.1
ENST00000370404.1 ENST00000483447.1 ENST00000370409.3 |
CXorf40B
|
chromosome X open reading frame 40B |
chr9_+_131451480 | 50.33 |
ENST00000322030.8
|
SET
|
SET nuclear oncogene |
chr14_-_69446034 | 50.33 |
ENST00000193403.6
|
ACTN1
|
actinin, alpha 1 |
chr7_-_99698338 | 50.23 |
ENST00000354230.3
ENST00000425308.1 |
MCM7
|
minichromosome maintenance complex component 7 |
chr1_+_165864821 | 50.07 |
ENST00000470820.1
|
UCK2
|
uridine-cytidine kinase 2 |
chr11_+_844067 | 50.01 |
ENST00000397406.1
ENST00000409543.2 ENST00000525201.1 |
TSPAN4
|
tetraspanin 4 |
chr14_+_24605389 | 49.72 |
ENST00000382708.3
ENST00000561435.1 |
PSME1
|
proteasome (prosome, macropain) activator subunit 1 (PA28 alpha) |
chr11_+_65686952 | 49.54 |
ENST00000527119.1
|
DRAP1
|
DR1-associated protein 1 (negative cofactor 2 alpha) |
chr7_-_121036337 | 49.51 |
ENST00000426156.1
ENST00000359943.3 ENST00000412653.1 |
FAM3C
|
family with sequence similarity 3, member C |
chr12_-_109125285 | 49.38 |
ENST00000552871.1
ENST00000261401.3 |
CORO1C
|
coronin, actin binding protein, 1C |
chr12_+_104609550 | 49.34 |
ENST00000525566.1
ENST00000429002.2 |
TXNRD1
|
thioredoxin reductase 1 |
chr1_-_153538292 | 49.30 |
ENST00000497140.1
ENST00000368708.3 |
S100A2
|
S100 calcium binding protein A2 |
chr11_-_47447767 | 49.22 |
ENST00000530651.1
ENST00000524447.2 ENST00000531051.2 ENST00000526993.1 ENST00000602866.1 |
PSMC3
|
proteasome (prosome, macropain) 26S subunit, ATPase, 3 |
chr1_-_156722015 | 49.06 |
ENST00000368209.5
|
HDGF
|
hepatoma-derived growth factor |
chr18_+_3449821 | 48.97 |
ENST00000407501.2
ENST00000405385.3 ENST00000546979.1 |
TGIF1
|
TGFB-induced factor homeobox 1 |
chr17_-_8113542 | 48.93 |
ENST00000578549.1
ENST00000535053.1 ENST00000582368.1 |
AURKB
|
aurora kinase B |
chr2_+_181845074 | 48.69 |
ENST00000602959.1
ENST00000602479.1 ENST00000392415.2 ENST00000602291.1 |
UBE2E3
|
ubiquitin-conjugating enzyme E2E 3 |
chr14_+_53173890 | 48.64 |
ENST00000445930.2
|
PSMC6
|
proteasome (prosome, macropain) 26S subunit, ATPase, 6 |
chr1_+_41445413 | 48.52 |
ENST00000541520.1
|
CTPS1
|
CTP synthase 1 |
chr3_+_184079492 | 48.45 |
ENST00000456318.1
ENST00000412877.1 ENST00000438240.1 |
POLR2H
|
polymerase (RNA) II (DNA directed) polypeptide H |
chr12_+_52626898 | 48.44 |
ENST00000331817.5
|
KRT7
|
keratin 7 |
chr22_-_24322019 | 48.39 |
ENST00000350608.3
|
DDT
|
D-dopachrome tautomerase |
chrX_+_118708517 | 48.37 |
ENST00000346330.3
|
UBE2A
|
ubiquitin-conjugating enzyme E2A |
chr14_-_45603657 | 48.33 |
ENST00000396062.3
|
FKBP3
|
FK506 binding protein 3, 25kDa |
chrX_+_118708493 | 48.26 |
ENST00000371558.2
|
UBE2A
|
ubiquitin-conjugating enzyme E2A |
chr3_+_105085734 | 48.15 |
ENST00000306107.5
|
ALCAM
|
activated leukocyte cell adhesion molecule |
chr21_-_46238034 | 48.11 |
ENST00000332859.6
|
SUMO3
|
small ubiquitin-like modifier 3 |
chr17_-_8113886 | 48.06 |
ENST00000577833.1
ENST00000534871.1 ENST00000583915.1 ENST00000316199.6 ENST00000581511.1 ENST00000585124.1 |
AURKB
|
aurora kinase B |
chr17_+_66508537 | 47.97 |
ENST00000392711.1
ENST00000585427.1 ENST00000589228.1 ENST00000536854.2 ENST00000588702.1 ENST00000589309.1 |
PRKAR1A
|
protein kinase, cAMP-dependent, regulatory, type I, alpha |
chrX_-_153599578 | 47.90 |
ENST00000360319.4
ENST00000344736.4 |
FLNA
|
filamin A, alpha |
chr1_+_203830703 | 47.65 |
ENST00000414487.2
|
SNRPE
|
small nuclear ribonucleoprotein polypeptide E |
chr2_+_200820269 | 47.59 |
ENST00000392290.1
|
C2orf47
|
chromosome 2 open reading frame 47 |
chr2_+_181845298 | 47.56 |
ENST00000410062.4
|
UBE2E3
|
ubiquitin-conjugating enzyme E2E 3 |
chr9_+_131447342 | 47.49 |
ENST00000409104.3
|
SET
|
SET nuclear oncogene |
chr17_-_20946338 | 47.41 |
ENST00000261497.4
|
USP22
|
ubiquitin specific peptidase 22 |
chr7_+_26241325 | 47.41 |
ENST00000456948.1
ENST00000409747.1 |
CBX3
|
chromobox homolog 3 |
chr11_+_70049269 | 47.40 |
ENST00000301838.4
|
FADD
|
Fas (TNFRSF6)-associated via death domain |
chr4_-_100871506 | 47.37 |
ENST00000296417.5
|
H2AFZ
|
H2A histone family, member Z |
chr1_+_111992064 | 47.26 |
ENST00000483994.1
|
ATP5F1
|
ATP synthase, H+ transporting, mitochondrial Fo complex, subunit B1 |
chrX_+_77359726 | 47.26 |
ENST00000442431.1
|
PGK1
|
phosphoglycerate kinase 1 |
chr9_+_138392483 | 47.07 |
ENST00000241600.5
|
MRPS2
|
mitochondrial ribosomal protein S2 |
chr17_-_40169161 | 47.04 |
ENST00000589586.2
ENST00000426588.3 ENST00000589576.1 |
DNAJC7
|
DnaJ (Hsp40) homolog, subfamily C, member 7 |
chr10_+_17686124 | 47.02 |
ENST00000377524.3
|
STAM
|
signal transducing adaptor molecule (SH3 domain and ITAM motif) 1 |
chr5_-_133340682 | 46.99 |
ENST00000265333.3
|
VDAC1
|
voltage-dependent anion channel 1 |
chr8_-_102217515 | 46.94 |
ENST00000520347.1
ENST00000523922.1 ENST00000520984.1 |
ZNF706
|
zinc finger protein 706 |
chr1_+_10459111 | 46.91 |
ENST00000541529.1
ENST00000270776.8 ENST00000483936.1 ENST00000538557.1 |
PGD
|
phosphogluconate dehydrogenase |
chr16_+_56691606 | 46.78 |
ENST00000334350.6
|
MT1F
|
metallothionein 1F |
chr17_-_4269768 | 46.67 |
ENST00000396981.2
|
UBE2G1
|
ubiquitin-conjugating enzyme E2G 1 |
chr12_-_56123444 | 46.54 |
ENST00000546457.1
ENST00000549117.1 |
CD63
|
CD63 molecule |
chr22_+_43547937 | 46.40 |
ENST00000329563.4
|
TSPO
|
translocator protein (18kDa) |
chr2_+_120124497 | 46.39 |
ENST00000355857.3
ENST00000535617.1 ENST00000535757.1 ENST00000409094.1 ENST00000311521.4 |
DBI
|
diazepam binding inhibitor (GABA receptor modulator, acyl-CoA binding protein) |
chr17_+_4699439 | 46.26 |
ENST00000270586.3
|
PSMB6
|
proteasome (prosome, macropain) subunit, beta type, 6 |
chr6_-_18265050 | 46.26 |
ENST00000397239.3
|
DEK
|
DEK oncogene |
chr1_-_43637915 | 46.16 |
ENST00000236051.2
|
EBNA1BP2
|
EBNA1 binding protein 2 |
chrX_-_53461288 | 46.04 |
ENST00000375298.4
ENST00000375304.5 |
HSD17B10
|
hydroxysteroid (17-beta) dehydrogenase 10 |
chr7_+_56019486 | 46.02 |
ENST00000446692.1
ENST00000285298.4 ENST00000443449.1 |
GBAS
MRPS17
|
glioblastoma amplified sequence mitochondrial ribosomal protein S17 |
chr2_-_152684977 | 45.93 |
ENST00000428992.2
ENST00000295087.8 |
ARL5A
|
ADP-ribosylation factor-like 5A |
chr1_+_165797024 | 45.89 |
ENST00000372212.4
|
UCK2
|
uridine-cytidine kinase 2 |
chr8_+_61429728 | 45.89 |
ENST00000529579.1
|
RAB2A
|
RAB2A, member RAS oncogene family |
chrX_-_151999269 | 45.87 |
ENST00000370277.3
|
CETN2
|
centrin, EF-hand protein, 2 |
chr21_-_46237959 | 45.74 |
ENST00000397898.3
ENST00000411651.2 |
SUMO3
|
small ubiquitin-like modifier 3 |
chr1_-_153599732 | 45.73 |
ENST00000392623.1
|
S100A13
|
S100 calcium binding protein A13 |
chr17_-_4852243 | 45.72 |
ENST00000225655.5
|
PFN1
|
profilin 1 |
chr11_+_105948216 | 45.72 |
ENST00000278618.4
|
AASDHPPT
|
aminoadipate-semialdehyde dehydrogenase-phosphopantetheinyl transferase |
chr4_+_57301896 | 45.61 |
ENST00000514888.1
ENST00000264221.2 ENST00000505164.1 |
PAICS
|
phosphoribosylaminoimidazole carboxylase, phosphoribosylaminoimidazole succinocarboxamide synthetase |
chr14_+_58711539 | 45.57 |
ENST00000216455.4
ENST00000412908.2 ENST00000557508.1 |
PSMA3
|
proteasome (prosome, macropain) subunit, alpha type, 3 |
chr7_+_32996997 | 45.49 |
ENST00000242209.4
ENST00000538336.1 ENST00000538443.1 |
FKBP9
|
FK506 binding protein 9, 63 kDa |
chr4_-_103789996 | 45.46 |
ENST00000508238.1
|
UBE2D3
|
ubiquitin-conjugating enzyme E2D 3 |
chr18_+_29077990 | 45.45 |
ENST00000261590.8
|
DSG2
|
desmoglein 2 |
chr17_-_73149921 | 45.30 |
ENST00000481647.1
ENST00000470924.1 |
HN1
|
hematological and neurological expressed 1 |
chr7_-_1980128 | 45.26 |
ENST00000437877.1
|
MAD1L1
|
MAD1 mitotic arrest deficient-like 1 (yeast) |
chrX_+_48433326 | 45.22 |
ENST00000376755.1
|
RBM3
|
RNA binding motif (RNP1, RRM) protein 3 |
chr10_-_17659234 | 45.20 |
ENST00000466335.1
|
PTPLA
|
protein tyrosine phosphatase-like (proline instead of catalytic arginine), member A |
chr9_+_36572851 | 45.16 |
ENST00000298048.2
ENST00000538311.1 ENST00000536987.1 ENST00000545008.1 ENST00000536860.1 ENST00000536329.1 ENST00000541717.1 ENST00000543751.1 |
MELK
|
maternal embryonic leucine zipper kinase |
chr14_+_54863667 | 44.94 |
ENST00000335183.6
|
CDKN3
|
cyclin-dependent kinase inhibitor 3 |
chr22_+_24951436 | 44.93 |
ENST00000215829.3
|
SNRPD3
|
small nuclear ribonucleoprotein D3 polypeptide 18kDa |
chr2_+_102608306 | 44.92 |
ENST00000332549.3
|
IL1R2
|
interleukin 1 receptor, type II |
chr2_+_216176761 | 44.91 |
ENST00000540518.1
ENST00000435675.1 |
ATIC
|
5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/IMP cyclohydrolase |
chr14_+_105219437 | 44.90 |
ENST00000329967.6
ENST00000347067.5 ENST00000553810.1 |
SIVA1
|
SIVA1, apoptosis-inducing factor |
chr18_+_3449695 | 44.88 |
ENST00000343820.5
|
TGIF1
|
TGFB-induced factor homeobox 1 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
70.0 | 209.9 | GO:0046586 | regulation of calcium-dependent cell-cell adhesion(GO:0046586) |
46.2 | 184.8 | GO:0009212 | dTTP biosynthetic process(GO:0006235) pyrimidine deoxyribonucleoside triphosphate biosynthetic process(GO:0009212) |
45.1 | 135.4 | GO:0051086 | chaperone mediated protein folding independent of cofactor(GO:0051086) |
45.0 | 134.9 | GO:1903609 | negative regulation of peptidyl-tyrosine autophosphorylation(GO:1900085) negative regulation of inward rectifier potassium channel activity(GO:1903609) |
42.9 | 171.4 | GO:0019322 | pentose biosynthetic process(GO:0019322) |
42.6 | 42.6 | GO:0018171 | peptidyl-cysteine oxidation(GO:0018171) |
38.9 | 194.4 | GO:0055014 | atrial cardiac muscle cell differentiation(GO:0055011) atrial cardiac muscle cell development(GO:0055014) |
38.8 | 116.5 | GO:0070901 | mitochondrial tRNA methylation(GO:0070901) |
38.3 | 153.2 | GO:1902626 | assembly of large subunit precursor of preribosome(GO:1902626) |
38.0 | 151.8 | GO:0006238 | CMP salvage(GO:0006238) CMP biosynthetic process(GO:0009224) CMP metabolic process(GO:0046035) |
37.2 | 37.2 | GO:0046102 | inosine metabolic process(GO:0046102) |
36.8 | 110.4 | GO:0031660 | regulation of cyclin-dependent protein serine/threonine kinase activity involved in G2/M transition of mitotic cell cycle(GO:0031660) positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G2/M transition of mitotic cell cycle(GO:0031662) response to DDT(GO:0046680) histone H3-S10 phosphorylation involved in chromosome condensation(GO:2000775) |
35.2 | 105.7 | GO:0044208 | 'de novo' AMP biosynthetic process(GO:0044208) |
34.6 | 103.9 | GO:0044878 | mitotic cytokinesis checkpoint(GO:0044878) |
33.7 | 134.8 | GO:0046452 | dihydrofolate metabolic process(GO:0046452) |
32.3 | 32.3 | GO:0015883 | FAD transport(GO:0015883) FAD transmembrane transport(GO:0035350) |
32.2 | 96.5 | GO:1902445 | regulation of mitochondrial membrane permeability involved in programmed necrotic cell death(GO:1902445) |
31.8 | 127.4 | GO:0090202 | transcriptional activation by promoter-enhancer looping(GO:0071733) gene looping(GO:0090202) dsDNA loop formation(GO:0090579) |
30.8 | 61.6 | GO:0046166 | glyceraldehyde-3-phosphate biosynthetic process(GO:0046166) |
30.6 | 91.9 | GO:0016344 | meiotic chromosome movement towards spindle pole(GO:0016344) |
30.6 | 122.5 | GO:0044837 | assembly of actomyosin apparatus involved in cytokinesis(GO:0000912) actomyosin contractile ring assembly(GO:0000915) actomyosin contractile ring organization(GO:0044837) |
29.7 | 118.9 | GO:0070982 | L-asparagine biosynthetic process(GO:0070981) L-asparagine metabolic process(GO:0070982) |
29.3 | 146.7 | GO:0006167 | AMP biosynthetic process(GO:0006167) |
29.1 | 87.3 | GO:0033140 | negative regulation of peptidyl-serine phosphorylation of STAT protein(GO:0033140) |
28.6 | 28.6 | GO:1900060 | negative regulation of sphingolipid biosynthetic process(GO:0090155) negative regulation of ceramide biosynthetic process(GO:1900060) |
27.2 | 81.6 | GO:0019242 | methylglyoxal biosynthetic process(GO:0019242) |
27.1 | 81.2 | GO:0006097 | glyoxylate cycle(GO:0006097) |
26.8 | 53.5 | GO:0051754 | meiotic sister chromatid cohesion, centromeric(GO:0051754) |
26.7 | 267.3 | GO:1904871 | regulation of protein localization to Cajal body(GO:1904869) positive regulation of protein localization to Cajal body(GO:1904871) |
26.6 | 79.9 | GO:0090149 | mitochondrial membrane fission(GO:0090149) |
26.6 | 53.2 | GO:0097212 | lysosomal membrane organization(GO:0097212) |
26.6 | 265.7 | GO:0046826 | negative regulation of protein export from nucleus(GO:0046826) |
25.9 | 103.6 | GO:0018364 | peptidyl-glutamine methylation(GO:0018364) |
25.8 | 77.4 | GO:0006420 | arginyl-tRNA aminoacylation(GO:0006420) |
25.7 | 77.1 | GO:0044314 | protein K27-linked ubiquitination(GO:0044314) |
25.7 | 128.5 | GO:1900264 | regulation of DNA-directed DNA polymerase activity(GO:1900262) positive regulation of DNA-directed DNA polymerase activity(GO:1900264) |
25.6 | 153.6 | GO:1903551 | regulation of extracellular exosome assembly(GO:1903551) |
25.6 | 639.7 | GO:0070979 | protein K11-linked ubiquitination(GO:0070979) |
25.4 | 76.1 | GO:0001732 | formation of cytoplasmic translation initiation complex(GO:0001732) |
25.3 | 151.8 | GO:0042866 | pyruvate biosynthetic process(GO:0042866) |
25.3 | 202.4 | GO:0006659 | phosphatidylserine biosynthetic process(GO:0006659) |
25.0 | 99.8 | GO:0019264 | glycine biosynthetic process(GO:0006545) glycine biosynthetic process from serine(GO:0019264) |
24.9 | 74.8 | GO:0006106 | fumarate metabolic process(GO:0006106) |
24.7 | 98.9 | GO:0033387 | putrescine biosynthetic process from ornithine(GO:0033387) |
24.6 | 123.2 | GO:0061198 | fungiform papilla formation(GO:0061198) |
24.6 | 98.5 | GO:1900535 | medium-chain fatty-acyl-CoA catabolic process(GO:0036114) long-chain fatty-acyl-CoA catabolic process(GO:0036116) palmitic acid metabolic process(GO:1900533) palmitic acid biosynthetic process(GO:1900535) |
24.6 | 147.7 | GO:0006616 | SRP-dependent cotranslational protein targeting to membrane, translocation(GO:0006616) |
24.6 | 147.7 | GO:0015853 | adenine transport(GO:0015853) |
23.8 | 71.3 | GO:1902463 | protein localization to cell leading edge(GO:1902463) |
23.7 | 94.9 | GO:0044571 | [2Fe-2S] cluster assembly(GO:0044571) |
23.7 | 118.4 | GO:0070682 | proteasome regulatory particle assembly(GO:0070682) |
23.7 | 71.0 | GO:0044501 | modulation of signal transduction in other organism(GO:0044501) modulation by symbiont of host signal transduction pathway(GO:0052027) modulation of signal transduction in other organism involved in symbiotic interaction(GO:0052250) modulation by symbiont of host I-kappaB kinase/NF-kappaB cascade(GO:0085032) |
23.6 | 236.1 | GO:1900029 | positive regulation of ruffle assembly(GO:1900029) |
23.5 | 23.5 | GO:0002183 | cytoplasmic translational initiation(GO:0002183) |
23.4 | 304.6 | GO:2000680 | rubidium ion transport(GO:0035826) regulation of rubidium ion transport(GO:2000680) |
23.2 | 46.3 | GO:0030174 | regulation of DNA-dependent DNA replication initiation(GO:0030174) |
22.8 | 45.6 | GO:0046075 | dTTP metabolic process(GO:0046075) |
22.7 | 22.7 | GO:0048254 | snoRNA localization(GO:0048254) |
22.6 | 113.1 | GO:0006294 | nucleotide-excision repair, preincision complex assembly(GO:0006294) |
22.6 | 135.5 | GO:0051305 | mitotic chromosome movement towards spindle pole(GO:0007079) chromosome movement towards spindle pole(GO:0051305) |
22.4 | 67.3 | GO:0042256 | mature ribosome assembly(GO:0042256) |
22.4 | 44.7 | GO:0002188 | translation reinitiation(GO:0002188) |
22.3 | 22.3 | GO:0048280 | vesicle fusion with Golgi apparatus(GO:0048280) |
22.0 | 88.0 | GO:0019065 | receptor-mediated endocytosis of virus by host cell(GO:0019065) endocytosis involved in viral entry into host cell(GO:0075509) |
21.8 | 87.1 | GO:1903778 | protein localization to vacuolar membrane(GO:1903778) |
21.8 | 87.1 | GO:0032218 | riboflavin transport(GO:0032218) |
21.5 | 64.6 | GO:0000379 | tRNA-type intron splice site recognition and cleavage(GO:0000379) |
21.5 | 21.5 | GO:0006041 | glucosamine metabolic process(GO:0006041) |
21.5 | 21.5 | GO:0030224 | monocyte differentiation(GO:0030224) |
21.4 | 64.2 | GO:1990022 | RNA polymerase II complex import to nucleus(GO:0044376) RNA polymerase III complex localization to nucleus(GO:1990022) |
21.4 | 85.6 | GO:0043335 | protein unfolding(GO:0043335) |
21.4 | 64.1 | GO:1901873 | regulation of post-translational protein modification(GO:1901873) |
21.3 | 212.7 | GO:0051096 | positive regulation of helicase activity(GO:0051096) |
20.9 | 208.6 | GO:0000492 | box C/D snoRNP assembly(GO:0000492) |
20.8 | 1542.6 | GO:0070125 | mitochondrial translational elongation(GO:0070125) |
20.8 | 62.5 | GO:0046294 | formaldehyde catabolic process(GO:0046294) |
20.8 | 104.2 | GO:0031120 | snRNA pseudouridine synthesis(GO:0031120) |
20.8 | 208.0 | GO:0030951 | establishment or maintenance of microtubule cytoskeleton polarity(GO:0030951) |
20.8 | 62.3 | GO:0006435 | threonyl-tRNA aminoacylation(GO:0006435) |
20.7 | 165.5 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
20.5 | 163.9 | GO:1900625 | regulation of monocyte aggregation(GO:1900623) positive regulation of monocyte aggregation(GO:1900625) |
20.2 | 141.4 | GO:0010756 | positive regulation of plasminogen activation(GO:0010756) |
20.1 | 80.4 | GO:0036228 | protein targeting to nuclear inner membrane(GO:0036228) |
19.9 | 39.8 | GO:0046086 | adenosine biosynthetic process(GO:0046086) |
19.9 | 298.5 | GO:0090168 | Golgi reassembly(GO:0090168) |
19.9 | 278.0 | GO:0007084 | mitotic nuclear envelope reassembly(GO:0007084) |
19.8 | 119.1 | GO:1902766 | skeletal muscle satellite cell migration(GO:1902766) |
19.8 | 59.5 | GO:1903722 | regulation of centriole elongation(GO:1903722) |
19.8 | 59.4 | GO:0006059 | hexitol metabolic process(GO:0006059) |
19.7 | 138.1 | GO:0010940 | positive regulation of necrotic cell death(GO:0010940) |
19.7 | 59.0 | GO:0043137 | DNA replication, removal of RNA primer(GO:0043137) |
19.6 | 117.7 | GO:0009113 | purine nucleobase biosynthetic process(GO:0009113) |
19.6 | 98.0 | GO:0033490 | cholesterol biosynthetic process via desmosterol(GO:0033489) cholesterol biosynthetic process via lathosterol(GO:0033490) |
19.6 | 78.3 | GO:0032072 | plasmacytoid dendritic cell activation(GO:0002270) T cell mediated immune response to tumor cell(GO:0002424) regulation of T cell mediated immune response to tumor cell(GO:0002840) regulation of restriction endodeoxyribonuclease activity(GO:0032072) negative regulation of apoptotic cell clearance(GO:2000426) |
19.5 | 78.0 | GO:1903288 | positive regulation of potassium ion import(GO:1903288) |
19.5 | 19.5 | GO:0031441 | negative regulation of mRNA 3'-end processing(GO:0031441) |
19.5 | 77.9 | GO:1902527 | positive regulation of protein monoubiquitination(GO:1902527) |
19.5 | 19.5 | GO:0072048 | pattern specification involved in kidney development(GO:0061004) renal system pattern specification(GO:0072048) |
19.3 | 115.8 | GO:0006189 | 'de novo' IMP biosynthetic process(GO:0006189) |
19.2 | 96.1 | GO:0015862 | uridine transport(GO:0015862) |
19.1 | 76.4 | GO:0000960 | mitochondrial RNA catabolic process(GO:0000957) regulation of mitochondrial RNA catabolic process(GO:0000960) |
19.1 | 57.3 | GO:1902499 | positive regulation of protein autoubiquitination(GO:1902499) |
19.1 | 171.5 | GO:0061732 | mitochondrial acetyl-CoA biosynthetic process from pyruvate(GO:0061732) |
19.0 | 57.0 | GO:0072334 | UDP-galactose transport(GO:0015785) UDP-galactose transmembrane transport(GO:0072334) |
19.0 | 57.0 | GO:0046080 | pyrimidine nucleoside triphosphate catabolic process(GO:0009149) pyrimidine deoxyribonucleoside triphosphate catabolic process(GO:0009213) dUTP metabolic process(GO:0046080) dUTP catabolic process(GO:0046081) |
18.8 | 56.5 | GO:0030327 | prenylated protein catabolic process(GO:0030327) |
18.8 | 75.1 | GO:0033484 | nitric oxide homeostasis(GO:0033484) |
18.7 | 56.1 | GO:1904815 | negative regulation of protein localization to chromosome, telomeric region(GO:1904815) |
18.6 | 74.5 | GO:0006620 | posttranslational protein targeting to membrane(GO:0006620) |
18.6 | 260.3 | GO:0009263 | deoxyribonucleotide biosynthetic process(GO:0009263) |
18.6 | 185.8 | GO:0006268 | DNA unwinding involved in DNA replication(GO:0006268) |
18.6 | 18.6 | GO:0072019 | proximal convoluted tubule development(GO:0072019) metanephric proximal convoluted tubule development(GO:0072229) |
18.5 | 74.1 | GO:0001971 | negative regulation of activation of membrane attack complex(GO:0001971) |
18.5 | 55.4 | GO:0042350 | GDP-L-fucose biosynthetic process(GO:0042350) 'de novo' GDP-L-fucose biosynthetic process(GO:0042351) |
18.4 | 36.9 | GO:2000374 | regulation of oxygen metabolic process(GO:2000374) |
18.4 | 55.1 | GO:0007057 | spindle assembly involved in female meiosis I(GO:0007057) |
18.3 | 55.0 | GO:0006597 | spermine biosynthetic process(GO:0006597) |
18.2 | 54.6 | GO:0006428 | isoleucyl-tRNA aminoacylation(GO:0006428) |
18.0 | 108.2 | GO:0035407 | histone H3-T11 phosphorylation(GO:0035407) |
17.8 | 71.1 | GO:0048205 | COPI-coated vesicle budding(GO:0035964) Golgi transport vesicle coating(GO:0048200) COPI coating of Golgi vesicle(GO:0048205) |
17.7 | 106.4 | GO:2000254 | regulation of male germ cell proliferation(GO:2000254) |
17.6 | 17.6 | GO:0009051 | pentose-phosphate shunt, oxidative branch(GO:0009051) |
17.5 | 70.2 | GO:0021564 | vagus nerve development(GO:0021564) |
17.4 | 52.1 | GO:0032911 | negative regulation of transforming growth factor beta1 production(GO:0032911) |
17.3 | 86.6 | GO:0030047 | actin modification(GO:0030047) |
17.3 | 138.5 | GO:0045040 | protein import into mitochondrial outer membrane(GO:0045040) |
17.3 | 17.3 | GO:0045645 | regulation of eosinophil differentiation(GO:0045643) positive regulation of eosinophil differentiation(GO:0045645) |
17.3 | 1764.5 | GO:0051436 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle(GO:0051436) |
17.3 | 207.4 | GO:0000920 | cell separation after cytokinesis(GO:0000920) |
17.3 | 34.5 | GO:0048478 | replication fork protection(GO:0048478) |
17.2 | 189.7 | GO:0043248 | proteasome assembly(GO:0043248) |
17.2 | 171.7 | GO:0033631 | cell-cell adhesion mediated by integrin(GO:0033631) |
17.2 | 85.8 | GO:0016321 | female meiosis chromosome segregation(GO:0016321) |
17.1 | 188.0 | GO:0050703 | interleukin-1 alpha secretion(GO:0050703) |
17.0 | 34.0 | GO:0010994 | regulation of ubiquitin homeostasis(GO:0010993) free ubiquitin chain polymerization(GO:0010994) |
17.0 | 135.9 | GO:0010032 | meiotic chromosome condensation(GO:0010032) |
17.0 | 33.9 | GO:0032071 | regulation of endodeoxyribonuclease activity(GO:0032071) |
16.8 | 101.1 | GO:0007296 | vitellogenesis(GO:0007296) |
16.8 | 16.8 | GO:1904046 | negative regulation of vascular endothelial growth factor production(GO:1904046) |
16.8 | 134.4 | GO:0072734 | response to staurosporine(GO:0072733) cellular response to staurosporine(GO:0072734) |
16.7 | 116.8 | GO:0032077 | positive regulation of deoxyribonuclease activity(GO:0032077) |
16.7 | 166.8 | GO:0071578 | zinc II ion transmembrane import(GO:0071578) |
16.6 | 99.8 | GO:0043353 | enucleate erythrocyte differentiation(GO:0043353) |
16.6 | 99.7 | GO:0006561 | proline biosynthetic process(GO:0006561) L-proline biosynthetic process(GO:0055129) |
16.6 | 66.4 | GO:0015965 | diadenosine polyphosphate biosynthetic process(GO:0015960) diadenosine tetraphosphate metabolic process(GO:0015965) diadenosine tetraphosphate biosynthetic process(GO:0015966) |
16.6 | 99.5 | GO:0071163 | DNA replication preinitiation complex assembly(GO:0071163) |
16.6 | 16.6 | GO:0031291 | Ran protein signal transduction(GO:0031291) |
16.5 | 82.7 | GO:0032487 | regulation of Rap protein signal transduction(GO:0032487) |
16.5 | 214.9 | GO:0030422 | production of siRNA involved in RNA interference(GO:0030422) |
16.5 | 33.1 | GO:1903377 | negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903377) |
16.4 | 196.9 | GO:0019388 | galactose catabolic process(GO:0019388) |
16.3 | 65.4 | GO:0046833 | positive regulation of RNA export from nucleus(GO:0046833) |
16.2 | 16.2 | GO:0043456 | regulation of pentose-phosphate shunt(GO:0043456) |
16.2 | 64.8 | GO:0051490 | negative regulation of filopodium assembly(GO:0051490) |
16.2 | 80.8 | GO:0000973 | posttranscriptional tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000973) |
16.1 | 64.6 | GO:0015866 | ADP transport(GO:0015866) |
16.1 | 177.1 | GO:0006621 | protein retention in ER lumen(GO:0006621) |
16.0 | 336.7 | GO:0006851 | mitochondrial calcium ion transport(GO:0006851) |
16.0 | 96.0 | GO:0030421 | defecation(GO:0030421) |
16.0 | 224.0 | GO:0006122 | mitochondrial electron transport, ubiquinol to cytochrome c(GO:0006122) |
15.9 | 79.6 | GO:1902896 | terminal web assembly(GO:1902896) |
15.9 | 63.5 | GO:0036496 | regulation of translational initiation by eIF2 alpha dephosphorylation(GO:0036496) |
15.9 | 31.7 | GO:1902570 | protein localization to nucleolus(GO:1902570) |
15.8 | 63.4 | GO:0010796 | regulation of multivesicular body size(GO:0010796) |
15.8 | 47.4 | GO:0006427 | histidyl-tRNA aminoacylation(GO:0006427) |
15.8 | 31.6 | GO:0032804 | negative regulation of low-density lipoprotein particle receptor catabolic process(GO:0032804) |
15.8 | 63.1 | GO:0031081 | nuclear pore distribution(GO:0031081) nuclear pore localization(GO:0051664) |
15.8 | 15.8 | GO:1903895 | negative regulation of IRE1-mediated unfolded protein response(GO:1903895) |
15.8 | 220.7 | GO:0006107 | oxaloacetate metabolic process(GO:0006107) |
15.7 | 47.1 | GO:0051066 | dihydrobiopterin metabolic process(GO:0051066) |
15.7 | 94.2 | GO:0006065 | UDP-glucuronate biosynthetic process(GO:0006065) |
15.6 | 62.4 | GO:0097010 | eukaryotic translation initiation factor 4F complex assembly(GO:0097010) |
15.6 | 46.7 | GO:1902396 | protein localization to bicellular tight junction(GO:1902396) |
15.5 | 93.1 | GO:0036111 | very long-chain fatty-acyl-CoA metabolic process(GO:0036111) |
15.5 | 46.5 | GO:0044210 | 'de novo' CTP biosynthetic process(GO:0044210) |
15.5 | 15.5 | GO:0033299 | secretion of lysosomal enzymes(GO:0033299) |
15.4 | 231.4 | GO:0000715 | nucleotide-excision repair, DNA damage recognition(GO:0000715) |
15.4 | 46.2 | GO:1905205 | positive regulation of connective tissue replacement(GO:1905205) |
15.3 | 76.6 | GO:1904154 | positive regulation of retrograde protein transport, ER to cytosol(GO:1904154) |
15.3 | 45.8 | GO:0046726 | positive regulation by virus of viral protein levels in host cell(GO:0046726) |
15.1 | 45.2 | GO:0051083 | 'de novo' cotranslational protein folding(GO:0051083) |
15.0 | 15.0 | GO:0045210 | FasL biosynthetic process(GO:0045210) |
15.0 | 59.9 | GO:0006218 | uridine catabolic process(GO:0006218) uridine metabolic process(GO:0046108) |
15.0 | 44.9 | GO:0098968 | neurotransmitter receptor transport postsynaptic membrane to endosome(GO:0098968) |
14.9 | 328.4 | GO:0070911 | global genome nucleotide-excision repair(GO:0070911) |
14.8 | 14.8 | GO:1904814 | regulation of protein localization to chromosome, telomeric region(GO:1904814) |
14.7 | 58.7 | GO:2000435 | regulation of protein neddylation(GO:2000434) negative regulation of protein neddylation(GO:2000435) |
14.7 | 102.7 | GO:1902903 | regulation of fibril organization(GO:1902903) |
14.6 | 72.9 | GO:1905098 | negative regulation of guanyl-nucleotide exchange factor activity(GO:1905098) |
14.5 | 101.8 | GO:0090204 | protein localization to nuclear pore(GO:0090204) |
14.5 | 14.5 | GO:0007008 | outer mitochondrial membrane organization(GO:0007008) |
14.5 | 43.5 | GO:2001245 | regulation of phosphatidylcholine biosynthetic process(GO:2001245) |
14.5 | 43.4 | GO:1902544 | regulation of DNA N-glycosylase activity(GO:1902544) |
14.4 | 158.5 | GO:2000576 | positive regulation of microtubule motor activity(GO:2000576) regulation of ATP-dependent microtubule motor activity, plus-end-directed(GO:2000580) positive regulation of ATP-dependent microtubule motor activity, plus-end-directed(GO:2000582) |
14.3 | 28.7 | GO:1903542 | negative regulation of exosomal secretion(GO:1903542) |
14.3 | 71.6 | GO:0000710 | meiotic mismatch repair(GO:0000710) |
14.3 | 644.5 | GO:0006370 | 7-methylguanosine mRNA capping(GO:0006370) |
14.3 | 128.9 | GO:0071787 | endoplasmic reticulum tubular network assembly(GO:0071787) |
14.3 | 28.6 | GO:1903595 | positive regulation of histamine secretion by mast cell(GO:1903595) |
14.3 | 57.0 | GO:0016479 | negative regulation of transcription from RNA polymerase I promoter(GO:0016479) |
14.2 | 42.7 | GO:0006121 | mitochondrial electron transport, succinate to ubiquinone(GO:0006121) |
14.2 | 56.9 | GO:0071047 | U1 snRNA 3'-end processing(GO:0034473) U5 snRNA 3'-end processing(GO:0034476) nuclear polyadenylation-dependent mRNA catabolic process(GO:0071042) polyadenylation-dependent mRNA catabolic process(GO:0071047) |
14.0 | 69.9 | GO:0032790 | ribosome disassembly(GO:0032790) |
13.9 | 41.7 | GO:0006015 | 5-phosphoribose 1-diphosphate biosynthetic process(GO:0006015) 5-phosphoribose 1-diphosphate metabolic process(GO:0046391) |
13.9 | 41.6 | GO:1904772 | hepatocyte homeostasis(GO:0036333) response to tetrachloromethane(GO:1904772) |
13.8 | 13.8 | GO:2000645 | negative regulation of receptor catabolic process(GO:2000645) |
13.8 | 55.1 | GO:0007144 | female meiosis I(GO:0007144) |
13.7 | 13.7 | GO:0032310 | prostaglandin secretion(GO:0032310) |
13.7 | 13.7 | GO:0048009 | insulin-like growth factor receptor signaling pathway(GO:0048009) |
13.7 | 54.6 | GO:0046121 | deoxyribonucleoside catabolic process(GO:0046121) |
13.6 | 40.9 | GO:1904386 | response to thyroxine(GO:0097068) response to L-phenylalanine derivative(GO:1904386) |
13.5 | 121.9 | GO:0051315 | attachment of mitotic spindle microtubules to kinetochore(GO:0051315) |
13.5 | 54.2 | GO:0050689 | negative regulation of defense response to virus by host(GO:0050689) |
13.5 | 94.7 | GO:0033183 | negative regulation of histone ubiquitination(GO:0033183) negative regulation of protein K63-linked ubiquitination(GO:1900045) regulation of histone H2A K63-linked ubiquitination(GO:1901314) negative regulation of histone H2A K63-linked ubiquitination(GO:1901315) negative regulation of protein polyubiquitination(GO:1902915) |
13.5 | 67.6 | GO:0019348 | dolichol metabolic process(GO:0019348) |
13.5 | 40.5 | GO:0036353 | histone H2A-K119 monoubiquitination(GO:0036353) |
13.4 | 26.9 | GO:2001162 | regulation of histone H3-K79 methylation(GO:2001160) positive regulation of histone H3-K79 methylation(GO:2001162) |
13.4 | 107.4 | GO:0001887 | selenium compound metabolic process(GO:0001887) |
13.4 | 40.2 | GO:1901301 | regulation of cargo loading into COPII-coated vesicle(GO:1901301) |
13.4 | 174.0 | GO:0051639 | actin filament network formation(GO:0051639) |
13.3 | 146.4 | GO:0045835 | negative regulation of meiotic nuclear division(GO:0045835) |
13.3 | 13.3 | GO:0019858 | cytosine metabolic process(GO:0019858) |
13.3 | 26.6 | GO:0048597 | B cell negative selection(GO:0002352) post-embryonic camera-type eye morphogenesis(GO:0048597) |
13.3 | 399.0 | GO:0042776 | mitochondrial ATP synthesis coupled proton transport(GO:0042776) |
13.3 | 79.8 | GO:0007023 | post-chaperonin tubulin folding pathway(GO:0007023) |
13.2 | 39.7 | GO:0000412 | histone peptidyl-prolyl isomerization(GO:0000412) |
13.2 | 118.9 | GO:0002934 | desmosome organization(GO:0002934) |
13.2 | 171.4 | GO:0034975 | protein folding in endoplasmic reticulum(GO:0034975) |
13.2 | 26.4 | GO:0009438 | methylglyoxal metabolic process(GO:0009438) |
13.1 | 52.5 | GO:0099640 | axo-dendritic protein transport(GO:0099640) |
13.1 | 39.3 | GO:0018103 | protein C-linked glycosylation(GO:0018103) peptidyl-tryptophan modification(GO:0018211) protein C-linked glycosylation via tryptophan(GO:0018317) protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan(GO:0018406) |
13.1 | 78.5 | GO:1904044 | response to aldosterone(GO:1904044) |
13.1 | 156.9 | GO:0006089 | lactate metabolic process(GO:0006089) |
13.0 | 65.2 | GO:1904274 | tricellular tight junction assembly(GO:1904274) |
13.0 | 13.0 | GO:0035927 | RNA import into mitochondrion(GO:0035927) |
13.0 | 13.0 | GO:0031547 | brain-derived neurotrophic factor receptor signaling pathway(GO:0031547) |
13.0 | 51.9 | GO:0043985 | histone H4-R3 methylation(GO:0043985) |
12.9 | 64.5 | GO:0035965 | cardiolipin acyl-chain remodeling(GO:0035965) |
12.9 | 51.5 | GO:0071894 | histone H2B conserved C-terminal lysine ubiquitination(GO:0071894) |
12.9 | 38.6 | GO:2000653 | regulation of genetic imprinting(GO:2000653) |
12.8 | 77.0 | GO:0006933 | negative regulation of cell adhesion involved in substrate-bound cell migration(GO:0006933) |
12.8 | 51.2 | GO:0090646 | mitochondrial tRNA processing(GO:0090646) |
12.8 | 38.4 | GO:0006286 | base-excision repair, base-free sugar-phosphate removal(GO:0006286) |
12.8 | 89.5 | GO:0042407 | cristae formation(GO:0042407) |
12.8 | 63.9 | GO:0032511 | late endosome to vacuole transport via multivesicular body sorting pathway(GO:0032511) |
12.8 | 38.3 | GO:0070902 | mitochondrial tRNA pseudouridine synthesis(GO:0070902) |
12.8 | 38.3 | GO:0033341 | regulation of collagen binding(GO:0033341) |
12.7 | 216.0 | GO:0090343 | positive regulation of cell aging(GO:0090343) |
12.6 | 37.8 | GO:1902031 | regulation of NADP metabolic process(GO:1902031) |
12.6 | 37.7 | GO:0031145 | anaphase-promoting complex-dependent catabolic process(GO:0031145) |
12.6 | 829.2 | GO:0006120 | mitochondrial electron transport, NADH to ubiquinone(GO:0006120) |
12.5 | 87.6 | GO:1903679 | regulation of cap-independent translational initiation(GO:1903677) positive regulation of cap-independent translational initiation(GO:1903679) regulation of cytoplasmic translational initiation(GO:1904688) positive regulation of cytoplasmic translational initiation(GO:1904690) |
12.5 | 50.0 | GO:0006391 | transcription initiation from mitochondrial promoter(GO:0006391) |
12.5 | 137.4 | GO:0030043 | actin filament fragmentation(GO:0030043) |
12.5 | 99.9 | GO:0000055 | ribosomal large subunit export from nucleus(GO:0000055) |
12.5 | 74.9 | GO:0030581 | intracellular transport of viral protein in host cell(GO:0019060) symbiont intracellular protein transport in host(GO:0030581) intracellular protein transport in other organism involved in symbiotic interaction(GO:0051708) |
12.4 | 87.1 | GO:0070934 | CRD-mediated mRNA stabilization(GO:0070934) |
12.4 | 12.4 | GO:0051177 | meiotic sister chromatid cohesion(GO:0051177) |
12.4 | 12.4 | GO:0001916 | positive regulation of T cell mediated cytotoxicity(GO:0001916) |
12.4 | 12.4 | GO:0052255 | induction by symbiont of host defense response(GO:0044416) induction of host immune response by virus(GO:0046730) active induction of host immune response by virus(GO:0046732) modulation by symbiont of host defense response(GO:0052031) induction by organism of defense response of other organism involved in symbiotic interaction(GO:0052251) modulation by organism of defense response of other organism involved in symbiotic interaction(GO:0052255) positive regulation by symbiont of host defense response(GO:0052509) positive regulation by organism of defense response of other organism involved in symbiotic interaction(GO:0052510) modulation by organism of immune response of other organism involved in symbiotic interaction(GO:0052552) modulation by symbiont of host immune response(GO:0052553) modulation by virus of host immune response(GO:0075528) |
12.4 | 37.1 | GO:0042727 | flavin-containing compound biosynthetic process(GO:0042727) |
12.4 | 247.4 | GO:0042773 | ATP synthesis coupled electron transport(GO:0042773) mitochondrial ATP synthesis coupled electron transport(GO:0042775) |
12.3 | 295.2 | GO:0071294 | cellular response to zinc ion(GO:0071294) |
12.3 | 49.1 | GO:0061083 | regulation of protein refolding(GO:0061083) negative regulation of protein refolding(GO:0061084) |
12.2 | 36.7 | GO:2000298 | regulation of Rho-dependent protein serine/threonine kinase activity(GO:2000298) |
12.2 | 36.7 | GO:0002184 | cytoplasmic translational termination(GO:0002184) |
12.1 | 48.5 | GO:0018002 | N-terminal peptidyl-serine acetylation(GO:0017198) N-terminal peptidyl-glutamic acid acetylation(GO:0018002) peptidyl-serine acetylation(GO:0030920) |
12.1 | 12.1 | GO:0002176 | male germ cell proliferation(GO:0002176) germ cell proliferation(GO:0036093) |
12.0 | 48.1 | GO:1904667 | negative regulation of ubiquitin protein ligase activity(GO:1904667) |
12.0 | 96.0 | GO:0003065 | positive regulation of heart rate by epinephrine(GO:0003065) |
12.0 | 12.0 | GO:0045903 | positive regulation of translational fidelity(GO:0045903) |
12.0 | 59.9 | GO:0006104 | succinyl-CoA metabolic process(GO:0006104) |
11.9 | 11.9 | GO:0036506 | maintenance of unfolded protein(GO:0036506) maintenance of unfolded protein involved in ERAD pathway(GO:1904378) |
11.9 | 143.0 | GO:1900028 | negative regulation of ruffle assembly(GO:1900028) |
11.9 | 23.7 | GO:2000145 | regulation of cell motility(GO:2000145) |
11.8 | 47.1 | GO:0043126 | regulation of 1-phosphatidylinositol 4-kinase activity(GO:0043126) positive regulation of 1-phosphatidylinositol 4-kinase activity(GO:0043128) |
11.8 | 565.1 | GO:0000387 | spliceosomal snRNP assembly(GO:0000387) |
11.8 | 47.1 | GO:1902460 | regulation of mesenchymal stem cell proliferation(GO:1902460) positive regulation of mesenchymal stem cell proliferation(GO:1902462) |
11.7 | 70.4 | GO:0035709 | memory T cell activation(GO:0035709) regulation of memory T cell activation(GO:2000567) positive regulation of memory T cell activation(GO:2000568) |
11.7 | 46.8 | GO:0046146 | tetrahydrobiopterin biosynthetic process(GO:0006729) tetrahydrobiopterin metabolic process(GO:0046146) |
11.7 | 69.9 | GO:0061441 | renal artery morphogenesis(GO:0061441) |
11.6 | 34.7 | GO:0042450 | arginine biosynthetic process via ornithine(GO:0042450) |
11.5 | 80.8 | GO:0010792 | DNA double-strand break processing involved in repair via single-strand annealing(GO:0010792) |
11.5 | 103.8 | GO:0031444 | slow-twitch skeletal muscle fiber contraction(GO:0031444) |
11.5 | 11.5 | GO:0051097 | negative regulation of helicase activity(GO:0051097) |
11.5 | 310.4 | GO:0061641 | CENP-A containing nucleosome assembly(GO:0034080) CENP-A containing chromatin organization(GO:0061641) |
11.5 | 34.4 | GO:2000234 | positive regulation of ribosome biogenesis(GO:0090070) positive regulation of rRNA processing(GO:2000234) |
11.5 | 57.4 | GO:0042816 | vitamin B6 metabolic process(GO:0042816) |
11.4 | 79.9 | GO:0006880 | intracellular sequestering of iron ion(GO:0006880) sequestering of iron ion(GO:0097577) |
11.4 | 307.7 | GO:0032986 | protein-DNA complex disassembly(GO:0032986) |
11.3 | 45.3 | GO:1904872 | regulation of telomerase RNA localization to Cajal body(GO:1904872) |
11.3 | 45.3 | GO:0000972 | transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000972) |
11.3 | 78.9 | GO:0016199 | axon midline choice point recognition(GO:0016199) |
11.3 | 169.1 | GO:0001682 | tRNA 5'-leader removal(GO:0001682) |
11.2 | 11.2 | GO:2000017 | positive regulation of determination of dorsal identity(GO:2000017) |
11.2 | 44.9 | GO:0044375 | regulation of peroxisome size(GO:0044375) |
11.2 | 44.7 | GO:0035879 | plasma membrane lactate transport(GO:0035879) |
11.2 | 33.5 | GO:0046185 | aldehyde catabolic process(GO:0046185) |
11.2 | 111.7 | GO:0015939 | pantothenate metabolic process(GO:0015939) |
11.2 | 44.6 | GO:0006177 | GMP biosynthetic process(GO:0006177) |
11.1 | 33.4 | GO:0071344 | diphosphate metabolic process(GO:0071344) |
11.1 | 44.4 | GO:2000483 | negative regulation of interleukin-8 secretion(GO:2000483) |
11.1 | 33.3 | GO:0046116 | queuosine biosynthetic process(GO:0008616) queuosine metabolic process(GO:0046116) |
11.1 | 44.3 | GO:0072683 | T cell extravasation(GO:0072683) |
11.1 | 110.6 | GO:0009414 | response to water deprivation(GO:0009414) |
11.0 | 44.1 | GO:0019747 | regulation of isoprenoid metabolic process(GO:0019747) |
11.0 | 66.1 | GO:0031648 | protein destabilization(GO:0031648) |
11.0 | 55.0 | GO:0046940 | nucleoside monophosphate phosphorylation(GO:0046940) |
10.9 | 32.8 | GO:1902415 | regulation of mRNA binding(GO:1902415) |
10.9 | 54.4 | GO:0002084 | protein depalmitoylation(GO:0002084) |
10.9 | 32.6 | GO:1903233 | regulation of calcium ion-dependent exocytosis of neurotransmitter(GO:1903233) |
10.9 | 10.9 | GO:0070487 | monocyte aggregation(GO:0070487) |
10.9 | 119.5 | GO:0019511 | peptidyl-proline hydroxylation(GO:0019511) |
10.8 | 32.5 | GO:1902938 | regulation of intracellular calcium activated chloride channel activity(GO:1902938) |
10.8 | 21.7 | GO:0071442 | positive regulation of histone H3-K14 acetylation(GO:0071442) |
10.8 | 21.7 | GO:0070601 | centromeric sister chromatid cohesion(GO:0070601) |
10.8 | 64.9 | GO:2000825 | positive regulation of androgen receptor activity(GO:2000825) |
10.8 | 43.2 | GO:0070131 | positive regulation of mitochondrial translation(GO:0070131) |
10.8 | 32.4 | GO:0046947 | hydroxylysine metabolic process(GO:0046946) hydroxylysine biosynthetic process(GO:0046947) |
10.8 | 53.9 | GO:0075525 | viral translational termination-reinitiation(GO:0075525) |
10.8 | 43.1 | GO:0010986 | positive regulation of lipoprotein particle clearance(GO:0010986) |
10.7 | 42.8 | GO:0035752 | lysosomal lumen pH elevation(GO:0035752) |
10.7 | 21.4 | GO:1902309 | negative regulation of peptidyl-serine dephosphorylation(GO:1902309) |
10.7 | 10.7 | GO:0097252 | oligodendrocyte apoptotic process(GO:0097252) |
10.6 | 42.6 | GO:0045047 | protein targeting to ER(GO:0045047) |
10.6 | 21.3 | GO:0098502 | DNA dephosphorylation(GO:0098502) |
10.6 | 85.0 | GO:0042262 | DNA protection(GO:0042262) |
10.6 | 21.2 | GO:0018312 | peptidyl-serine ADP-ribosylation(GO:0018312) |
10.6 | 74.0 | GO:0090151 | establishment of protein localization to mitochondrial membrane(GO:0090151) |
10.6 | 31.7 | GO:0006269 | DNA replication, synthesis of RNA primer(GO:0006269) |
10.6 | 116.1 | GO:0048026 | positive regulation of mRNA splicing, via spliceosome(GO:0048026) |
10.5 | 42.2 | GO:1903026 | negative regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903026) |
10.5 | 42.1 | GO:0009439 | cyanate metabolic process(GO:0009439) cyanate catabolic process(GO:0009440) |
10.5 | 105.1 | GO:0018202 | peptidyl-histidine modification(GO:0018202) |
10.5 | 52.5 | GO:0006983 | ER overload response(GO:0006983) |
10.5 | 21.0 | GO:1903371 | regulation of endoplasmic reticulum tubular network organization(GO:1903371) |
10.5 | 10.5 | GO:0036388 | pre-replicative complex assembly involved in nuclear cell cycle DNA replication(GO:0006267) pre-replicative complex assembly(GO:0036388) pre-replicative complex assembly involved in cell cycle DNA replication(GO:1902299) |
10.5 | 31.4 | GO:0071460 | cellular response to cell-matrix adhesion(GO:0071460) |
10.4 | 31.3 | GO:1900186 | negative regulation of clathrin-mediated endocytosis(GO:1900186) |
10.4 | 41.8 | GO:1904715 | negative regulation of chaperone-mediated autophagy(GO:1904715) |
10.4 | 94.0 | GO:0045338 | farnesyl diphosphate metabolic process(GO:0045338) |
10.4 | 10.4 | GO:0032785 | negative regulation of DNA-templated transcription, elongation(GO:0032785) negative regulation of transcription elongation from RNA polymerase II promoter(GO:0034244) |
10.4 | 114.2 | GO:0030150 | protein import into mitochondrial matrix(GO:0030150) |
10.4 | 10.4 | GO:0010730 | negative regulation of hydrogen peroxide biosynthetic process(GO:0010730) |
10.3 | 299.0 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
10.3 | 61.8 | GO:0000727 | double-strand break repair via break-induced replication(GO:0000727) |
10.3 | 41.1 | GO:0014012 | peripheral nervous system axon regeneration(GO:0014012) |
10.3 | 41.1 | GO:0015746 | tricarboxylic acid transport(GO:0006842) citrate transport(GO:0015746) |
10.3 | 727.9 | GO:0042273 | ribosomal large subunit biogenesis(GO:0042273) |
10.2 | 61.5 | GO:0010643 | cell communication by chemical coupling(GO:0010643) |
10.2 | 81.8 | GO:0033211 | adiponectin-activated signaling pathway(GO:0033211) |
10.2 | 122.5 | GO:0001778 | plasma membrane repair(GO:0001778) |
10.2 | 30.6 | GO:0043490 | malate-aspartate shuttle(GO:0043490) |
10.2 | 20.3 | GO:0007113 | endomitotic cell cycle(GO:0007113) |
10.1 | 40.5 | GO:0070836 | caveola assembly(GO:0070836) |
10.1 | 100.9 | GO:1902455 | negative regulation of stem cell population maintenance(GO:1902455) |
10.1 | 20.2 | GO:0071963 | establishment or maintenance of cell polarity regulating cell shape(GO:0071963) |
10.1 | 30.3 | GO:0042997 | negative regulation of Golgi to plasma membrane protein transport(GO:0042997) |
10.0 | 380.6 | GO:0061621 | NADH regeneration(GO:0006735) glycolytic process through fructose-6-phosphate(GO:0061615) glycolytic process through glucose-6-phosphate(GO:0061620) canonical glycolysis(GO:0061621) glucose catabolic process to pyruvate(GO:0061718) |
10.0 | 10.0 | GO:0090069 | regulation of ribosome biogenesis(GO:0090069) |
10.0 | 19.9 | GO:0036363 | transforming growth factor beta activation(GO:0036363) |
10.0 | 59.8 | GO:0071475 | cellular hyperosmotic salinity response(GO:0071475) |
10.0 | 39.8 | GO:0038195 | urokinase plasminogen activator signaling pathway(GO:0038195) |
10.0 | 129.4 | GO:0070389 | chaperone cofactor-dependent protein refolding(GO:0070389) |
9.9 | 89.3 | GO:0048386 | positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
9.9 | 9.9 | GO:0002063 | chondrocyte development(GO:0002063) |
9.9 | 9.9 | GO:1905146 | lysosomal protein catabolic process(GO:1905146) |
9.9 | 49.4 | GO:0071680 | response to indole-3-methanol(GO:0071680) cellular response to indole-3-methanol(GO:0071681) |
9.8 | 19.7 | GO:0097327 | response to antineoplastic agent(GO:0097327) |
9.8 | 29.4 | GO:0060380 | regulation of single-stranded telomeric DNA binding(GO:0060380) positive regulation of single-stranded telomeric DNA binding(GO:0060381) positive regulation of telomeric DNA binding(GO:1904744) |
9.8 | 49.0 | GO:0006436 | tryptophanyl-tRNA aminoacylation(GO:0006436) |
9.8 | 49.0 | GO:0003420 | regulation of growth plate cartilage chondrocyte proliferation(GO:0003420) |
9.8 | 9.8 | GO:0060613 | fat pad development(GO:0060613) |
9.7 | 39.0 | GO:0043387 | mycotoxin catabolic process(GO:0043387) aflatoxin catabolic process(GO:0046223) organic heteropentacyclic compound catabolic process(GO:1901377) regulation of glutathione biosynthetic process(GO:1903786) positive regulation of glutathione biosynthetic process(GO:1903788) |
9.7 | 19.4 | GO:0006740 | NADPH regeneration(GO:0006740) |
9.7 | 29.1 | GO:0015680 | intracellular copper ion transport(GO:0015680) |
9.7 | 38.7 | GO:0021812 | neuronal-glial interaction involved in cerebral cortex radial glia guided migration(GO:0021812) |
9.7 | 29.0 | GO:0046900 | tetrahydrofolylpolyglutamate metabolic process(GO:0046900) |
9.6 | 77.0 | GO:0030497 | fatty acid elongation(GO:0030497) very long-chain fatty acid biosynthetic process(GO:0042761) |
9.6 | 19.2 | GO:0043400 | cortisol secretion(GO:0043400) regulation of cortisol secretion(GO:0051462) |
9.6 | 105.3 | GO:2000210 | positive regulation of anoikis(GO:2000210) |
9.6 | 9.6 | GO:0051684 | maintenance of Golgi location(GO:0051684) |
9.6 | 86.0 | GO:0006388 | tRNA splicing, via endonucleolytic cleavage and ligation(GO:0006388) |
9.5 | 124.0 | GO:0006782 | protoporphyrinogen IX biosynthetic process(GO:0006782) |
9.5 | 161.6 | GO:0071803 | positive regulation of podosome assembly(GO:0071803) |
9.5 | 38.0 | GO:0045541 | negative regulation of cholesterol biosynthetic process(GO:0045541) negative regulation of cholesterol metabolic process(GO:0090206) |
9.5 | 18.9 | GO:0044111 | development involved in symbiotic interaction(GO:0044111) |
9.4 | 18.9 | GO:1904885 | beta-catenin destruction complex assembly(GO:1904885) |
9.4 | 37.8 | GO:0043144 | snoRNA processing(GO:0043144) |
9.4 | 18.8 | GO:0048294 | negative regulation of isotype switching to IgE isotypes(GO:0048294) |
9.4 | 46.9 | GO:0014886 | transition between slow and fast fiber(GO:0014886) |
9.4 | 37.4 | GO:0042695 | thelarche(GO:0042695) development of secondary female sexual characteristics(GO:0046543) mammary gland branching involved in thelarche(GO:0060744) |
9.3 | 130.6 | GO:0034134 | toll-like receptor 2 signaling pathway(GO:0034134) |
9.3 | 18.6 | GO:0007206 | phospholipase C-activating G-protein coupled glutamate receptor signaling pathway(GO:0007206) |
9.3 | 298.3 | GO:0090383 | phagosome acidification(GO:0090383) |
9.3 | 18.6 | GO:0003415 | chondrocyte hypertrophy(GO:0003415) |
9.3 | 9.3 | GO:0060368 | regulation of Fc receptor mediated stimulatory signaling pathway(GO:0060368) |
9.3 | 139.3 | GO:0006101 | citrate metabolic process(GO:0006101) |
9.3 | 18.5 | GO:0035900 | response to isolation stress(GO:0035900) |
9.2 | 55.3 | GO:0061635 | regulation of protein complex stability(GO:0061635) |
9.2 | 73.5 | GO:0045716 | positive regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045716) |
9.2 | 18.3 | GO:2000048 | negative regulation of cell-cell adhesion mediated by cadherin(GO:2000048) |
9.1 | 438.8 | GO:0045454 | cell redox homeostasis(GO:0045454) |
9.1 | 228.5 | GO:0000291 | nuclear-transcribed mRNA catabolic process, exonucleolytic(GO:0000291) |
9.1 | 182.2 | GO:0015949 | nucleobase-containing small molecule interconversion(GO:0015949) |
9.1 | 27.3 | GO:0006425 | glutaminyl-tRNA aminoacylation(GO:0006425) |
9.0 | 9.0 | GO:0016074 | snoRNA metabolic process(GO:0016074) |
9.0 | 81.0 | GO:0060712 | spongiotrophoblast layer development(GO:0060712) |
8.9 | 71.3 | GO:0016446 | somatic hypermutation of immunoglobulin genes(GO:0016446) |
8.9 | 44.6 | GO:0015677 | copper ion import(GO:0015677) |
8.9 | 142.3 | GO:0032802 | low-density lipoprotein particle receptor catabolic process(GO:0032802) |
8.9 | 17.8 | GO:0021683 | cerebellar granular layer morphogenesis(GO:0021683) |
8.9 | 26.6 | GO:2000097 | regulation of smooth muscle cell-matrix adhesion(GO:2000097) |
8.9 | 8.9 | GO:1903033 | regulation of microtubule plus-end binding(GO:1903031) positive regulation of microtubule plus-end binding(GO:1903033) positive regulation of microtubule binding(GO:1904528) |
8.8 | 123.7 | GO:2000675 | negative regulation of type B pancreatic cell apoptotic process(GO:2000675) |
8.8 | 52.8 | GO:0009157 | deoxyribonucleoside monophosphate biosynthetic process(GO:0009157) |
8.8 | 26.3 | GO:0060715 | syncytiotrophoblast cell differentiation involved in labyrinthine layer development(GO:0060715) |
8.8 | 43.8 | GO:0019464 | glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
8.7 | 26.2 | GO:0044205 | 'de novo' UMP biosynthetic process(GO:0044205) |
8.7 | 8.7 | GO:0048199 | vesicle targeting, to, from or within Golgi(GO:0048199) |
8.7 | 51.9 | GO:0051834 | evasion or tolerance of host defenses by virus(GO:0019049) avoidance of host defenses(GO:0044413) evasion or tolerance of host defenses(GO:0044415) avoidance of defenses of other organism involved in symbiotic interaction(GO:0051832) evasion or tolerance of defenses of other organism involved in symbiotic interaction(GO:0051834) |
8.6 | 60.4 | GO:0045048 | protein insertion into ER membrane(GO:0045048) |
8.6 | 17.2 | GO:1901491 | negative regulation of lymphangiogenesis(GO:1901491) |
8.6 | 25.8 | GO:0060166 | olfactory pit development(GO:0060166) |
8.5 | 42.6 | GO:0051661 | maintenance of centrosome location(GO:0051661) |
8.5 | 8.5 | GO:0006789 | bilirubin conjugation(GO:0006789) |
8.5 | 25.4 | GO:0006423 | cysteinyl-tRNA aminoacylation(GO:0006423) |
8.5 | 8.5 | GO:1990314 | cellular response to insulin-like growth factor stimulus(GO:1990314) |
8.4 | 25.3 | GO:0097240 | meiotic telomere tethering at nuclear periphery(GO:0044821) meiotic attachment of telomere to nuclear envelope(GO:0070197) chromosome attachment to the nuclear envelope(GO:0097240) |
8.4 | 33.7 | GO:1903803 | glutamine secretion(GO:0010585) L-glutamine import(GO:0036229) L-glutamine import into cell(GO:1903803) |
8.4 | 25.1 | GO:0002439 | chronic inflammatory response to antigenic stimulus(GO:0002439) |
8.3 | 41.7 | GO:1904925 | positive regulation of macromitophagy(GO:1901526) positive regulation of mitophagy in response to mitochondrial depolarization(GO:1904925) |
8.2 | 82.0 | GO:0051988 | regulation of attachment of spindle microtubules to kinetochore(GO:0051988) |
8.2 | 16.4 | GO:0098902 | regulation of membrane depolarization during action potential(GO:0098902) |
8.2 | 73.7 | GO:0031936 | negative regulation of chromatin silencing(GO:0031936) |
8.2 | 32.7 | GO:0070358 | actin polymerization-dependent cell motility(GO:0070358) |
8.2 | 32.7 | GO:0006348 | chromatin silencing at telomere(GO:0006348) |
8.1 | 32.5 | GO:0003409 | optic cup structural organization(GO:0003409) |
8.1 | 16.3 | GO:1901856 | negative regulation of cellular respiration(GO:1901856) |
8.1 | 81.2 | GO:0060753 | regulation of mast cell chemotaxis(GO:0060753) |
8.1 | 40.5 | GO:1903301 | positive regulation of glucokinase activity(GO:0033133) positive regulation of hexokinase activity(GO:1903301) |
8.1 | 88.8 | GO:0090344 | negative regulation of cell aging(GO:0090344) |
8.1 | 24.2 | GO:1900039 | positive regulation of cellular response to hypoxia(GO:1900039) |
8.0 | 104.6 | GO:0042769 | DNA damage response, detection of DNA damage(GO:0042769) |
8.0 | 23.9 | GO:0006556 | S-adenosylmethionine biosynthetic process(GO:0006556) |
8.0 | 87.7 | GO:0018206 | peptidyl-methionine modification(GO:0018206) |
7.9 | 31.8 | GO:0032815 | negative regulation of natural killer cell activation(GO:0032815) |
7.9 | 31.7 | GO:0035973 | aggrephagy(GO:0035973) |
7.9 | 23.8 | GO:0045324 | late endosome to vacuole transport(GO:0045324) |
7.9 | 7.9 | GO:0071480 | cellular response to gamma radiation(GO:0071480) |
7.9 | 47.4 | GO:0007386 | compartment pattern specification(GO:0007386) |
7.9 | 94.6 | GO:0007080 | mitotic metaphase plate congression(GO:0007080) |
7.9 | 39.3 | GO:0019418 | sulfide oxidation(GO:0019418) sulfide oxidation, using sulfide:quinone oxidoreductase(GO:0070221) |
7.9 | 7.9 | GO:0007007 | inner mitochondrial membrane organization(GO:0007007) |
7.8 | 7.8 | GO:2000620 | positive regulation of histone H4-K16 acetylation(GO:2000620) |
7.8 | 23.5 | GO:0045876 | positive regulation of sister chromatid cohesion(GO:0045876) |
7.8 | 375.0 | GO:0035329 | hippo signaling(GO:0035329) |
7.8 | 15.6 | GO:0009162 | deoxyribonucleoside monophosphate metabolic process(GO:0009162) |
7.8 | 31.2 | GO:0015910 | peroxisomal long-chain fatty acid import(GO:0015910) |
7.8 | 15.6 | GO:1900041 | negative regulation of interleukin-2 secretion(GO:1900041) |
7.8 | 54.4 | GO:0030579 | ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
7.7 | 54.0 | GO:0032968 | positive regulation of transcription elongation from RNA polymerase II promoter(GO:0032968) |
7.7 | 53.9 | GO:1904714 | regulation of chaperone-mediated autophagy(GO:1904714) |
7.7 | 23.0 | GO:0007412 | axon target recognition(GO:0007412) |
7.7 | 7.7 | GO:2000302 | positive regulation of synaptic vesicle exocytosis(GO:2000302) |
7.6 | 45.9 | GO:0061302 | smooth muscle cell-matrix adhesion(GO:0061302) |
7.6 | 61.1 | GO:0031468 | nuclear envelope reassembly(GO:0031468) |
7.6 | 38.2 | GO:0010724 | regulation of definitive erythrocyte differentiation(GO:0010724) |
7.6 | 91.6 | GO:0010971 | positive regulation of G2/M transition of mitotic cell cycle(GO:0010971) |
7.6 | 22.8 | GO:0090481 | pyrimidine nucleotide-sugar transmembrane transport(GO:0090481) |
7.6 | 22.8 | GO:0060901 | regulation of monophenol monooxygenase activity(GO:0032771) positive regulation of monophenol monooxygenase activity(GO:0032773) negative regulation of transforming growth factor beta2 production(GO:0032912) negative regulation of catagen(GO:0051796) regulation of hair cycle by canonical Wnt signaling pathway(GO:0060901) positive regulation of melanosome transport(GO:1902910) |
7.6 | 30.2 | GO:0043555 | regulation of translation in response to stress(GO:0043555) |
7.6 | 121.0 | GO:0018345 | protein palmitoylation(GO:0018345) |
7.6 | 52.9 | GO:0030091 | protein repair(GO:0030091) |
7.5 | 15.1 | GO:2000563 | positive regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000563) |
7.5 | 45.2 | GO:0015846 | polyamine transport(GO:0015846) |
7.5 | 75.2 | GO:0046040 | IMP metabolic process(GO:0046040) |
7.5 | 7.5 | GO:1903416 | response to glycoside(GO:1903416) |
7.5 | 37.5 | GO:0010499 | proteasomal ubiquitin-independent protein catabolic process(GO:0010499) |
7.5 | 30.0 | GO:0061290 | cell-cell signaling involved in kidney development(GO:0060995) Wnt signaling pathway involved in kidney development(GO:0061289) canonical Wnt signaling pathway involved in metanephric kidney development(GO:0061290) cell-cell signaling involved in metanephros development(GO:0072204) |
7.5 | 22.5 | GO:0061357 | positive regulation of Wnt protein secretion(GO:0061357) |
7.5 | 164.5 | GO:0042255 | ribosome assembly(GO:0042255) |
7.4 | 52.1 | GO:1990144 | intrinsic apoptotic signaling pathway in response to hypoxia(GO:1990144) |
7.4 | 44.6 | GO:1901977 | negative regulation of cell cycle checkpoint(GO:1901977) negative regulation of DNA damage checkpoint(GO:2000002) |
7.4 | 7.4 | GO:1902255 | positive regulation of intrinsic apoptotic signaling pathway by p53 class mediator(GO:1902255) |
7.4 | 51.6 | GO:1901407 | regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901407) |
7.4 | 14.7 | GO:0002232 | leukocyte chemotaxis involved in inflammatory response(GO:0002232) |
7.4 | 147.5 | GO:0042178 | xenobiotic catabolic process(GO:0042178) |
7.3 | 29.3 | GO:0006432 | phenylalanyl-tRNA aminoacylation(GO:0006432) |
7.3 | 29.2 | GO:0090170 | regulation of Golgi inheritance(GO:0090170) |
7.3 | 21.8 | GO:1904578 | response to thapsigargin(GO:1904578) cellular response to thapsigargin(GO:1904579) |
7.3 | 189.3 | GO:0000281 | mitotic cytokinesis(GO:0000281) |
7.3 | 21.8 | GO:0000354 | cis assembly of pre-catalytic spliceosome(GO:0000354) |
7.3 | 21.8 | GO:0006447 | regulation of translational initiation by iron(GO:0006447) |
7.2 | 28.9 | GO:2001286 | regulation of caveolin-mediated endocytosis(GO:2001286) positive regulation of caveolin-mediated endocytosis(GO:2001288) |
7.2 | 7.2 | GO:0048817 | negative regulation of hair follicle maturation(GO:0048817) |
7.2 | 21.6 | GO:0061086 | negative regulation of histone H3-K27 methylation(GO:0061086) |
7.2 | 35.8 | GO:0050428 | purine ribonucleoside bisphosphate biosynthetic process(GO:0034036) 3'-phosphoadenosine 5'-phosphosulfate biosynthetic process(GO:0050428) |
7.1 | 50.0 | GO:0051307 | meiotic chromosome separation(GO:0051307) |
7.1 | 21.4 | GO:1990441 | negative regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress(GO:1990441) |
7.1 | 21.3 | GO:0017186 | peptidyl-pyroglutamic acid biosynthetic process, using glutaminyl-peptide cyclotransferase(GO:0017186) |
7.1 | 21.3 | GO:1900038 | negative regulation of cellular response to hypoxia(GO:1900038) |
7.1 | 28.4 | GO:0071314 | cellular response to cocaine(GO:0071314) |
7.1 | 70.8 | GO:0045116 | protein neddylation(GO:0045116) |
7.1 | 7.1 | GO:0051495 | positive regulation of cytoskeleton organization(GO:0051495) |
7.1 | 21.2 | GO:0060178 | regulation of exocyst assembly(GO:0001928) regulation of exocyst localization(GO:0060178) |
7.0 | 63.2 | GO:0060261 | positive regulation of transcription initiation from RNA polymerase II promoter(GO:0060261) |
7.0 | 14.0 | GO:2000273 | positive regulation of receptor activity(GO:2000273) |
7.0 | 34.9 | GO:0000389 | mRNA 3'-splice site recognition(GO:0000389) |
7.0 | 20.9 | GO:1901355 | response to rapamycin(GO:1901355) |
7.0 | 13.9 | GO:0060574 | intestinal epithelial cell maturation(GO:0060574) |
7.0 | 7.0 | GO:0060528 | secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development(GO:0060528) |
6.9 | 20.8 | GO:0035880 | embryonic nail plate morphogenesis(GO:0035880) |
6.9 | 34.6 | GO:0006398 | mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
6.9 | 13.8 | GO:0005997 | xylulose metabolic process(GO:0005997) |
6.9 | 27.5 | GO:0045743 | positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
6.9 | 41.2 | GO:0006021 | inositol biosynthetic process(GO:0006021) |
6.9 | 13.7 | GO:1900368 | regulation of RNA interference(GO:1900368) negative regulation of RNA interference(GO:1900369) |
6.9 | 27.4 | GO:0018032 | peptide amidation(GO:0001519) protein amidation(GO:0018032) peptide modification(GO:0031179) |
6.9 | 6.9 | GO:0051792 | medium-chain fatty acid biosynthetic process(GO:0051792) |
6.8 | 13.7 | GO:0006222 | UMP biosynthetic process(GO:0006222) pyrimidine ribonucleoside monophosphate metabolic process(GO:0009173) pyrimidine ribonucleoside monophosphate biosynthetic process(GO:0009174) UMP metabolic process(GO:0046049) |
6.8 | 61.5 | GO:0019509 | L-methionine biosynthetic process from methylthioadenosine(GO:0019509) |
6.8 | 20.5 | GO:0015920 | lipopolysaccharide transport(GO:0015920) |
6.8 | 6.8 | GO:0006529 | asparagine biosynthetic process(GO:0006529) |
6.8 | 20.4 | GO:0031017 | exocrine pancreas development(GO:0031017) |
6.8 | 61.2 | GO:0032075 | positive regulation of nuclease activity(GO:0032075) |
6.8 | 6.8 | GO:0007354 | zygotic determination of anterior/posterior axis, embryo(GO:0007354) |
6.8 | 33.9 | GO:0050668 | cellular response to phosphate starvation(GO:0016036) positive regulation of sulfur amino acid metabolic process(GO:0031337) negative regulation of catecholamine metabolic process(GO:0045914) negative regulation of dopamine metabolic process(GO:0045963) positive regulation of homocysteine metabolic process(GO:0050668) |
6.7 | 74.1 | GO:0002190 | cap-independent translational initiation(GO:0002190) IRES-dependent translational initiation(GO:0002192) |
6.7 | 562.8 | GO:0006901 | vesicle coating(GO:0006901) vesicle targeting, rough ER to cis-Golgi(GO:0048207) COPII vesicle coating(GO:0048208) |
6.7 | 33.3 | GO:0070072 | proton-transporting V-type ATPase complex assembly(GO:0070070) vacuolar proton-transporting V-type ATPase complex assembly(GO:0070072) |
6.6 | 19.9 | GO:0046778 | modification by virus of host mRNA processing(GO:0046778) positive regulation of polynucleotide adenylyltransferase activity(GO:1904247) |
6.6 | 6.6 | GO:0006296 | nucleotide-excision repair, DNA incision, 5'-to lesion(GO:0006296) |
6.6 | 19.9 | GO:0043314 | negative regulation of neutrophil degranulation(GO:0043314) |
6.6 | 26.5 | GO:1903224 | regulation of endodermal cell differentiation(GO:1903224) |
6.6 | 59.3 | GO:0010592 | positive regulation of lamellipodium assembly(GO:0010592) |
6.6 | 79.0 | GO:0021670 | lateral ventricle development(GO:0021670) |
6.6 | 59.2 | GO:0006787 | porphyrin-containing compound catabolic process(GO:0006787) tetrapyrrole catabolic process(GO:0033015) heme catabolic process(GO:0042167) pigment catabolic process(GO:0046149) |
6.6 | 45.9 | GO:0050915 | sensory perception of sour taste(GO:0050915) |
6.6 | 19.7 | GO:0016255 | attachment of GPI anchor to protein(GO:0016255) |
6.5 | 45.8 | GO:1990564 | protein polyufmylation(GO:1990564) protein K69-linked ufmylation(GO:1990592) |
6.5 | 26.1 | GO:0008090 | retrograde axonal transport(GO:0008090) |
6.5 | 19.6 | GO:0070885 | negative regulation of calcineurin-NFAT signaling cascade(GO:0070885) |
6.5 | 13.0 | GO:0006221 | pyrimidine nucleotide biosynthetic process(GO:0006221) |
6.5 | 32.4 | GO:0030200 | heparan sulfate proteoglycan catabolic process(GO:0030200) |
6.4 | 44.8 | GO:0071888 | macrophage apoptotic process(GO:0071888) |
6.4 | 19.2 | GO:0036071 | N-glycan fucosylation(GO:0036071) GDP-L-fucose metabolic process(GO:0046368) |
6.4 | 6.4 | GO:0060296 | regulation of cilium movement involved in cell motility(GO:0060295) regulation of cilium beat frequency involved in ciliary motility(GO:0060296) regulation of cilium-dependent cell motility(GO:1902019) |
6.4 | 25.4 | GO:0060434 | bronchus morphogenesis(GO:0060434) |
6.3 | 120.5 | GO:0000462 | maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000462) |
6.3 | 183.8 | GO:0032008 | positive regulation of TOR signaling(GO:0032008) |
6.3 | 12.7 | GO:0099515 | actin filament-based transport(GO:0099515) |
6.3 | 126.3 | GO:0006465 | signal peptide processing(GO:0006465) |
6.3 | 63.0 | GO:0002480 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent(GO:0002480) |
6.3 | 56.4 | GO:0038007 | netrin-activated signaling pathway(GO:0038007) |
6.3 | 50.1 | GO:0006931 | substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
6.3 | 6.3 | GO:0022615 | protein to membrane docking(GO:0022615) |
6.2 | 112.2 | GO:0097031 | NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
6.2 | 12.5 | GO:1901656 | glycoside transport(GO:1901656) |
6.2 | 18.7 | GO:0042369 | vitamin D catabolic process(GO:0042369) |
6.2 | 68.4 | GO:0000460 | maturation of 5.8S rRNA(GO:0000460) |
6.2 | 30.9 | GO:1903265 | positive regulation of tumor necrosis factor-mediated signaling pathway(GO:1903265) |
6.2 | 61.8 | GO:0060148 | positive regulation of posttranscriptional gene silencing(GO:0060148) positive regulation of gene silencing by miRNA(GO:2000637) |
6.2 | 12.4 | GO:0048382 | mesendoderm development(GO:0048382) |
6.2 | 24.7 | GO:1904798 | positive regulation of core promoter binding(GO:1904798) |
6.2 | 68.0 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
6.2 | 30.8 | GO:0000212 | meiotic spindle organization(GO:0000212) |
6.2 | 6.2 | GO:0032070 | regulation of deoxyribonuclease activity(GO:0032070) |
6.1 | 18.4 | GO:0000012 | single strand break repair(GO:0000012) |
6.1 | 12.2 | GO:0043309 | regulation of eosinophil degranulation(GO:0043309) positive regulation of eosinophil degranulation(GO:0043311) positive regulation of eosinophil activation(GO:1902568) |
6.1 | 36.5 | GO:1903435 | positive regulation of constitutive secretory pathway(GO:1903435) |
6.1 | 6.1 | GO:0043922 | negative regulation by host of viral transcription(GO:0043922) |
6.1 | 24.2 | GO:0033131 | regulation of glucokinase activity(GO:0033131) negative regulation of glucokinase activity(GO:0033132) regulation of hexokinase activity(GO:1903299) negative regulation of hexokinase activity(GO:1903300) |
6.1 | 18.2 | GO:0016559 | peroxisome fission(GO:0016559) |
6.0 | 6.0 | GO:1904751 | positive regulation of protein localization to nucleolus(GO:1904751) |
6.0 | 90.2 | GO:0097264 | self proteolysis(GO:0097264) |
6.0 | 18.0 | GO:0061470 | T follicular helper cell differentiation(GO:0061470) |
6.0 | 18.0 | GO:0016561 | protein import into peroxisome matrix, translocation(GO:0016561) |
6.0 | 41.9 | GO:2000628 | regulation of miRNA metabolic process(GO:2000628) |
6.0 | 35.8 | GO:0043402 | glucocorticoid mediated signaling pathway(GO:0043402) |
6.0 | 11.9 | GO:1904923 | regulation of mitophagy in response to mitochondrial depolarization(GO:1904923) |
6.0 | 35.7 | GO:0001712 | ectodermal cell fate commitment(GO:0001712) |
6.0 | 41.7 | GO:0006307 | DNA dealkylation involved in DNA repair(GO:0006307) |
6.0 | 202.4 | GO:0043044 | ATP-dependent chromatin remodeling(GO:0043044) |
5.9 | 59.4 | GO:0034498 | early endosome to Golgi transport(GO:0034498) |
5.9 | 572.4 | GO:0006613 | cotranslational protein targeting to membrane(GO:0006613) |
5.9 | 11.8 | GO:0038026 | reelin-mediated signaling pathway(GO:0038026) |
5.9 | 29.3 | GO:0070933 | histone H4 deacetylation(GO:0070933) |
5.9 | 29.3 | GO:1901252 | regulation of intracellular transport of viral material(GO:1901252) |
5.8 | 5.8 | GO:0022007 | neural plate elongation(GO:0014022) convergent extension involved in neural plate elongation(GO:0022007) |
5.8 | 17.5 | GO:1902669 | positive regulation of axon guidance(GO:1902669) |
5.8 | 11.7 | GO:0019087 | transformation of host cell by virus(GO:0019087) |
5.8 | 5.8 | GO:0072711 | cellular response to hydroxyurea(GO:0072711) |
5.8 | 104.7 | GO:0046341 | CDP-diacylglycerol metabolic process(GO:0046341) |
5.8 | 40.5 | GO:0070973 | protein localization to endoplasmic reticulum exit site(GO:0070973) |
5.7 | 11.5 | GO:0007518 | myoblast fate determination(GO:0007518) |
5.7 | 34.3 | GO:1900027 | regulation of ruffle assembly(GO:1900027) |
5.7 | 28.5 | GO:2000643 | positive regulation of early endosome to late endosome transport(GO:2000643) |
5.7 | 45.6 | GO:0036109 | alpha-linolenic acid metabolic process(GO:0036109) |
5.7 | 22.8 | GO:0031914 | negative regulation of synaptic plasticity(GO:0031914) |
5.7 | 28.4 | GO:1901838 | positive regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:1901838) |
5.7 | 192.5 | GO:0006378 | mRNA polyadenylation(GO:0006378) |
5.7 | 5.7 | GO:0035166 | post-embryonic hemopoiesis(GO:0035166) |
5.7 | 22.6 | GO:0045218 | zonula adherens maintenance(GO:0045218) |
5.6 | 28.2 | GO:0003070 | age-dependent response to oxidative stress(GO:0001306) age-dependent response to reactive oxygen species(GO:0001315) regulation of systemic arterial blood pressure by acetylcholine(GO:0003068) vasodilation by acetylcholine involved in regulation of systemic arterial blood pressure(GO:0003069) regulation of systemic arterial blood pressure by neurotransmitter(GO:0003070) age-dependent general metabolic decline(GO:0007571) |
5.6 | 11.3 | GO:0072526 | pyridine-containing compound catabolic process(GO:0072526) |
5.6 | 5.6 | GO:0002855 | natural killer cell mediated cytotoxicity directed against tumor cell target(GO:0002420) natural killer cell mediated immune response to tumor cell(GO:0002423) regulation of natural killer cell mediated immune response to tumor cell(GO:0002855) regulation of natural killer cell mediated cytotoxicity directed against tumor cell target(GO:0002858) |
5.6 | 28.1 | GO:0032786 | positive regulation of DNA-templated transcription, elongation(GO:0032786) |
5.6 | 5.6 | GO:0003162 | atrioventricular node development(GO:0003162) |
5.6 | 140.0 | GO:0051031 | tRNA transport(GO:0051031) |
5.6 | 16.7 | GO:0046490 | isopentenyl diphosphate biosynthetic process(GO:0009240) isopentenyl diphosphate metabolic process(GO:0046490) |
5.6 | 22.2 | GO:0060694 | regulation of cholesterol transporter activity(GO:0060694) negative regulation of pancreatic stellate cell proliferation(GO:2000230) |
5.6 | 150.0 | GO:0006270 | DNA replication initiation(GO:0006270) |
5.5 | 11.1 | GO:0046292 | spermatid nucleus elongation(GO:0007290) formaldehyde metabolic process(GO:0046292) |
5.5 | 5.5 | GO:0060056 | mammary gland involution(GO:0060056) |
5.5 | 27.6 | GO:0034393 | positive regulation of smooth muscle cell apoptotic process(GO:0034393) |
5.5 | 5.5 | GO:1900037 | regulation of cellular response to hypoxia(GO:1900037) |
5.5 | 5.5 | GO:0030968 | endoplasmic reticulum unfolded protein response(GO:0030968) |
5.5 | 5.5 | GO:1902897 | regulation of postsynaptic density protein 95 clustering(GO:1902897) |
5.5 | 82.2 | GO:0007213 | G-protein coupled acetylcholine receptor signaling pathway(GO:0007213) |
5.5 | 5.5 | GO:0031055 | chromatin remodeling at centromere(GO:0031055) |
5.5 | 49.1 | GO:0060576 | intestinal epithelial cell development(GO:0060576) |
5.4 | 16.3 | GO:0043105 | regulation of GTP cyclohydrolase I activity(GO:0043095) negative regulation of GTP cyclohydrolase I activity(GO:0043105) |
5.4 | 10.9 | GO:2000641 | regulation of early endosome to late endosome transport(GO:2000641) |
5.4 | 27.1 | GO:0042985 | negative regulation of amyloid precursor protein biosynthetic process(GO:0042985) |
5.4 | 16.2 | GO:0014736 | negative regulation of muscle atrophy(GO:0014736) response to injury involved in regulation of muscle adaptation(GO:0014876) |
5.4 | 5.4 | GO:0036510 | trimming of terminal mannose on B branch(GO:0036509) trimming of terminal mannose on C branch(GO:0036510) trimming of first mannose on A branch(GO:0036511) trimming of second mannose on A branch(GO:0036512) |
5.4 | 10.7 | GO:0010825 | positive regulation of centrosome duplication(GO:0010825) |
5.3 | 117.4 | GO:0070534 | protein K63-linked ubiquitination(GO:0070534) |
5.3 | 32.0 | GO:0034508 | centromere complex assembly(GO:0034508) |
5.3 | 5.3 | GO:0098501 | polynucleotide dephosphorylation(GO:0098501) |
5.3 | 26.6 | GO:0018243 | protein O-linked glycosylation via threonine(GO:0018243) |
5.3 | 15.9 | GO:0048549 | positive regulation of pinocytosis(GO:0048549) |
5.3 | 5.3 | GO:1903671 | negative regulation of sprouting angiogenesis(GO:1903671) |
5.3 | 5.3 | GO:0070213 | protein auto-ADP-ribosylation(GO:0070213) |
5.3 | 84.4 | GO:0016540 | protein autoprocessing(GO:0016540) |
5.3 | 215.9 | GO:0000413 | protein peptidyl-prolyl isomerization(GO:0000413) |
5.3 | 10.5 | GO:0032730 | positive regulation of interleukin-1 alpha production(GO:0032730) |
5.3 | 10.5 | GO:0097201 | negative regulation of transcription from RNA polymerase II promoter in response to stress(GO:0097201) |
5.2 | 105.0 | GO:0006362 | transcription elongation from RNA polymerase I promoter(GO:0006362) |
5.2 | 26.2 | GO:0060356 | leucine import(GO:0060356) |
5.2 | 5.2 | GO:0035811 | negative regulation of urine volume(GO:0035811) |
5.2 | 125.0 | GO:0006418 | tRNA aminoacylation for protein translation(GO:0006418) |
5.2 | 5.2 | GO:0090235 | regulation of metaphase plate congression(GO:0090235) |
5.2 | 5.2 | GO:1901098 | regulation of autophagosome maturation(GO:1901096) positive regulation of autophagosome maturation(GO:1901098) |
5.2 | 5.2 | GO:0003383 | apical constriction(GO:0003383) |
5.2 | 41.5 | GO:0071550 | death-inducing signaling complex assembly(GO:0071550) |
5.2 | 15.5 | GO:0006283 | transcription-coupled nucleotide-excision repair(GO:0006283) |
5.2 | 15.5 | GO:2000521 | negative regulation of immunological synapse formation(GO:2000521) |
5.2 | 51.5 | GO:0045793 | positive regulation of cell size(GO:0045793) |
5.2 | 61.9 | GO:0030050 | vesicle transport along actin filament(GO:0030050) |
5.1 | 15.4 | GO:0002678 | positive regulation of chronic inflammatory response(GO:0002678) |
5.1 | 30.8 | GO:0060120 | auditory receptor cell fate commitment(GO:0009912) inner ear receptor cell fate commitment(GO:0060120) |
5.1 | 30.8 | GO:0048050 | post-embryonic eye morphogenesis(GO:0048050) |
5.1 | 10.2 | GO:0051563 | smooth endoplasmic reticulum calcium ion homeostasis(GO:0051563) |
5.1 | 30.6 | GO:0090382 | phagosome maturation(GO:0090382) |
5.1 | 35.7 | GO:0021902 | commitment of neuronal cell to specific neuron type in forebrain(GO:0021902) |
5.1 | 15.2 | GO:0032747 | positive regulation of interleukin-23 production(GO:0032747) |
5.1 | 293.5 | GO:0006353 | DNA-templated transcription, termination(GO:0006353) |
5.0 | 30.2 | GO:0018214 | peptidyl-glutamic acid carboxylation(GO:0017187) protein carboxylation(GO:0018214) |
5.0 | 50.3 | GO:1903944 | regulation of hepatocyte apoptotic process(GO:1903943) negative regulation of hepatocyte apoptotic process(GO:1903944) |
5.0 | 85.1 | GO:0045948 | positive regulation of translational initiation(GO:0045948) |
5.0 | 363.6 | GO:0043488 | regulation of mRNA stability(GO:0043488) |
5.0 | 19.9 | GO:1901419 | regulation of response to alcohol(GO:1901419) |
5.0 | 9.9 | GO:0033197 | response to vitamin E(GO:0033197) |
5.0 | 9.9 | GO:0061643 | chemorepulsion of dopaminergic neuron axon(GO:0036518) chemorepulsion of axon(GO:0061643) |
5.0 | 84.4 | GO:0031163 | iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
5.0 | 5.0 | GO:0033591 | response to L-ascorbic acid(GO:0033591) |
4.9 | 9.9 | GO:0010801 | negative regulation of peptidyl-threonine phosphorylation(GO:0010801) |
4.9 | 19.7 | GO:0090647 | modulation of age-related behavioral decline(GO:0090647) |
4.9 | 19.7 | GO:0031339 | negative regulation of vesicle fusion(GO:0031339) |
4.9 | 19.6 | GO:0008612 | peptidyl-lysine modification to peptidyl-hypusine(GO:0008612) |
4.9 | 4.9 | GO:1902512 | positive regulation of apoptotic DNA fragmentation(GO:1902512) |
4.9 | 49.0 | GO:0006527 | arginine catabolic process(GO:0006527) |
4.9 | 24.4 | GO:0043615 | astrocyte cell migration(GO:0043615) |
4.9 | 14.6 | GO:0090073 | positive regulation of protein homodimerization activity(GO:0090073) |
4.9 | 14.6 | GO:0031064 | negative regulation of histone deacetylation(GO:0031064) |
4.8 | 9.7 | GO:0042373 | vitamin K metabolic process(GO:0042373) |
4.8 | 14.5 | GO:0043418 | homocysteine catabolic process(GO:0043418) |
4.8 | 14.4 | GO:0070407 | oxidation-dependent protein catabolic process(GO:0070407) |
4.8 | 4.8 | GO:0010637 | negative regulation of mitochondrial fusion(GO:0010637) |
4.8 | 9.6 | GO:0006103 | 2-oxoglutarate metabolic process(GO:0006103) |
4.8 | 33.4 | GO:0040032 | post-embryonic body morphogenesis(GO:0040032) |
4.7 | 4.7 | GO:0010512 | negative regulation of phosphatidylinositol biosynthetic process(GO:0010512) negative regulation of phospholipid biosynthetic process(GO:0071072) |
4.7 | 23.7 | GO:0009137 | purine nucleoside diphosphate catabolic process(GO:0009137) purine ribonucleoside diphosphate catabolic process(GO:0009181) |
4.7 | 14.2 | GO:0031548 | regulation of brain-derived neurotrophic factor receptor signaling pathway(GO:0031548) |
4.7 | 18.8 | GO:0030259 | lipid glycosylation(GO:0030259) |
4.7 | 140.8 | GO:0034314 | Arp2/3 complex-mediated actin nucleation(GO:0034314) |
4.7 | 14.1 | GO:0051685 | maintenance of ER location(GO:0051685) |
4.7 | 14.0 | GO:0042796 | snRNA transcription from RNA polymerase III promoter(GO:0042796) |
4.7 | 9.3 | GO:0090559 | regulation of membrane permeability(GO:0090559) |
4.7 | 251.6 | GO:0036498 | IRE1-mediated unfolded protein response(GO:0036498) |
4.7 | 41.9 | GO:0006552 | leucine catabolic process(GO:0006552) |
4.6 | 32.5 | GO:0045329 | carnitine biosynthetic process(GO:0045329) |
4.6 | 240.8 | GO:0007157 | heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0007157) |
4.6 | 41.6 | GO:0035518 | histone H2A monoubiquitination(GO:0035518) |
4.6 | 64.7 | GO:0006488 | dolichol-linked oligosaccharide biosynthetic process(GO:0006488) |
4.6 | 87.0 | GO:1902857 | positive regulation of nonmotile primary cilium assembly(GO:1902857) |
4.6 | 4.6 | GO:0015825 | L-serine transport(GO:0015825) |
4.6 | 18.3 | GO:2000354 | regulation of ovarian follicle development(GO:2000354) |
4.5 | 4.5 | GO:0032096 | negative regulation of response to food(GO:0032096) negative regulation of appetite(GO:0032099) |
4.5 | 18.2 | GO:0015986 | energy coupled proton transport, down electrochemical gradient(GO:0015985) ATP synthesis coupled proton transport(GO:0015986) |
4.5 | 13.5 | GO:0006624 | vacuolar protein processing(GO:0006624) |
4.5 | 54.1 | GO:0007253 | cytoplasmic sequestering of NF-kappaB(GO:0007253) |
4.5 | 9.0 | GO:1901223 | negative regulation of NIK/NF-kappaB signaling(GO:1901223) |
4.5 | 31.4 | GO:2000252 | negative regulation of feeding behavior(GO:2000252) |
4.5 | 31.2 | GO:0070294 | renal sodium ion absorption(GO:0070294) |
4.4 | 289.0 | GO:0006890 | retrograde vesicle-mediated transport, Golgi to ER(GO:0006890) |
4.4 | 8.9 | GO:0060967 | negative regulation of posttranscriptional gene silencing(GO:0060149) negative regulation of gene silencing by RNA(GO:0060967) |
4.4 | 8.8 | GO:1902044 | regulation of Fas signaling pathway(GO:1902044) |
4.4 | 8.8 | GO:0052199 | negative regulation of catalytic activity in other organism involved in symbiotic interaction(GO:0052199) |
4.4 | 105.7 | GO:0051123 | RNA polymerase II transcriptional preinitiation complex assembly(GO:0051123) |
4.4 | 26.4 | GO:1900119 | positive regulation of execution phase of apoptosis(GO:1900119) |
4.4 | 30.7 | GO:0046618 | drug export(GO:0046618) |
4.4 | 30.6 | GO:0051660 | establishment of centrosome localization(GO:0051660) |
4.4 | 13.1 | GO:1904504 | regulation of lipophagy(GO:1904502) positive regulation of lipophagy(GO:1904504) |
4.3 | 21.7 | GO:0045938 | positive regulation of circadian sleep/wake cycle, sleep(GO:0045938) |
4.3 | 13.0 | GO:0060743 | epithelial cell maturation involved in prostate gland development(GO:0060743) |
4.3 | 69.3 | GO:0006415 | translational termination(GO:0006415) |
4.3 | 4.3 | GO:0048636 | positive regulation of striated muscle tissue development(GO:0045844) positive regulation of muscle organ development(GO:0048636) positive regulation of muscle tissue development(GO:1901863) |
4.3 | 30.0 | GO:0040016 | embryonic cleavage(GO:0040016) |
4.3 | 29.9 | GO:0021842 | directional guidance of interneurons involved in migration from the subpallium to the cortex(GO:0021840) chemorepulsion involved in interneuron migration from the subpallium to the cortex(GO:0021842) |
4.2 | 21.2 | GO:0070345 | negative regulation of fat cell proliferation(GO:0070345) |
4.2 | 46.6 | GO:0032876 | negative regulation of DNA endoreduplication(GO:0032876) |
4.2 | 8.5 | GO:1905123 | regulation of glucosylceramidase activity(GO:1905123) |
4.2 | 8.5 | GO:0018197 | peptidyl-aspartic acid modification(GO:0018197) peptidyl-aspartic acid hydroxylation(GO:0042264) |
4.2 | 21.1 | GO:0039526 | suppression by virus of host apoptotic process(GO:0019050) modulation by virus of host apoptotic process(GO:0039526) cellular process regulating host cell cycle in response to virus(GO:0060154) |
4.2 | 223.2 | GO:0070671 | response to interleukin-12(GO:0070671) |
4.2 | 273.6 | GO:0000079 | regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0000079) |
4.2 | 4.2 | GO:0009298 | GDP-mannose biosynthetic process(GO:0009298) |
4.2 | 25.1 | GO:0090224 | regulation of spindle organization(GO:0090224) |
4.2 | 8.4 | GO:0060075 | regulation of resting membrane potential(GO:0060075) |
4.2 | 12.5 | GO:0090136 | epithelial cell-cell adhesion(GO:0090136) |
4.1 | 8.3 | GO:0072205 | metanephric collecting duct development(GO:0072205) |
4.1 | 4.1 | GO:0010728 | regulation of hydrogen peroxide biosynthetic process(GO:0010728) |
4.1 | 24.5 | GO:0043101 | purine-containing compound salvage(GO:0043101) |
4.1 | 16.3 | GO:0060020 | Bergmann glial cell differentiation(GO:0060020) |
4.1 | 4.1 | GO:0051930 | regulation of sensory perception of pain(GO:0051930) regulation of sensory perception(GO:0051931) |
4.1 | 4.1 | GO:0010587 | miRNA catabolic process(GO:0010587) |
4.1 | 16.3 | GO:0048541 | mucosal-associated lymphoid tissue development(GO:0048537) Peyer's patch development(GO:0048541) Peyer's patch morphogenesis(GO:0061146) |
4.1 | 4.1 | GO:0090315 | negative regulation of protein targeting to membrane(GO:0090315) |
4.0 | 28.3 | GO:0006264 | mitochondrial DNA replication(GO:0006264) |
4.0 | 8.0 | GO:0051534 | negative regulation of NFAT protein import into nucleus(GO:0051534) |
4.0 | 28.1 | GO:0032905 | transforming growth factor beta1 production(GO:0032905) regulation of transforming growth factor beta1 production(GO:0032908) |
4.0 | 8.0 | GO:0060437 | lung growth(GO:0060437) |
4.0 | 4.0 | GO:0015820 | leucine transport(GO:0015820) |
4.0 | 4.0 | GO:2000816 | negative regulation of sister chromatid segregation(GO:0033046) negative regulation of mitotic sister chromatid segregation(GO:0033048) negative regulation of chromosome segregation(GO:0051985) negative regulation of mitotic sister chromatid separation(GO:2000816) |
4.0 | 4.0 | GO:0046349 | amino sugar biosynthetic process(GO:0046349) |
4.0 | 19.9 | GO:0070200 | establishment of protein localization to telomere(GO:0070200) |
4.0 | 7.9 | GO:0033619 | membrane protein proteolysis(GO:0033619) |
4.0 | 7.9 | GO:0045082 | positive regulation of interleukin-10 biosynthetic process(GO:0045082) |
3.9 | 7.9 | GO:1904352 | positive regulation of protein catabolic process in the vacuole(GO:1904352) |
3.9 | 31.6 | GO:0051601 | exocyst localization(GO:0051601) |
3.9 | 3.9 | GO:0061034 | olfactory bulb mitral cell layer development(GO:0061034) |
3.9 | 27.3 | GO:0015760 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
3.9 | 3.9 | GO:0090161 | Golgi ribbon formation(GO:0090161) |
3.9 | 7.8 | GO:0030953 | astral microtubule organization(GO:0030953) |
3.9 | 147.3 | GO:0045214 | sarcomere organization(GO:0045214) |
3.9 | 3.9 | GO:0051310 | metaphase plate congression(GO:0051310) |
3.9 | 7.7 | GO:0007076 | mitotic chromosome condensation(GO:0007076) |
3.9 | 7.7 | GO:0042659 | regulation of cell fate specification(GO:0042659) |
3.8 | 103.6 | GO:0042438 | melanin biosynthetic process(GO:0042438) |
3.8 | 34.5 | GO:1902036 | regulation of hematopoietic stem cell differentiation(GO:1902036) |
3.8 | 11.4 | GO:0070863 | positive regulation of protein exit from endoplasmic reticulum(GO:0070863) |
3.8 | 3.8 | GO:0016093 | polyprenol metabolic process(GO:0016093) |
3.8 | 3.8 | GO:1902715 | positive regulation of interferon-gamma secretion(GO:1902715) |
3.8 | 33.8 | GO:0046951 | ketone body biosynthetic process(GO:0046951) |
3.7 | 7.5 | GO:2000253 | positive regulation of feeding behavior(GO:2000253) |
3.7 | 7.5 | GO:1901203 | positive regulation of extracellular matrix assembly(GO:1901203) |
3.7 | 18.6 | GO:0048194 | Golgi vesicle budding(GO:0048194) |
3.7 | 11.1 | GO:2000864 | estrogen secretion(GO:0035937) estradiol secretion(GO:0035938) regulation of estrogen secretion(GO:2000861) regulation of estradiol secretion(GO:2000864) |
3.7 | 11.1 | GO:0035413 | positive regulation of catenin import into nucleus(GO:0035413) |
3.7 | 14.8 | GO:1900016 | negative regulation of cytokine production involved in inflammatory response(GO:1900016) |
3.7 | 33.3 | GO:0048262 | determination of dorsal/ventral asymmetry(GO:0048262) |
3.7 | 29.3 | GO:0042182 | ketone catabolic process(GO:0042182) |
3.7 | 58.7 | GO:0008631 | intrinsic apoptotic signaling pathway in response to oxidative stress(GO:0008631) |
3.7 | 29.3 | GO:0001866 | NK T cell proliferation(GO:0001866) |
3.7 | 11.0 | GO:1901503 | ether lipid biosynthetic process(GO:0008611) glycerol ether biosynthetic process(GO:0046504) ether biosynthetic process(GO:1901503) |
3.7 | 11.0 | GO:0070212 | protein poly-ADP-ribosylation(GO:0070212) |
3.6 | 10.9 | GO:0060244 | negative regulation of cell proliferation involved in contact inhibition(GO:0060244) |
3.6 | 14.6 | GO:2001295 | malonyl-CoA biosynthetic process(GO:2001295) |
3.6 | 43.7 | GO:0070327 | thyroid hormone transport(GO:0070327) |
3.6 | 7.3 | GO:0071033 | nuclear retention of pre-mRNA at the site of transcription(GO:0071033) |
3.6 | 14.5 | GO:1903593 | regulation of histamine secretion by mast cell(GO:1903593) |
3.6 | 18.1 | GO:0038065 | collagen-activated signaling pathway(GO:0038065) |
3.6 | 28.8 | GO:0033234 | negative regulation of protein sumoylation(GO:0033234) |
3.6 | 10.8 | GO:0000738 | DNA catabolic process, exonucleolytic(GO:0000738) |
3.6 | 14.3 | GO:0044857 | plasma membrane raft assembly(GO:0044854) plasma membrane raft organization(GO:0044857) |
3.6 | 21.5 | GO:0006498 | N-terminal protein lipidation(GO:0006498) N-terminal protein myristoylation(GO:0006499) |
3.6 | 10.7 | GO:0006679 | glucosylceramide biosynthetic process(GO:0006679) |
3.6 | 3.6 | GO:1900120 | regulation of receptor binding(GO:1900120) |
3.6 | 78.1 | GO:0032392 | DNA geometric change(GO:0032392) |
3.5 | 14.2 | GO:0030950 | establishment or maintenance of actin cytoskeleton polarity(GO:0030950) |
3.5 | 45.5 | GO:0072697 | protein localization to cell cortex(GO:0072697) |
3.5 | 45.2 | GO:0045663 | positive regulation of myoblast differentiation(GO:0045663) |
3.4 | 3.4 | GO:0034141 | positive regulation of toll-like receptor 3 signaling pathway(GO:0034141) |
3.4 | 20.6 | GO:0003433 | chondrocyte development involved in endochondral bone morphogenesis(GO:0003433) |
3.4 | 6.8 | GO:0045213 | neurotransmitter receptor metabolic process(GO:0045213) |
3.4 | 6.8 | GO:0032972 | regulation of muscle filament sliding(GO:0032971) regulation of muscle filament sliding speed(GO:0032972) |
3.4 | 6.8 | GO:0035507 | regulation of myosin-light-chain-phosphatase activity(GO:0035507) |
3.4 | 17.1 | GO:0048293 | isotype switching to IgE isotypes(GO:0048289) regulation of isotype switching to IgE isotypes(GO:0048293) positive regulation of isotype switching to IgE isotypes(GO:0048295) |
3.4 | 10.2 | GO:0035092 | sperm chromatin condensation(GO:0035092) |
3.4 | 85.1 | GO:0016578 | histone deubiquitination(GO:0016578) |
3.4 | 20.3 | GO:1903027 | regulation of opsonization(GO:1903027) |
3.4 | 10.2 | GO:0051135 | positive regulation of NK T cell activation(GO:0051135) |
3.4 | 6.8 | GO:0061760 | antifungal innate immune response(GO:0061760) |
3.4 | 3.4 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
3.4 | 23.6 | GO:0051561 | positive regulation of mitochondrial calcium ion concentration(GO:0051561) |
3.4 | 3.4 | GO:2000969 | positive regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000969) |
3.4 | 13.5 | GO:0044068 | modulation by symbiont of host cellular process(GO:0044068) |
3.4 | 10.1 | GO:0044843 | cell cycle G1/S phase transition(GO:0044843) |
3.3 | 13.4 | GO:0036150 | phosphatidylserine acyl-chain remodeling(GO:0036150) |
3.3 | 19.9 | GO:1903758 | regulation of transcription from RNA polymerase II promoter by histone modification(GO:1903756) negative regulation of transcription from RNA polymerase II promoter by histone modification(GO:1903758) |
3.3 | 23.1 | GO:0045292 | mRNA cis splicing, via spliceosome(GO:0045292) |
3.3 | 6.6 | GO:0010641 | positive regulation of platelet-derived growth factor receptor signaling pathway(GO:0010641) |
3.3 | 6.6 | GO:0051984 | positive regulation of chromosome segregation(GO:0051984) |
3.3 | 22.9 | GO:0009142 | nucleoside triphosphate biosynthetic process(GO:0009142) |
3.3 | 39.3 | GO:0043388 | positive regulation of DNA binding(GO:0043388) |
3.3 | 6.5 | GO:0034982 | mitochondrial protein processing(GO:0034982) |
3.2 | 6.5 | GO:0002572 | pro-T cell differentiation(GO:0002572) |
3.2 | 22.6 | GO:0046498 | S-adenosylhomocysteine metabolic process(GO:0046498) |
3.2 | 138.4 | GO:0007062 | sister chromatid cohesion(GO:0007062) |
3.2 | 6.4 | GO:0032799 | low-density lipoprotein receptor particle metabolic process(GO:0032799) |
3.2 | 3.2 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
3.2 | 9.6 | GO:0033630 | positive regulation of cell adhesion mediated by integrin(GO:0033630) |
3.2 | 12.8 | GO:0006051 | mannosamine metabolic process(GO:0006050) N-acetylmannosamine metabolic process(GO:0006051) |
3.2 | 22.3 | GO:0060155 | platelet dense granule organization(GO:0060155) |
3.2 | 12.7 | GO:0003278 | apoptotic process involved in heart morphogenesis(GO:0003278) |
3.2 | 12.6 | GO:0016139 | glycoside catabolic process(GO:0016139) |
3.1 | 6.3 | GO:0023016 | signal transduction by trans-phosphorylation(GO:0023016) |
3.1 | 6.3 | GO:0010944 | negative regulation of transcription by competitive promoter binding(GO:0010944) |
3.1 | 3.1 | GO:0060585 | regulation of prostaglandin-endoperoxide synthase activity(GO:0060584) positive regulation of prostaglandin-endoperoxide synthase activity(GO:0060585) |
3.1 | 6.2 | GO:0010982 | regulation of high-density lipoprotein particle clearance(GO:0010982) |
3.1 | 12.3 | GO:0035803 | egg coat formation(GO:0035803) |
3.1 | 30.7 | GO:0046599 | regulation of centriole replication(GO:0046599) |
3.1 | 3.1 | GO:0033686 | positive regulation of luteinizing hormone secretion(GO:0033686) |
3.1 | 15.3 | GO:0061085 | regulation of histone H3-K27 methylation(GO:0061085) positive regulation of histone H3-K27 methylation(GO:0061087) |
3.0 | 3.0 | GO:0035627 | ceramide transport(GO:0035627) |
3.0 | 15.2 | GO:0046689 | response to mercury ion(GO:0046689) |
3.0 | 3.0 | GO:0042551 | neuron maturation(GO:0042551) |
3.0 | 12.1 | GO:0045349 | interferon-alpha biosynthetic process(GO:0045349) regulation of interferon-alpha biosynthetic process(GO:0045354) |
3.0 | 6.1 | GO:2000249 | regulation of actin cytoskeleton reorganization(GO:2000249) |
3.0 | 21.2 | GO:0046325 | negative regulation of glucose import(GO:0046325) |
3.0 | 21.2 | GO:0051014 | actin filament severing(GO:0051014) |
3.0 | 9.0 | GO:2000035 | regulation of stem cell division(GO:2000035) |
3.0 | 9.0 | GO:2001032 | regulation of double-strand break repair via nonhomologous end joining(GO:2001032) |
3.0 | 6.0 | GO:0060340 | positive regulation of type I interferon-mediated signaling pathway(GO:0060340) |
3.0 | 30.0 | GO:0034356 | NAD biosynthesis via nicotinamide riboside salvage pathway(GO:0034356) |
3.0 | 3.0 | GO:0061009 | common bile duct development(GO:0061009) |
3.0 | 8.9 | GO:0072513 | positive regulation of secondary heart field cardioblast proliferation(GO:0072513) |
3.0 | 65.3 | GO:0043968 | histone H2A acetylation(GO:0043968) |
3.0 | 26.7 | GO:0070986 | left/right axis specification(GO:0070986) |
3.0 | 3.0 | GO:0034381 | plasma lipoprotein particle clearance(GO:0034381) |
2.9 | 5.9 | GO:0001731 | formation of translation preinitiation complex(GO:0001731) |
2.9 | 17.7 | GO:0071638 | negative regulation of monocyte chemotactic protein-1 production(GO:0071638) |
2.9 | 8.7 | GO:0031122 | cytoplasmic microtubule organization(GO:0031122) |
2.9 | 20.1 | GO:0060486 | Clara cell differentiation(GO:0060486) |
2.9 | 11.4 | GO:1900246 | positive regulation of RIG-I signaling pathway(GO:1900246) |
2.9 | 5.7 | GO:0006289 | nucleotide-excision repair(GO:0006289) |
2.8 | 34.0 | GO:0050774 | negative regulation of dendrite morphogenesis(GO:0050774) |
2.8 | 8.4 | GO:1904729 | regulation of intestinal cholesterol absorption(GO:0030300) regulation of intestinal lipid absorption(GO:1904729) |
2.8 | 16.9 | GO:0009099 | branched-chain amino acid biosynthetic process(GO:0009082) leucine biosynthetic process(GO:0009098) valine biosynthetic process(GO:0009099) |
2.8 | 151.4 | GO:0006413 | translational initiation(GO:0006413) |
2.8 | 2.8 | GO:1901187 | regulation of ephrin receptor signaling pathway(GO:1901187) |
2.8 | 5.6 | GO:0060762 | regulation of branching involved in mammary gland duct morphogenesis(GO:0060762) |
2.8 | 13.9 | GO:0001522 | pseudouridine synthesis(GO:0001522) |
2.8 | 16.7 | GO:0051012 | microtubule sliding(GO:0051012) |
2.8 | 2.8 | GO:0009048 | dosage compensation(GO:0007549) dosage compensation by inactivation of X chromosome(GO:0009048) |
2.8 | 5.5 | GO:0070585 | protein localization to mitochondrion(GO:0070585) |
2.8 | 5.5 | GO:0003221 | right ventricular cardiac muscle tissue morphogenesis(GO:0003221) |
2.7 | 2.7 | GO:0072350 | tricarboxylic acid metabolic process(GO:0072350) |
2.7 | 19.2 | GO:0050686 | negative regulation of mRNA processing(GO:0050686) |
2.7 | 22.0 | GO:0016137 | glycoside metabolic process(GO:0016137) |
2.7 | 5.5 | GO:0070071 | proton-transporting two-sector ATPase complex assembly(GO:0070071) |
2.7 | 5.5 | GO:0080182 | histone H3-K4 trimethylation(GO:0080182) |
2.7 | 5.5 | GO:0050434 | positive regulation of viral transcription(GO:0050434) |
2.7 | 5.4 | GO:0035721 | intraciliary retrograde transport(GO:0035721) |
2.7 | 2.7 | GO:0090205 | positive regulation of cholesterol metabolic process(GO:0090205) |
2.7 | 27.1 | GO:0060547 | negative regulation of necrotic cell death(GO:0060547) |
2.7 | 5.4 | GO:0051036 | regulation of endosome size(GO:0051036) |
2.7 | 21.4 | GO:2000144 | positive regulation of DNA-templated transcription, initiation(GO:2000144) |
2.7 | 5.3 | GO:0032922 | circadian regulation of gene expression(GO:0032922) |
2.6 | 18.4 | GO:0008218 | bioluminescence(GO:0008218) |
2.6 | 13.0 | GO:1990089 | response to nerve growth factor(GO:1990089) |
2.6 | 2.6 | GO:0043652 | engulfment of apoptotic cell(GO:0043652) |
2.6 | 28.5 | GO:0045191 | regulation of isotype switching(GO:0045191) |
2.6 | 5.2 | GO:0043382 | regulation of memory T cell differentiation(GO:0043380) positive regulation of memory T cell differentiation(GO:0043382) |
2.6 | 13.0 | GO:0097062 | dendritic spine maintenance(GO:0097062) |
2.6 | 33.2 | GO:0042347 | negative regulation of NF-kappaB import into nucleus(GO:0042347) |
2.5 | 12.7 | GO:0060430 | lung saccule development(GO:0060430) |
2.5 | 15.1 | GO:0015742 | alpha-ketoglutarate transport(GO:0015742) |
2.5 | 15.0 | GO:0071763 | nuclear membrane organization(GO:0071763) |
2.5 | 7.5 | GO:0002326 | B cell lineage commitment(GO:0002326) |
2.5 | 452.6 | GO:0000398 | RNA splicing, via transesterification reactions with bulged adenosine as nucleophile(GO:0000377) mRNA splicing, via spliceosome(GO:0000398) |
2.5 | 7.4 | GO:0070236 | regulation of activation-induced cell death of T cells(GO:0070235) negative regulation of activation-induced cell death of T cells(GO:0070236) |
2.5 | 14.8 | GO:1901741 | positive regulation of myoblast fusion(GO:1901741) |
2.5 | 12.3 | GO:0070383 | DNA deamination(GO:0045006) DNA cytosine deamination(GO:0070383) |
2.5 | 9.9 | GO:0072383 | plus-end-directed vesicle transport along microtubule(GO:0072383) |
2.5 | 4.9 | GO:0035822 | gene conversion(GO:0035822) |
2.5 | 9.8 | GO:0051437 | positive regulation of ubiquitin-protein ligase activity involved in regulation of mitotic cell cycle transition(GO:0051437) |
2.5 | 31.9 | GO:0033689 | negative regulation of osteoblast proliferation(GO:0033689) |
2.4 | 7.3 | GO:1990834 | response to odorant(GO:1990834) |
2.4 | 9.8 | GO:0051958 | methotrexate transport(GO:0051958) reduced folate transmembrane transport(GO:0098838) |
2.4 | 19.5 | GO:0048227 | plasma membrane to endosome transport(GO:0048227) |
2.4 | 7.3 | GO:0071415 | cellular response to purine-containing compound(GO:0071415) |
2.4 | 12.0 | GO:1902513 | regulation of organelle transport along microtubule(GO:1902513) |
2.4 | 4.8 | GO:0051180 | vitamin transport(GO:0051180) |
2.4 | 4.7 | GO:0048539 | bone marrow development(GO:0048539) |
2.4 | 47.2 | GO:0016254 | preassembly of GPI anchor in ER membrane(GO:0016254) |
2.4 | 23.6 | GO:0042455 | ribonucleoside biosynthetic process(GO:0042455) |
2.3 | 7.0 | GO:2001140 | regulation of phospholipid transport(GO:2001138) positive regulation of phospholipid transport(GO:2001140) |
2.3 | 7.0 | GO:0006478 | peptidyl-tyrosine sulfation(GO:0006478) |
2.3 | 11.6 | GO:1903361 | protein localization to basolateral plasma membrane(GO:1903361) |
2.3 | 11.6 | GO:0009838 | abscission(GO:0009838) |
2.3 | 2.3 | GO:0048596 | embryonic camera-type eye morphogenesis(GO:0048596) |
2.3 | 4.6 | GO:0032286 | central nervous system myelin maintenance(GO:0032286) |
2.3 | 4.6 | GO:0051156 | glucose 6-phosphate metabolic process(GO:0051156) |
2.3 | 6.8 | GO:0032641 | lymphotoxin A production(GO:0032641) lymphotoxin A biosynthetic process(GO:0042109) |
2.3 | 2.3 | GO:0045399 | regulation of interleukin-3 production(GO:0032672) positive regulation of interleukin-3 production(GO:0032752) interleukin-3 biosynthetic process(GO:0042223) regulation of interleukin-3 biosynthetic process(GO:0045399) positive regulation of interleukin-3 biosynthetic process(GO:0045401) |
2.3 | 4.5 | GO:0035989 | tendon development(GO:0035989) |
2.3 | 11.3 | GO:0090160 | Golgi to lysosome transport(GO:0090160) |
2.3 | 11.3 | GO:0035246 | peptidyl-arginine N-methylation(GO:0035246) |
2.3 | 6.8 | GO:0046521 | sphingoid catabolic process(GO:0046521) |
2.3 | 4.5 | GO:0046449 | creatinine metabolic process(GO:0046449) |
2.3 | 9.0 | GO:0051451 | myoblast migration(GO:0051451) |
2.3 | 20.3 | GO:0000002 | mitochondrial genome maintenance(GO:0000002) |
2.2 | 4.5 | GO:0061030 | epithelial cell differentiation involved in mammary gland alveolus development(GO:0061030) |
2.2 | 8.9 | GO:0071243 | cellular response to arsenic-containing substance(GO:0071243) |
2.2 | 8.9 | GO:0008206 | bile acid metabolic process(GO:0008206) |
2.2 | 2.2 | GO:0070816 | phosphorylation of RNA polymerase II C-terminal domain(GO:0070816) |
2.2 | 4.4 | GO:0097320 | membrane tubulation(GO:0097320) |
2.2 | 41.4 | GO:0006414 | translational elongation(GO:0006414) |
2.2 | 2.2 | GO:0060316 | positive regulation of ryanodine-sensitive calcium-release channel activity(GO:0060316) |
2.2 | 21.6 | GO:0010839 | negative regulation of keratinocyte proliferation(GO:0010839) |
2.1 | 6.4 | GO:1900223 | positive regulation of beta-amyloid clearance(GO:1900223) |
2.1 | 12.8 | GO:0060011 | Sertoli cell proliferation(GO:0060011) |
2.1 | 4.3 | GO:0043154 | negative regulation of cysteine-type endopeptidase activity involved in apoptotic process(GO:0043154) |
2.1 | 6.4 | GO:0051560 | mitochondrial calcium ion homeostasis(GO:0051560) |
2.1 | 27.4 | GO:0006825 | copper ion transport(GO:0006825) |
2.1 | 37.9 | GO:0071392 | cellular response to estradiol stimulus(GO:0071392) |
2.1 | 16.8 | GO:0046688 | response to copper ion(GO:0046688) |
2.1 | 4.2 | GO:0010591 | regulation of lamellipodium assembly(GO:0010591) |
2.1 | 6.2 | GO:1902961 | positive regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902961) positive regulation of aspartic-type peptidase activity(GO:1905247) |
2.1 | 2.1 | GO:0042222 | interleukin-1 biosynthetic process(GO:0042222) interleukin-1 beta biosynthetic process(GO:0050720) |
2.1 | 8.2 | GO:0007598 | blood coagulation, extrinsic pathway(GO:0007598) |
2.1 | 6.2 | GO:0006990 | positive regulation of transcription from RNA polymerase II promoter involved in unfolded protein response(GO:0006990) |
2.1 | 18.5 | GO:0016180 | snRNA processing(GO:0016180) |
2.0 | 14.3 | GO:0034067 | protein localization to Golgi apparatus(GO:0034067) |
2.0 | 20.3 | GO:0031268 | pseudopodium organization(GO:0031268) |
2.0 | 16.2 | GO:0006564 | L-serine biosynthetic process(GO:0006564) |
2.0 | 8.1 | GO:0045359 | positive regulation of interferon-beta biosynthetic process(GO:0045359) |
2.0 | 16.1 | GO:0007077 | mitotic nuclear envelope disassembly(GO:0007077) |
2.0 | 21.8 | GO:0001967 | suckling behavior(GO:0001967) |
2.0 | 5.9 | GO:1903845 | negative regulation of transforming growth factor beta receptor signaling pathway(GO:0030512) negative regulation of cellular response to transforming growth factor beta stimulus(GO:1903845) |
2.0 | 2.0 | GO:0042986 | positive regulation of amyloid precursor protein biosynthetic process(GO:0042986) |
2.0 | 2.0 | GO:0061307 | cardiac neural crest cell differentiation involved in heart development(GO:0061307) cardiac neural crest cell development involved in heart development(GO:0061308) |
2.0 | 19.6 | GO:0048385 | regulation of retinoic acid receptor signaling pathway(GO:0048385) |
2.0 | 5.9 | GO:0050917 | sensory perception of umami taste(GO:0050917) |
1.9 | 15.6 | GO:2000587 | negative regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000587) |
1.9 | 11.6 | GO:0006623 | protein targeting to lysosome(GO:0006622) protein targeting to vacuole(GO:0006623) |
1.9 | 3.9 | GO:0007566 | embryo implantation(GO:0007566) |
1.9 | 19.3 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
1.9 | 7.7 | GO:0051552 | flavone metabolic process(GO:0051552) |
1.9 | 9.6 | GO:0036438 | maintenance of lens transparency(GO:0036438) |
1.9 | 7.6 | GO:0006662 | glycerol ether metabolic process(GO:0006662) |
1.9 | 3.8 | GO:0038030 | non-canonical Wnt signaling pathway via MAPK cascade(GO:0038030) |
1.9 | 1.9 | GO:0097374 | sensory neuron axon guidance(GO:0097374) |
1.9 | 3.7 | GO:0051547 | regulation of keratinocyte migration(GO:0051547) |
1.9 | 9.3 | GO:0010663 | positive regulation of striated muscle cell apoptotic process(GO:0010663) positive regulation of cardiac muscle cell apoptotic process(GO:0010666) |
1.9 | 3.7 | GO:0061053 | somite development(GO:0061053) |
1.9 | 3.7 | GO:0038165 | oncostatin-M-mediated signaling pathway(GO:0038165) |
1.9 | 7.4 | GO:0000733 | DNA strand renaturation(GO:0000733) |
1.8 | 68.4 | GO:0006656 | phosphatidylcholine biosynthetic process(GO:0006656) |
1.8 | 1.8 | GO:0007413 | axonal fasciculation(GO:0007413) |
1.8 | 40.5 | GO:0007216 | G-protein coupled glutamate receptor signaling pathway(GO:0007216) |
1.8 | 1.8 | GO:0030318 | melanocyte differentiation(GO:0030318) |
1.8 | 7.3 | GO:2001206 | positive regulation of osteoclast development(GO:2001206) |
1.8 | 7.2 | GO:0031953 | negative regulation of protein autophosphorylation(GO:0031953) |
1.8 | 7.2 | GO:0001765 | membrane raft assembly(GO:0001765) |
1.8 | 3.6 | GO:0006474 | N-terminal protein amino acid acetylation(GO:0006474) |
1.8 | 1.8 | GO:0019915 | lipid storage(GO:0019915) |
1.8 | 7.1 | GO:0051001 | negative regulation of nitric-oxide synthase activity(GO:0051001) |
1.8 | 1.8 | GO:0070278 | extracellular matrix constituent secretion(GO:0070278) |
1.8 | 23.1 | GO:0031639 | plasminogen activation(GO:0031639) |
1.8 | 14.2 | GO:0031000 | response to caffeine(GO:0031000) |
1.8 | 10.6 | GO:0032468 | Golgi calcium ion homeostasis(GO:0032468) |
1.8 | 15.9 | GO:0046476 | galactosylceramide biosynthetic process(GO:0006682) galactolipid biosynthetic process(GO:0019375) glycosylceramide biosynthetic process(GO:0046476) |
1.8 | 3.5 | GO:0006678 | glucosylceramide metabolic process(GO:0006678) |
1.8 | 1.8 | GO:2000465 | regulation of glycogen (starch) synthase activity(GO:2000465) |
1.8 | 7.0 | GO:0038203 | TORC2 signaling(GO:0038203) |
1.7 | 5.2 | GO:0010606 | positive regulation of cytoplasmic mRNA processing body assembly(GO:0010606) |
1.7 | 6.9 | GO:0043568 | positive regulation of insulin-like growth factor receptor signaling pathway(GO:0043568) |
1.7 | 5.2 | GO:0019321 | pentose metabolic process(GO:0019321) |
1.7 | 3.4 | GO:0090080 | positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway(GO:0090080) |
1.7 | 1.7 | GO:0060157 | urinary bladder development(GO:0060157) |
1.7 | 41.9 | GO:0009235 | cobalamin metabolic process(GO:0009235) |
1.7 | 6.7 | GO:1902237 | positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902237) |
1.7 | 3.3 | GO:0071109 | superior temporal gyrus development(GO:0071109) |
1.7 | 6.7 | GO:0044351 | macropinocytosis(GO:0044351) |
1.7 | 16.6 | GO:0048305 | immunoglobulin secretion(GO:0048305) |
1.7 | 6.6 | GO:2000484 | positive regulation of interleukin-8 secretion(GO:2000484) |
1.7 | 8.3 | GO:0061001 | regulation of dendritic spine morphogenesis(GO:0061001) |
1.6 | 54.3 | GO:0006261 | DNA-dependent DNA replication(GO:0006261) |
1.6 | 6.6 | GO:0030207 | chondroitin sulfate catabolic process(GO:0030207) |
1.6 | 9.8 | GO:0032328 | alanine transport(GO:0032328) |
1.6 | 11.4 | GO:0071694 | protein localization to extracellular region(GO:0071692) maintenance of protein location in extracellular region(GO:0071694) |
1.6 | 37.3 | GO:0006739 | NADP metabolic process(GO:0006739) |
1.6 | 62.9 | GO:0042147 | retrograde transport, endosome to Golgi(GO:0042147) |
1.6 | 6.4 | GO:0006012 | galactose metabolic process(GO:0006012) |
1.6 | 3.2 | GO:0035694 | mitochondrial protein catabolic process(GO:0035694) |
1.6 | 3.2 | GO:0050859 | negative regulation of B cell receptor signaling pathway(GO:0050859) |
1.6 | 3.1 | GO:0042360 | vitamin E metabolic process(GO:0042360) |
1.6 | 3.1 | GO:0016240 | autophagosome docking(GO:0016240) |
1.5 | 4.6 | GO:0006003 | fructose 2,6-bisphosphate metabolic process(GO:0006003) |
1.5 | 9.2 | GO:0006521 | regulation of cellular amino acid metabolic process(GO:0006521) |
1.5 | 1.5 | GO:0090038 | negative regulation of protein kinase C signaling(GO:0090038) |
1.5 | 1.5 | GO:1903094 | regulation of protein K48-linked deubiquitination(GO:1903093) negative regulation of protein K48-linked deubiquitination(GO:1903094) negative regulation of ubiquitin-specific protease activity(GO:2000157) |
1.5 | 39.5 | GO:0006699 | bile acid biosynthetic process(GO:0006699) |
1.5 | 3.0 | GO:0009635 | response to herbicide(GO:0009635) |
1.5 | 3.0 | GO:0071372 | cellular response to follicle-stimulating hormone stimulus(GO:0071372) |
1.5 | 18.2 | GO:0035435 | phosphate ion transmembrane transport(GO:0035435) |
1.5 | 3.0 | GO:0015722 | canalicular bile acid transport(GO:0015722) |
1.5 | 3.0 | GO:0031507 | heterochromatin assembly(GO:0031507) |
1.5 | 3.0 | GO:0010536 | positive regulation of activation of Janus kinase activity(GO:0010536) |
1.5 | 11.9 | GO:0010739 | positive regulation of protein kinase A signaling(GO:0010739) |
1.5 | 1.5 | GO:0009191 | ribonucleoside diphosphate catabolic process(GO:0009191) |
1.5 | 16.2 | GO:0009226 | nucleotide-sugar biosynthetic process(GO:0009226) |
1.5 | 4.4 | GO:1903070 | negative regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903070) |
1.5 | 4.4 | GO:1900077 | negative regulation of insulin receptor signaling pathway(GO:0046627) negative regulation of cellular response to insulin stimulus(GO:1900077) |
1.5 | 2.9 | GO:1901143 | insulin catabolic process(GO:1901143) |
1.5 | 8.7 | GO:0055092 | cholesterol homeostasis(GO:0042632) sterol homeostasis(GO:0055092) |
1.4 | 5.8 | GO:0035814 | negative regulation of renal sodium excretion(GO:0035814) |
1.4 | 1.4 | GO:0071542 | dopaminergic neuron differentiation(GO:0071542) |
1.4 | 5.7 | GO:2000270 | negative regulation of fibroblast apoptotic process(GO:2000270) |
1.4 | 2.9 | GO:0060025 | regulation of synaptic activity(GO:0060025) |
1.4 | 9.9 | GO:0071926 | endocannabinoid signaling pathway(GO:0071926) regulation of endocannabinoid signaling pathway(GO:2000124) |
1.4 | 4.2 | GO:0035520 | monoubiquitinated protein deubiquitination(GO:0035520) |
1.4 | 11.2 | GO:0051764 | actin crosslink formation(GO:0051764) |
1.4 | 2.8 | GO:0048703 | embryonic viscerocranium morphogenesis(GO:0048703) |
1.4 | 1.4 | GO:0032472 | Golgi calcium ion transport(GO:0032472) |
1.4 | 7.0 | GO:1904977 | lymphatic endothelial cell migration(GO:1904977) |
1.4 | 1.4 | GO:0051088 | PMA-inducible membrane protein ectodomain proteolysis(GO:0051088) |
1.4 | 5.5 | GO:0008053 | mitochondrial fusion(GO:0008053) |
1.3 | 1.3 | GO:1902908 | regulation of melanosome transport(GO:1902908) |
1.3 | 2.7 | GO:0070584 | mitochondrion morphogenesis(GO:0070584) |
1.3 | 9.3 | GO:0060628 | regulation of ER to Golgi vesicle-mediated transport(GO:0060628) |
1.3 | 2.6 | GO:0061484 | hematopoietic stem cell homeostasis(GO:0061484) |
1.3 | 2.6 | GO:0002101 | tRNA wobble cytosine modification(GO:0002101) |
1.3 | 10.5 | GO:0035268 | protein mannosylation(GO:0035268) protein O-linked mannosylation(GO:0035269) |
1.3 | 24.8 | GO:0031954 | positive regulation of protein autophosphorylation(GO:0031954) |
1.3 | 2.6 | GO:0045579 | positive regulation of B cell differentiation(GO:0045579) |
1.3 | 2.6 | GO:0036337 | Fas signaling pathway(GO:0036337) |
1.3 | 76.1 | GO:0006626 | protein targeting to mitochondrion(GO:0006626) |
1.3 | 3.9 | GO:0042635 | positive regulation of hair cycle(GO:0042635) |
1.3 | 12.8 | GO:0090190 | positive regulation of branching involved in ureteric bud morphogenesis(GO:0090190) |
1.3 | 7.7 | GO:1901164 | negative regulation of trophoblast cell migration(GO:1901164) |
1.3 | 6.3 | GO:1901660 | calcium ion export(GO:1901660) |
1.3 | 2.5 | GO:0021773 | striatal medium spiny neuron differentiation(GO:0021773) |
1.3 | 1.3 | GO:0046889 | positive regulation of lipid biosynthetic process(GO:0046889) |
1.3 | 2.5 | GO:0060253 | negative regulation of glial cell proliferation(GO:0060253) |
1.2 | 3.7 | GO:1900864 | mitochondrial tRNA modification(GO:0070900) mitochondrial RNA modification(GO:1900864) |
1.2 | 54.7 | GO:0018279 | peptidyl-asparagine modification(GO:0018196) protein N-linked glycosylation via asparagine(GO:0018279) |
1.2 | 3.7 | GO:0019852 | L-ascorbic acid metabolic process(GO:0019852) |
1.2 | 3.7 | GO:0090283 | regulation of protein glycosylation in Golgi(GO:0090283) |
1.2 | 2.5 | GO:0048845 | venous blood vessel morphogenesis(GO:0048845) |
1.2 | 18.3 | GO:0033146 | regulation of intracellular estrogen receptor signaling pathway(GO:0033146) |
1.2 | 6.1 | GO:0002415 | immunoglobulin transcytosis in epithelial cells mediated by polymeric immunoglobulin receptor(GO:0002415) |
1.2 | 8.4 | GO:0048752 | semicircular canal morphogenesis(GO:0048752) |
1.2 | 19.2 | GO:0071498 | cellular response to fluid shear stress(GO:0071498) |
1.2 | 6.0 | GO:0000183 | chromatin silencing at rDNA(GO:0000183) |
1.2 | 4.8 | GO:0050928 | negative regulation of positive chemotaxis(GO:0050928) |
1.2 | 7.1 | GO:0006689 | ganglioside catabolic process(GO:0006689) |
1.2 | 2.4 | GO:0042100 | B cell proliferation(GO:0042100) |
1.2 | 4.7 | GO:1903206 | negative regulation of hydrogen peroxide-induced cell death(GO:1903206) |
1.2 | 1.2 | GO:0048625 | myoblast fate commitment(GO:0048625) |
1.2 | 4.7 | GO:0048286 | lung alveolus development(GO:0048286) |
1.1 | 4.6 | GO:0021759 | globus pallidus development(GO:0021759) |
1.1 | 2.3 | GO:0002353 | kinin cascade(GO:0002254) plasma kallikrein-kinin cascade(GO:0002353) |
1.1 | 12.6 | GO:0007220 | Notch receptor processing(GO:0007220) |
1.1 | 4.6 | GO:0072528 | pyrimidine-containing compound biosynthetic process(GO:0072528) |
1.1 | 5.6 | GO:1903385 | regulation of homophilic cell adhesion(GO:1903385) |
1.1 | 25.7 | GO:0015721 | bile acid and bile salt transport(GO:0015721) |
1.1 | 8.9 | GO:1902235 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902235) |
1.1 | 76.6 | GO:0006334 | nucleosome assembly(GO:0006334) |
1.1 | 19.9 | GO:1903393 | positive regulation of adherens junction organization(GO:1903393) |
1.1 | 18.7 | GO:0061418 | regulation of transcription from RNA polymerase II promoter in response to hypoxia(GO:0061418) |
1.1 | 10.9 | GO:0006516 | glycoprotein catabolic process(GO:0006516) |
1.1 | 3.3 | GO:0002925 | positive regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002925) |
1.1 | 38.3 | GO:0030212 | hyaluronan metabolic process(GO:0030212) |
1.1 | 5.3 | GO:0033148 | positive regulation of intracellular estrogen receptor signaling pathway(GO:0033148) |
1.1 | 1.1 | GO:1902358 | sulfate transmembrane transport(GO:1902358) |
1.1 | 5.3 | GO:0097296 | activation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:0097296) |
1.1 | 8.4 | GO:0010529 | regulation of transposition(GO:0010528) negative regulation of transposition(GO:0010529) |
1.1 | 6.3 | GO:0002943 | tRNA dihydrouridine synthesis(GO:0002943) |
1.1 | 2.1 | GO:0042938 | dipeptide transport(GO:0042938) |
1.0 | 2.1 | GO:0045165 | cell fate commitment(GO:0045165) |
1.0 | 1.0 | GO:0007028 | cytoplasm organization(GO:0007028) |
1.0 | 12.2 | GO:0030033 | microvillus assembly(GO:0030033) |
1.0 | 1.0 | GO:0060729 | intestinal epithelial structure maintenance(GO:0060729) |
1.0 | 8.0 | GO:0009313 | oligosaccharide catabolic process(GO:0009313) |
1.0 | 5.0 | GO:0090103 | cochlea morphogenesis(GO:0090103) |
1.0 | 1.0 | GO:0045636 | regulation of melanocyte differentiation(GO:0045634) positive regulation of melanocyte differentiation(GO:0045636) positive regulation of neuroepithelial cell differentiation(GO:1902913) |
1.0 | 2.9 | GO:0006771 | riboflavin metabolic process(GO:0006771) negative regulation of superoxide anion generation(GO:0032929) flavin-containing compound metabolic process(GO:0042726) |
1.0 | 2.0 | GO:0061042 | vascular wound healing(GO:0061042) |
1.0 | 2.9 | GO:0070966 | nuclear-transcribed mRNA catabolic process, no-go decay(GO:0070966) |
1.0 | 2.9 | GO:0070886 | positive regulation of calcineurin-NFAT signaling cascade(GO:0070886) |
1.0 | 1.9 | GO:0003350 | pulmonary myocardium development(GO:0003350) |
0.9 | 0.9 | GO:0070166 | enamel mineralization(GO:0070166) |
0.9 | 0.9 | GO:0042501 | serine phosphorylation of STAT protein(GO:0042501) |
0.9 | 6.6 | GO:0018344 | protein geranylgeranylation(GO:0018344) |
0.9 | 10.3 | GO:0000038 | very long-chain fatty acid metabolic process(GO:0000038) |
0.9 | 4.7 | GO:0043542 | endothelial cell migration(GO:0043542) |
0.9 | 1.9 | GO:0042091 | interleukin-10 biosynthetic process(GO:0042091) regulation of interleukin-10 biosynthetic process(GO:0045074) |
0.9 | 2.8 | GO:0009650 | UV protection(GO:0009650) |
0.9 | 13.8 | GO:0061098 | positive regulation of protein tyrosine kinase activity(GO:0061098) |
0.9 | 0.9 | GO:1990523 | bone regeneration(GO:1990523) |
0.9 | 1.8 | GO:1904338 | regulation of dopaminergic neuron differentiation(GO:1904338) |
0.9 | 4.5 | GO:0030263 | apoptotic chromosome condensation(GO:0030263) |
0.9 | 0.9 | GO:0060242 | contact inhibition(GO:0060242) |
0.9 | 2.7 | GO:1903054 | negative regulation of extracellular matrix organization(GO:1903054) |
0.9 | 7.1 | GO:0032781 | positive regulation of ATPase activity(GO:0032781) |
0.9 | 1.8 | GO:0015865 | purine nucleotide transport(GO:0015865) purine ribonucleotide transport(GO:0015868) |
0.9 | 11.4 | GO:0036148 | phosphatidylglycerol acyl-chain remodeling(GO:0036148) |
0.9 | 7.8 | GO:0009812 | flavonoid metabolic process(GO:0009812) |
0.9 | 0.9 | GO:0042149 | cellular response to glucose starvation(GO:0042149) |
0.9 | 0.9 | GO:0009441 | glycolate metabolic process(GO:0009441) |
0.9 | 7.7 | GO:0030490 | maturation of SSU-rRNA(GO:0030490) |
0.8 | 2.5 | GO:0044117 | growth of symbiont in host(GO:0044117) regulation of growth of symbiont in host(GO:0044126) negative regulation of growth of symbiont in host(GO:0044130) |
0.8 | 3.4 | GO:0016557 | peroxisome membrane biogenesis(GO:0016557) |
0.8 | 0.8 | GO:0016129 | ergosterol biosynthetic process(GO:0006696) ergosterol metabolic process(GO:0008204) phytosteroid metabolic process(GO:0016128) phytosteroid biosynthetic process(GO:0016129) |
0.8 | 3.3 | GO:0031666 | positive regulation of lipopolysaccharide-mediated signaling pathway(GO:0031666) |
0.8 | 0.8 | GO:0090086 | negative regulation of protein deubiquitination(GO:0090086) |
0.8 | 2.5 | GO:0006711 | estrogen catabolic process(GO:0006711) |
0.8 | 3.3 | GO:0007252 | I-kappaB phosphorylation(GO:0007252) |
0.8 | 1.6 | GO:0001507 | acetylcholine catabolic process in synaptic cleft(GO:0001507) acetylcholine catabolic process(GO:0006581) |
0.8 | 1.6 | GO:0002638 | negative regulation of immunoglobulin production(GO:0002638) |
0.8 | 6.4 | GO:0032515 | negative regulation of phosphoprotein phosphatase activity(GO:0032515) |
0.8 | 1.6 | GO:0009146 | purine nucleoside triphosphate catabolic process(GO:0009146) |
0.8 | 3.2 | GO:2000480 | negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
0.8 | 1.6 | GO:0070541 | response to platinum ion(GO:0070541) |
0.8 | 8.6 | GO:0042590 | antigen processing and presentation of exogenous peptide antigen via MHC class I(GO:0042590) |
0.8 | 0.8 | GO:0005988 | lactose metabolic process(GO:0005988) lactose biosynthetic process(GO:0005989) |
0.8 | 0.8 | GO:0009303 | rRNA transcription(GO:0009303) |
0.8 | 36.6 | GO:0006695 | cholesterol biosynthetic process(GO:0006695) |
0.8 | 8.4 | GO:0031915 | positive regulation of synaptic plasticity(GO:0031915) |
0.8 | 4.5 | GO:0090051 | negative regulation of cell migration involved in sprouting angiogenesis(GO:0090051) |
0.7 | 26.2 | GO:0006891 | intra-Golgi vesicle-mediated transport(GO:0006891) |
0.7 | 0.7 | GO:0051835 | positive regulation of synapse structural plasticity(GO:0051835) |
0.7 | 1.5 | GO:0032808 | lacrimal gland development(GO:0032808) |
0.7 | 1.5 | GO:0006833 | water transport(GO:0006833) |
0.7 | 2.2 | GO:0046532 | regulation of photoreceptor cell differentiation(GO:0046532) |
0.7 | 0.7 | GO:0060920 | cardiac pacemaker cell differentiation(GO:0060920) cardiac pacemaker cell development(GO:0060926) |
0.7 | 1.5 | GO:1902902 | negative regulation of autophagosome assembly(GO:1902902) |
0.7 | 1.5 | GO:0043376 | regulation of CD8-positive, alpha-beta T cell differentiation(GO:0043376) |
0.7 | 2.2 | GO:0048743 | positive regulation of skeletal muscle fiber development(GO:0048743) |
0.7 | 1.4 | GO:0009448 | gamma-aminobutyric acid metabolic process(GO:0009448) |
0.7 | 1.4 | GO:0008063 | Toll signaling pathway(GO:0008063) |
0.7 | 2.1 | GO:0042418 | epinephrine metabolic process(GO:0042414) epinephrine biosynthetic process(GO:0042418) |
0.7 | 3.6 | GO:2001256 | regulation of store-operated calcium entry(GO:2001256) |
0.7 | 1.4 | GO:2001178 | mediator complex assembly(GO:0036034) regulation of mediator complex assembly(GO:2001176) positive regulation of mediator complex assembly(GO:2001178) |
0.7 | 2.0 | GO:0036060 | filtration diaphragm assembly(GO:0036058) slit diaphragm assembly(GO:0036060) |
0.7 | 4.7 | GO:0042791 | 5S class rRNA transcription from RNA polymerase III type 1 promoter(GO:0042791) tRNA transcription from RNA polymerase III promoter(GO:0042797) |
0.7 | 0.7 | GO:0070141 | response to UV-A(GO:0070141) |
0.7 | 24.7 | GO:0034260 | negative regulation of GTPase activity(GO:0034260) |
0.7 | 8.0 | GO:0030262 | apoptotic nuclear changes(GO:0030262) |
0.7 | 3.3 | GO:0035162 | embryonic hemopoiesis(GO:0035162) |
0.7 | 2.6 | GO:0007250 | activation of NF-kappaB-inducing kinase activity(GO:0007250) |
0.7 | 2.0 | GO:0001923 | B-1 B cell differentiation(GO:0001923) |
0.6 | 5.7 | GO:0010815 | bradykinin catabolic process(GO:0010815) |
0.6 | 3.2 | GO:0098967 | exocytic insertion of neurotransmitter receptor to plasma membrane(GO:0098881) exocytic insertion of neurotransmitter receptor to postsynaptic membrane(GO:0098967) |
0.6 | 4.4 | GO:0030252 | growth hormone secretion(GO:0030252) |
0.6 | 10.0 | GO:0003334 | keratinocyte development(GO:0003334) |
0.6 | 2.5 | GO:0038018 | Wnt receptor catabolic process(GO:0038018) |
0.6 | 1.2 | GO:0032679 | TRAIL production(GO:0032639) regulation of TRAIL production(GO:0032679) positive regulation of TRAIL production(GO:0032759) |
0.6 | 0.6 | GO:0044849 | estrous cycle(GO:0044849) |
0.6 | 2.9 | GO:0090084 | negative regulation of inclusion body assembly(GO:0090084) |
0.6 | 57.0 | GO:0070268 | cornification(GO:0070268) |
0.6 | 0.6 | GO:2000696 | regulation of epithelial cell differentiation involved in kidney development(GO:2000696) |
0.6 | 0.6 | GO:0071467 | cellular response to pH(GO:0071467) |
0.6 | 2.8 | GO:0016554 | cytidine to uridine editing(GO:0016554) |
0.6 | 0.6 | GO:0015682 | ferric iron transport(GO:0015682) trivalent inorganic cation transport(GO:0072512) |
0.6 | 1.7 | GO:0032488 | Cdc42 protein signal transduction(GO:0032488) |
0.6 | 0.6 | GO:0032425 | regulation of mismatch repair(GO:0032423) positive regulation of mismatch repair(GO:0032425) |
0.5 | 8.2 | GO:0002323 | natural killer cell activation involved in immune response(GO:0002323) |
0.5 | 6.5 | GO:0051351 | positive regulation of ligase activity(GO:0051351) |
0.5 | 8.7 | GO:0044804 | nucleophagy(GO:0044804) |
0.5 | 4.3 | GO:0036120 | cellular response to platelet-derived growth factor stimulus(GO:0036120) |
0.5 | 3.2 | GO:0052695 | cellular glucuronidation(GO:0052695) |
0.5 | 3.7 | GO:0001710 | mesodermal cell fate commitment(GO:0001710) |
0.5 | 11.7 | GO:0010595 | positive regulation of endothelial cell migration(GO:0010595) |
0.5 | 8.1 | GO:0032060 | bleb assembly(GO:0032060) |
0.5 | 6.1 | GO:0032467 | positive regulation of cytokinesis(GO:0032467) |
0.5 | 4.5 | GO:0035372 | protein localization to microtubule(GO:0035372) |
0.5 | 1.5 | GO:0021979 | hypothalamus cell differentiation(GO:0021979) |
0.5 | 1.0 | GO:0060040 | retinal bipolar neuron differentiation(GO:0060040) |
0.5 | 2.0 | GO:0090005 | negative regulation of establishment of protein localization to plasma membrane(GO:0090005) |
0.5 | 0.5 | GO:0051459 | regulation of corticotropin secretion(GO:0051459) |
0.5 | 1.0 | GO:0046222 | mycotoxin metabolic process(GO:0043385) aflatoxin metabolic process(GO:0046222) organic heteropentacyclic compound metabolic process(GO:1901376) |
0.5 | 7.6 | GO:0045851 | pH reduction(GO:0045851) |
0.5 | 2.3 | GO:0001302 | replicative cell aging(GO:0001302) |
0.5 | 2.7 | GO:0036010 | protein localization to endosome(GO:0036010) |
0.5 | 1.4 | GO:0034197 | acylglycerol transport(GO:0034196) triglyceride transport(GO:0034197) |
0.4 | 1.3 | GO:0045023 | G0 to G1 transition(GO:0045023) |
0.4 | 0.4 | GO:2000359 | regulation of binding of sperm to zona pellucida(GO:2000359) |
0.4 | 1.3 | GO:0090400 | stress-induced premature senescence(GO:0090400) |
0.4 | 9.1 | GO:0046856 | phosphatidylinositol dephosphorylation(GO:0046856) |
0.4 | 0.8 | GO:0031100 | organ regeneration(GO:0031100) |
0.4 | 3.6 | GO:1903321 | negative regulation of protein modification by small protein conjugation or removal(GO:1903321) |
0.4 | 1.6 | GO:0006047 | UDP-N-acetylglucosamine metabolic process(GO:0006047) |
0.4 | 3.5 | GO:0035860 | glial cell-derived neurotrophic factor receptor signaling pathway(GO:0035860) |
0.4 | 1.2 | GO:0018125 | peptidyl-cysteine methylation(GO:0018125) |
0.4 | 0.8 | GO:0010310 | regulation of hydrogen peroxide metabolic process(GO:0010310) |
0.4 | 3.0 | GO:0042753 | positive regulation of circadian rhythm(GO:0042753) |
0.4 | 4.3 | GO:0071425 | hematopoietic stem cell proliferation(GO:0071425) |
0.4 | 0.7 | GO:0007497 | posterior midgut development(GO:0007497) |
0.3 | 2.4 | GO:0045599 | negative regulation of fat cell differentiation(GO:0045599) |
0.3 | 1.0 | GO:1900383 | regulation of synaptic plasticity by receptor localization to synapse(GO:1900383) |
0.3 | 0.3 | GO:0002886 | regulation of myeloid leukocyte mediated immunity(GO:0002886) |
0.3 | 1.4 | GO:0042026 | protein refolding(GO:0042026) |
0.3 | 5.0 | GO:0019184 | nonribosomal peptide biosynthetic process(GO:0019184) |
0.3 | 1.0 | GO:0017004 | cytochrome complex assembly(GO:0017004) |
0.3 | 1.0 | GO:0032464 | positive regulation of protein homooligomerization(GO:0032464) |
0.3 | 1.3 | GO:1990668 | vesicle fusion with endoplasmic reticulum-Golgi intermediate compartment (ERGIC) membrane(GO:1990668) |
0.3 | 1.0 | GO:0050894 | determination of affect(GO:0050894) |
0.3 | 0.3 | GO:0070837 | dehydroascorbic acid transport(GO:0070837) |
0.3 | 4.0 | GO:0034383 | low-density lipoprotein particle clearance(GO:0034383) |
0.3 | 1.8 | GO:0038172 | interleukin-33-mediated signaling pathway(GO:0038172) |
0.3 | 3.4 | GO:0000018 | regulation of DNA recombination(GO:0000018) |
0.3 | 2.0 | GO:1990001 | inhibition of cysteine-type endopeptidase activity involved in apoptotic process(GO:1990001) |
0.3 | 0.3 | GO:0050653 | chondroitin sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0050653) |
0.3 | 1.1 | GO:0036003 | positive regulation of transcription from RNA polymerase II promoter in response to stress(GO:0036003) |
0.3 | 1.9 | GO:0098704 | fructose transport(GO:0015755) fructose import(GO:0032445) carbohydrate import into cell(GO:0097319) carbohydrate import across plasma membrane(GO:0098704) fructose import across plasma membrane(GO:1990539) |
0.3 | 0.8 | GO:0051775 | response to redox state(GO:0051775) |
0.2 | 0.2 | GO:0019442 | tryptophan catabolic process to acetyl-CoA(GO:0019442) |
0.2 | 0.5 | GO:0032926 | negative regulation of activin receptor signaling pathway(GO:0032926) |
0.2 | 0.2 | GO:0039530 | MDA-5 signaling pathway(GO:0039530) |
0.2 | 4.3 | GO:0061003 | positive regulation of dendritic spine morphogenesis(GO:0061003) |
0.2 | 0.7 | GO:0060161 | positive regulation of dopamine receptor signaling pathway(GO:0060161) |
0.2 | 3.6 | GO:0030104 | water homeostasis(GO:0030104) |
0.2 | 2.1 | GO:0044872 | lipoprotein transport(GO:0042953) lipoprotein localization(GO:0044872) |
0.2 | 0.2 | GO:0033189 | response to vitamin A(GO:0033189) |
0.2 | 1.3 | GO:0035641 | locomotory exploration behavior(GO:0035641) |
0.2 | 1.5 | GO:0046039 | GTP metabolic process(GO:0046039) |
0.2 | 0.9 | GO:0021591 | ventricular system development(GO:0021591) |
0.2 | 0.7 | GO:0060059 | embryonic retina morphogenesis in camera-type eye(GO:0060059) |
0.2 | 0.2 | GO:0071545 | inositol phosphate catabolic process(GO:0071545) |
0.2 | 0.3 | GO:0060033 | anatomical structure regression(GO:0060033) |
0.2 | 0.8 | GO:0045617 | negative regulation of keratinocyte differentiation(GO:0045617) |
0.2 | 0.5 | GO:0010513 | positive regulation of phosphatidylinositol biosynthetic process(GO:0010513) |
0.2 | 0.3 | GO:0097033 | respiratory chain complex III assembly(GO:0017062) mitochondrial respiratory chain complex III assembly(GO:0034551) mitochondrial respiratory chain complex III biogenesis(GO:0097033) |
0.2 | 0.2 | GO:0090003 | regulation of establishment of protein localization to plasma membrane(GO:0090003) |
0.1 | 0.1 | GO:0006145 | purine nucleobase catabolic process(GO:0006145) xanthine metabolic process(GO:0046110) |
0.1 | 0.5 | GO:0051694 | pointed-end actin filament capping(GO:0051694) |
0.1 | 1.3 | GO:0016925 | protein sumoylation(GO:0016925) |
0.1 | 0.6 | GO:0070307 | lens fiber cell development(GO:0070307) |
0.1 | 0.9 | GO:0002931 | response to ischemia(GO:0002931) |
0.1 | 5.3 | GO:0016072 | rRNA metabolic process(GO:0016072) |
0.1 | 0.1 | GO:1904888 | cranial skeletal system development(GO:1904888) |
0.1 | 2.6 | GO:0071526 | semaphorin-plexin signaling pathway(GO:0071526) |
0.1 | 0.5 | GO:0019885 | antigen processing and presentation of endogenous peptide antigen via MHC class I(GO:0019885) |
0.1 | 0.3 | GO:0051493 | regulation of cytoskeleton organization(GO:0051493) |
0.1 | 0.4 | GO:0021517 | ventral spinal cord development(GO:0021517) |
0.1 | 0.1 | GO:0099590 | neurotransmitter receptor internalization(GO:0099590) |
0.1 | 0.1 | GO:0003344 | pericardium morphogenesis(GO:0003344) |
0.1 | 0.5 | GO:0007352 | zygotic specification of dorsal/ventral axis(GO:0007352) |
0.1 | 0.3 | GO:0007185 | transmembrane receptor protein tyrosine phosphatase signaling pathway(GO:0007185) |
0.1 | 0.1 | GO:0030916 | otic vesicle formation(GO:0030916) |
0.1 | 3.3 | GO:0001909 | leukocyte mediated cytotoxicity(GO:0001909) |
0.1 | 0.2 | GO:0035459 | cargo loading into vesicle(GO:0035459) |
0.1 | 0.2 | GO:1900017 | positive regulation of cytokine production involved in inflammatory response(GO:1900017) |
0.1 | 0.2 | GO:0072313 | metanephric glomerular epithelium development(GO:0072244) metanephric glomerular visceral epithelial cell differentiation(GO:0072248) metanephric glomerular visceral epithelial cell development(GO:0072249) metanephric glomerular epithelial cell differentiation(GO:0072312) metanephric glomerular epithelial cell development(GO:0072313) |
0.1 | 0.2 | GO:0060761 | negative regulation of response to cytokine stimulus(GO:0060761) |
0.0 | 0.3 | GO:0030520 | intracellular estrogen receptor signaling pathway(GO:0030520) |
0.0 | 0.4 | GO:0060416 | response to growth hormone(GO:0060416) |
0.0 | 0.0 | GO:2001240 | negative regulation of signal transduction in absence of ligand(GO:1901099) negative regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001240) |
0.0 | 0.3 | GO:0008210 | estrogen metabolic process(GO:0008210) |
0.0 | 0.1 | GO:0043457 | regulation of cellular respiration(GO:0043457) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
43.3 | 43.3 | GO:0036449 | microtubule minus-end(GO:0036449) |
43.2 | 216.0 | GO:0009368 | endopeptidase Clp complex(GO:0009368) |
38.3 | 153.1 | GO:0005971 | ribonucleoside-diphosphate reductase complex(GO:0005971) |
35.8 | 178.9 | GO:0097149 | centralspindlin complex(GO:0097149) |
34.5 | 413.9 | GO:0019773 | proteasome core complex, alpha-subunit complex(GO:0019773) |
33.7 | 269.2 | GO:0034715 | pICln-Sm protein complex(GO:0034715) |
31.3 | 156.5 | GO:0097125 | cyclin B1-CDK1 complex(GO:0097125) |
31.0 | 93.1 | GO:0034667 | integrin alpha3-beta1 complex(GO:0034667) |
30.4 | 212.7 | GO:0005663 | DNA replication factor C complex(GO:0005663) |
28.7 | 86.2 | GO:0031523 | Myb complex(GO:0031523) |
28.4 | 85.2 | GO:0031262 | Ndc80 complex(GO:0031262) |
28.0 | 112.0 | GO:0031510 | SUMO activating enzyme complex(GO:0031510) |
27.9 | 167.6 | GO:0008537 | proteasome activator complex(GO:0008537) |
27.6 | 165.8 | GO:0071817 | MMXD complex(GO:0071817) |
26.7 | 346.6 | GO:0002199 | zona pellucida receptor complex(GO:0002199) |
26.4 | 131.8 | GO:0033503 | HULC complex(GO:0033503) |
26.3 | 78.9 | GO:1990298 | mitotic checkpoint complex(GO:0033597) bub1-bub3 complex(GO:1990298) |
26.1 | 104.4 | GO:0070985 | TFIIK complex(GO:0070985) |
26.0 | 468.9 | GO:0005736 | DNA-directed RNA polymerase I complex(GO:0005736) |
26.0 | 104.0 | GO:0032301 | MutSalpha complex(GO:0032301) |
25.6 | 307.1 | GO:0031595 | nuclear proteasome complex(GO:0031595) |
25.3 | 253.1 | GO:0097255 | R2TP complex(GO:0097255) |
25.0 | 150.1 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
25.0 | 675.6 | GO:0000314 | organellar small ribosomal subunit(GO:0000314) mitochondrial small ribosomal subunit(GO:0005763) |
24.8 | 124.0 | GO:0030678 | mitochondrial ribonuclease P complex(GO:0030678) |
24.7 | 221.9 | GO:0071541 | eukaryotic translation initiation factor 3 complex, eIF3m(GO:0071541) |
24.2 | 145.0 | GO:0070761 | pre-snoRNP complex(GO:0070761) |
23.3 | 93.2 | GO:0043259 | laminin-10 complex(GO:0043259) |
22.9 | 114.4 | GO:0045323 | interleukin-1 receptor complex(GO:0045323) |
22.7 | 22.7 | GO:0005687 | U4 snRNP(GO:0005687) |
22.3 | 89.2 | GO:0002189 | ribose phosphate diphosphokinase complex(GO:0002189) |
22.2 | 155.3 | GO:0016272 | prefoldin complex(GO:0016272) |
22.1 | 353.3 | GO:0019774 | proteasome core complex, beta-subunit complex(GO:0019774) |
21.4 | 256.8 | GO:0097487 | multivesicular body, internal vesicle(GO:0097487) |
21.4 | 235.0 | GO:0045275 | mitochondrial respiratory chain complex III(GO:0005750) respiratory chain complex III(GO:0045275) |
21.1 | 105.5 | GO:0034750 | Scrib-APC-beta-catenin complex(GO:0034750) |
20.8 | 41.6 | GO:0035861 | site of double-strand break(GO:0035861) |
20.8 | 145.6 | GO:0005787 | signal peptidase complex(GO:0005787) |
20.5 | 164.2 | GO:0008540 | proteasome regulatory particle, base subcomplex(GO:0008540) |
20.2 | 101.1 | GO:0017102 | methionyl glutamyl tRNA synthetase complex(GO:0017102) |
20.1 | 60.4 | GO:0016222 | procollagen-proline 4-dioxygenase complex(GO:0016222) |
20.0 | 60.1 | GO:0005960 | glycine cleavage complex(GO:0005960) |
19.9 | 19.9 | GO:0005771 | multivesicular body(GO:0005771) |
19.9 | 99.5 | GO:0071986 | Ragulator complex(GO:0071986) |
19.6 | 78.2 | GO:0001405 | presequence translocase-associated import motor(GO:0001405) |
19.5 | 58.4 | GO:0070435 | Shc-EGFR complex(GO:0070435) |
19.4 | 97.0 | GO:0045272 | plasma membrane respiratory chain complex I(GO:0045272) |
19.2 | 730.5 | GO:0005762 | organellar large ribosomal subunit(GO:0000315) mitochondrial large ribosomal subunit(GO:0005762) |
19.0 | 113.8 | GO:0031597 | cytosolic proteasome complex(GO:0031597) |
18.9 | 283.5 | GO:0090543 | Flemming body(GO:0090543) |
18.9 | 113.2 | GO:0072588 | box H/ACA snoRNP complex(GO:0031429) box H/ACA RNP complex(GO:0072588) box H/ACA scaRNP complex(GO:0072589) box H/ACA telomerase RNP complex(GO:0090661) |
18.9 | 132.1 | GO:0035692 | macrophage migration inhibitory factor receptor complex(GO:0035692) |
18.8 | 56.5 | GO:0044393 | microspike(GO:0044393) |
18.8 | 94.0 | GO:0000408 | EKC/KEOPS complex(GO:0000408) |
18.5 | 148.3 | GO:0005786 | signal recognition particle, endoplasmic reticulum targeting(GO:0005786) |
18.5 | 92.6 | GO:0001940 | male pronucleus(GO:0001940) |
18.5 | 148.0 | GO:0000940 | condensed chromosome outer kinetochore(GO:0000940) |
18.4 | 73.8 | GO:0000214 | tRNA-intron endonuclease complex(GO:0000214) |
18.4 | 128.5 | GO:0000172 | ribonuclease MRP complex(GO:0000172) |
18.3 | 18.3 | GO:0034665 | integrin alpha1-beta1 complex(GO:0034665) |
18.0 | 107.7 | GO:0071256 | Sec61 translocon complex(GO:0005784) translocon complex(GO:0071256) |
17.9 | 53.6 | GO:0009330 | DNA topoisomerase complex (ATP-hydrolyzing)(GO:0009330) |
17.8 | 195.4 | GO:0005688 | U6 snRNP(GO:0005688) |
17.6 | 52.7 | GO:0033565 | ESCRT-0 complex(GO:0033565) |
17.5 | 70.1 | GO:0045273 | mitochondrial respiratory chain complex II, succinate dehydrogenase complex (ubiquinone)(GO:0005749) succinate dehydrogenase complex (ubiquinone)(GO:0045257) respiratory chain complex II(GO:0045273) succinate dehydrogenase complex(GO:0045281) fumarate reductase complex(GO:0045283) |
17.5 | 174.5 | GO:0000796 | condensin complex(GO:0000796) |
17.3 | 51.9 | GO:0033185 | dolichol-phosphate-mannose synthase complex(GO:0033185) |
17.2 | 68.9 | GO:1990730 | VCP-NSFL1C complex(GO:1990730) |
17.2 | 326.7 | GO:0005885 | Arp2/3 protein complex(GO:0005885) |
17.1 | 171.0 | GO:0034709 | methylosome(GO:0034709) |
17.0 | 305.3 | GO:0000276 | mitochondrial proton-transporting ATP synthase complex, coupling factor F(o)(GO:0000276) |
16.8 | 201.6 | GO:0022624 | proteasome accessory complex(GO:0022624) |
16.7 | 133.8 | GO:0070552 | BRISC complex(GO:0070552) |
16.4 | 261.9 | GO:0017101 | aminoacyl-tRNA synthetase multienzyme complex(GO:0017101) |
16.4 | 196.3 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
16.3 | 228.0 | GO:0030663 | COPI-coated vesicle membrane(GO:0030663) |
16.2 | 242.7 | GO:0031080 | nuclear pore outer ring(GO:0031080) |
15.9 | 47.8 | GO:0031428 | box C/D snoRNP complex(GO:0031428) |
15.8 | 220.9 | GO:0005753 | mitochondrial proton-transporting ATP synthase complex(GO:0005753) |
15.7 | 488.2 | GO:0030687 | preribosome, large subunit precursor(GO:0030687) |
15.7 | 47.2 | GO:0070762 | nuclear pore transmembrane ring(GO:0070762) |
15.6 | 46.9 | GO:0005656 | nuclear pre-replicative complex(GO:0005656) pre-replicative complex(GO:0036387) |
15.6 | 62.2 | GO:0000811 | GINS complex(GO:0000811) |
15.3 | 122.7 | GO:0098559 | cytoplasmic side of early endosome membrane(GO:0098559) |
15.3 | 91.5 | GO:0001740 | Barr body(GO:0001740) |
15.2 | 106.2 | GO:0002178 | palmitoyltransferase complex(GO:0002178) |
14.7 | 29.4 | GO:0005732 | small nucleolar ribonucleoprotein complex(GO:0005732) |
14.3 | 114.1 | GO:0042382 | paraspeckles(GO:0042382) |
14.1 | 98.6 | GO:0098575 | lumenal side of lysosomal membrane(GO:0098575) |
14.0 | 42.0 | GO:0005715 | late recombination nodule(GO:0005715) |
13.9 | 153.3 | GO:0035985 | senescence-associated heterochromatin focus(GO:0035985) |
13.9 | 13.9 | GO:0070557 | PCNA-p21 complex(GO:0070557) |
13.9 | 83.3 | GO:1990357 | terminal web(GO:1990357) |
13.9 | 124.9 | GO:0072546 | ER membrane protein complex(GO:0072546) |
13.8 | 193.5 | GO:0034098 | VCP-NPL4-UFD1 AAA ATPase complex(GO:0034098) |
13.7 | 68.7 | GO:0043564 | Ku70:Ku80 complex(GO:0043564) |
13.6 | 54.5 | GO:0031436 | BRCA1-BARD1 complex(GO:0031436) |
13.5 | 13.5 | GO:0005675 | holo TFIIH complex(GO:0005675) |
13.5 | 67.4 | GO:0097422 | tubular endosome(GO:0097422) |
13.4 | 53.5 | GO:0005846 | nuclear cap binding complex(GO:0005846) |
13.4 | 93.6 | GO:0071204 | histone pre-mRNA 3'end processing complex(GO:0071204) |
13.4 | 40.1 | GO:0031298 | replication fork protection complex(GO:0031298) |
13.1 | 91.9 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
13.1 | 131.2 | GO:0045254 | pyruvate dehydrogenase complex(GO:0045254) |
12.9 | 206.3 | GO:0005852 | eukaryotic translation initiation factor 3 complex(GO:0005852) |
12.8 | 51.1 | GO:1990423 | RZZ complex(GO:1990423) |
12.8 | 89.4 | GO:0016589 | NURF complex(GO:0016589) |
12.7 | 598.2 | GO:0042645 | nucleoid(GO:0009295) mitochondrial nucleoid(GO:0042645) |
12.7 | 88.9 | GO:0031415 | NatA complex(GO:0031415) |
12.6 | 88.1 | GO:0005610 | laminin-5 complex(GO:0005610) |
12.5 | 12.5 | GO:0005642 | annulate lamellae(GO:0005642) |
12.5 | 37.4 | GO:0031372 | UBC13-MMS2 complex(GO:0031372) |
12.2 | 36.7 | GO:0018444 | translation release factor complex(GO:0018444) |
12.2 | 231.1 | GO:0005862 | muscle thin filament tropomyosin(GO:0005862) |
12.1 | 48.5 | GO:0005726 | perichromatin fibrils(GO:0005726) |
12.1 | 157.1 | GO:0005916 | fascia adherens(GO:0005916) |
12.1 | 84.4 | GO:0061617 | MICOS complex(GO:0061617) |
12.1 | 36.2 | GO:0005850 | eukaryotic translation initiation factor 2 complex(GO:0005850) |
12.0 | 36.1 | GO:0034455 | t-UTP complex(GO:0034455) |
12.0 | 132.2 | GO:0000176 | nuclear exosome (RNase complex)(GO:0000176) |
12.0 | 35.9 | GO:0043224 | nuclear SCF ubiquitin ligase complex(GO:0043224) |
11.9 | 83.0 | GO:0071203 | WASH complex(GO:0071203) |
11.8 | 59.2 | GO:0000221 | vacuolar proton-transporting V-type ATPase, V1 domain(GO:0000221) |
11.8 | 11.8 | GO:0031232 | extrinsic component of external side of plasma membrane(GO:0031232) |
11.8 | 718.9 | GO:0005747 | mitochondrial respiratory chain complex I(GO:0005747) NADH dehydrogenase complex(GO:0030964) respiratory chain complex I(GO:0045271) |
11.7 | 46.8 | GO:0030905 | retromer, tubulation complex(GO:0030905) |
11.7 | 151.9 | GO:0042555 | MCM complex(GO:0042555) |
11.7 | 35.0 | GO:0035370 | UBC13-UEV1A complex(GO:0035370) |
11.6 | 336.7 | GO:0005680 | anaphase-promoting complex(GO:0005680) |
11.6 | 150.9 | GO:0097470 | ribbon synapse(GO:0097470) |
11.5 | 11.5 | GO:0030915 | Smc5-Smc6 complex(GO:0030915) |
11.4 | 91.3 | GO:0042719 | mitochondrial intermembrane space protein transporter complex(GO:0042719) |
11.3 | 192.8 | GO:0034663 | endoplasmic reticulum chaperone complex(GO:0034663) |
11.2 | 67.3 | GO:0061689 | tricellular tight junction(GO:0061689) |
11.1 | 144.7 | GO:0033179 | proton-transporting V-type ATPase, V0 domain(GO:0033179) |
11.0 | 11.0 | GO:0005828 | kinetochore microtubule(GO:0005828) |
11.0 | 77.1 | GO:0005742 | mitochondrial outer membrane translocase complex(GO:0005742) |
10.9 | 76.5 | GO:0005956 | protein kinase CK2 complex(GO:0005956) |
10.9 | 54.3 | GO:0098837 | postsynaptic recycling endosome(GO:0098837) |
10.9 | 108.6 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
10.8 | 32.5 | GO:0070852 | cell body fiber(GO:0070852) |
10.8 | 205.0 | GO:0036020 | endolysosome membrane(GO:0036020) |
10.6 | 84.5 | GO:0044754 | autolysosome(GO:0044754) |
10.5 | 31.4 | GO:0034666 | integrin alpha2-beta1 complex(GO:0034666) |
10.4 | 41.6 | GO:0070288 | intracellular ferritin complex(GO:0008043) ferritin complex(GO:0070288) |
10.4 | 52.0 | GO:1905202 | 3-methylcrotonyl-CoA carboxylase complex, mitochondrial(GO:0002169) methylcrotonoyl-CoA carboxylase complex(GO:1905202) |
10.4 | 82.8 | GO:0042824 | MHC class I peptide loading complex(GO:0042824) |
10.3 | 41.4 | GO:0019907 | cyclin-dependent protein kinase activating kinase holoenzyme complex(GO:0019907) |
10.3 | 82.7 | GO:0032133 | chromosome passenger complex(GO:0032133) |
10.3 | 51.7 | GO:0034457 | Mpp10 complex(GO:0034457) |
10.3 | 72.3 | GO:0070938 | contractile ring(GO:0070938) |
10.3 | 41.1 | GO:0071001 | U4/U6 snRNP(GO:0071001) |
10.3 | 51.4 | GO:0031313 | extrinsic component of endosome membrane(GO:0031313) |
10.2 | 51.1 | GO:0032021 | NELF complex(GO:0032021) |
10.2 | 10.2 | GO:0097454 | Schwann cell microvillus(GO:0097454) |
10.2 | 30.6 | GO:0071159 | NF-kappaB complex(GO:0071159) |
10.1 | 141.2 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
10.1 | 100.7 | GO:0044233 | ER-mitochondrion membrane contact site(GO:0044233) |
10.0 | 100.4 | GO:0072357 | PTW/PP1 phosphatase complex(GO:0072357) |
10.0 | 20.0 | GO:1990726 | Lsm1-7-Pat1 complex(GO:1990726) |
9.9 | 29.8 | GO:0042765 | GPI-anchor transamidase complex(GO:0042765) |
9.9 | 69.3 | GO:0000110 | nucleotide-excision repair factor 1 complex(GO:0000110) |
9.8 | 264.6 | GO:0000502 | proteasome complex(GO:0000502) |
9.7 | 185.0 | GO:0005665 | DNA-directed RNA polymerase II, core complex(GO:0005665) |
9.7 | 38.8 | GO:0071598 | neuronal ribonucleoprotein granule(GO:0071598) |
9.7 | 29.0 | GO:0000939 | condensed chromosome inner kinetochore(GO:0000939) |
9.6 | 28.9 | GO:0034271 | phosphatidylinositol 3-kinase complex, class III, type I(GO:0034271) phosphatidylinositol 3-kinase complex, class III, type II(GO:0034272) |
9.6 | 105.8 | GO:0005751 | mitochondrial respiratory chain complex IV(GO:0005751) |
9.5 | 95.2 | GO:0016593 | Cdc73/Paf1 complex(GO:0016593) |
9.5 | 370.5 | GO:0008180 | COP9 signalosome(GO:0008180) |
9.5 | 1356.0 | GO:0042470 | melanosome(GO:0042470) pigment granule(GO:0048770) |
9.4 | 170.0 | GO:0070469 | respiratory chain(GO:0070469) |
9.4 | 28.2 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
9.4 | 140.8 | GO:0032433 | filopodium tip(GO:0032433) |
9.1 | 45.5 | GO:0005658 | alpha DNA polymerase:primase complex(GO:0005658) |
9.0 | 90.1 | GO:0031616 | spindle pole centrosome(GO:0031616) |
9.0 | 27.0 | GO:0034676 | integrin alpha6-beta4 complex(GO:0034676) |
8.9 | 107.0 | GO:0000815 | ESCRT III complex(GO:0000815) |
8.9 | 26.7 | GO:0030289 | protein phosphatase 4 complex(GO:0030289) |
8.9 | 8.9 | GO:0030981 | cortical microtubule cytoskeleton(GO:0030981) |
8.8 | 17.6 | GO:0030689 | Noc complex(GO:0030689) |
8.8 | 88.2 | GO:0030015 | CCR4-NOT core complex(GO:0030015) |
8.8 | 8.8 | GO:0031371 | ubiquitin conjugating enzyme complex(GO:0031371) |
8.8 | 113.9 | GO:0005662 | DNA replication factor A complex(GO:0005662) |
8.8 | 1356.4 | GO:0101002 | ficolin-1-rich granule(GO:0101002) ficolin-1-rich granule lumen(GO:1904813) |
8.7 | 26.2 | GO:1902636 | kinociliary basal body(GO:1902636) |
8.7 | 8.7 | GO:0005797 | Golgi medial cisterna(GO:0005797) |
8.6 | 68.9 | GO:0016012 | sarcoglycan complex(GO:0016012) |
8.6 | 17.2 | GO:0043203 | axon hillock(GO:0043203) |
8.6 | 85.6 | GO:0005686 | U2 snRNP(GO:0005686) |
8.5 | 76.4 | GO:0033588 | Elongator holoenzyme complex(GO:0033588) |
8.3 | 24.9 | GO:0045180 | basal cortex(GO:0045180) |
8.3 | 82.7 | GO:0000506 | glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex(GO:0000506) |
8.3 | 41.4 | GO:0034388 | Pwp2p-containing subcomplex of 90S preribosome(GO:0034388) |
8.2 | 73.8 | GO:0005638 | lamin filament(GO:0005638) |
8.2 | 24.6 | GO:1990246 | uniplex complex(GO:1990246) |
8.1 | 169.1 | GO:0031304 | intrinsic component of mitochondrial inner membrane(GO:0031304) integral component of mitochondrial inner membrane(GO:0031305) |
8.0 | 23.9 | GO:0048269 | methionine adenosyltransferase complex(GO:0048269) |
8.0 | 8.0 | GO:0005899 | insulin receptor complex(GO:0005899) |
7.9 | 373.0 | GO:0043034 | costamere(GO:0043034) |
7.9 | 165.4 | GO:0035098 | ESC/E(Z) complex(GO:0035098) |
7.8 | 7.8 | GO:0005588 | collagen type V trimer(GO:0005588) |
7.8 | 675.0 | GO:0000779 | condensed chromosome, centromeric region(GO:0000779) |
7.8 | 23.3 | GO:0097441 | basilar dendrite(GO:0097441) |
7.7 | 30.7 | GO:0043541 | UDP-N-acetylglucosamine transferase complex(GO:0043541) |
7.7 | 818.9 | GO:0015934 | large ribosomal subunit(GO:0015934) |
7.5 | 22.6 | GO:0005761 | organellar ribosome(GO:0000313) mitochondrial ribosome(GO:0005761) |
7.5 | 22.5 | GO:0031515 | tRNA (m1A) methyltransferase complex(GO:0031515) |
7.5 | 90.0 | GO:0016469 | proton-transporting two-sector ATPase complex(GO:0016469) |
7.5 | 202.0 | GO:0070971 | endoplasmic reticulum exit site(GO:0070971) |
7.5 | 67.2 | GO:0042612 | MHC class I protein complex(GO:0042612) |
7.5 | 52.2 | GO:0005851 | eukaryotic translation initiation factor 2B complex(GO:0005851) |
7.4 | 29.6 | GO:0071664 | catenin-TCF7L2 complex(GO:0071664) |
7.4 | 29.4 | GO:0043625 | delta DNA polymerase complex(GO:0043625) |
7.3 | 154.1 | GO:0031143 | pseudopodium(GO:0031143) |
7.3 | 50.8 | GO:0031465 | Cul4B-RING E3 ubiquitin ligase complex(GO:0031465) |
7.2 | 21.5 | GO:0034274 | Atg12-Atg5-Atg16 complex(GO:0034274) |
7.1 | 21.3 | GO:0097134 | cyclin E1-CDK2 complex(GO:0097134) |
7.1 | 35.5 | GO:0000235 | astral microtubule(GO:0000235) aster(GO:0005818) |
7.0 | 154.6 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
6.9 | 20.8 | GO:0005945 | 6-phosphofructokinase complex(GO:0005945) |
6.8 | 164.2 | GO:0071564 | npBAF complex(GO:0071564) |
6.8 | 20.5 | GO:0043291 | RAVE complex(GO:0043291) |
6.8 | 27.3 | GO:0042643 | actomyosin, actin portion(GO:0042643) |
6.8 | 20.4 | GO:0005873 | plus-end kinesin complex(GO:0005873) |
6.8 | 428.1 | GO:0033116 | endoplasmic reticulum-Golgi intermediate compartment membrane(GO:0033116) |
6.8 | 67.7 | GO:0030686 | 90S preribosome(GO:0030686) |
6.8 | 6.8 | GO:0016442 | RISC complex(GO:0016442) RNAi effector complex(GO:0031332) |
6.7 | 33.7 | GO:1990425 | ryanodine receptor complex(GO:1990425) |
6.7 | 53.5 | GO:0034719 | SMN-Sm protein complex(GO:0034719) |
6.6 | 53.0 | GO:0070765 | gamma-secretase complex(GO:0070765) |
6.6 | 26.3 | GO:0098799 | outer mitochondrial membrane protein complex(GO:0098799) |
6.5 | 26.1 | GO:0031673 | H zone(GO:0031673) |
6.4 | 96.1 | GO:0032156 | septin cytoskeleton(GO:0032156) |
6.4 | 6.4 | GO:0098592 | cytoplasmic side of apical plasma membrane(GO:0098592) |
6.3 | 44.2 | GO:0030870 | Mre11 complex(GO:0030870) |
6.3 | 56.8 | GO:0000439 | core TFIIH complex(GO:0000439) |
6.3 | 88.1 | GO:0070578 | RISC-loading complex(GO:0070578) |
6.3 | 144.7 | GO:0005685 | U1 snRNP(GO:0005685) |
6.3 | 12.6 | GO:0030130 | clathrin coat of trans-Golgi network vesicle(GO:0030130) |
6.2 | 31.2 | GO:0070937 | CRD-mediated mRNA stability complex(GO:0070937) |
6.2 | 31.2 | GO:0032449 | CBM complex(GO:0032449) |
6.1 | 165.2 | GO:0000776 | kinetochore(GO:0000776) |
6.1 | 12.2 | GO:0000322 | storage vacuole(GO:0000322) |
6.0 | 96.0 | GO:0071782 | endoplasmic reticulum tubular network(GO:0071782) |
6.0 | 36.0 | GO:0000931 | gamma-tubulin large complex(GO:0000931) gamma-tubulin ring complex(GO:0008274) |
5.9 | 71.1 | GO:0030008 | TRAPP complex(GO:0030008) |
5.9 | 65.1 | GO:0005689 | U12-type spliceosomal complex(GO:0005689) |
5.9 | 117.7 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
5.9 | 64.7 | GO:0044613 | nuclear pore central transport channel(GO:0044613) |
5.9 | 105.5 | GO:0097342 | ripoptosome(GO:0097342) |
5.7 | 2797.0 | GO:0005925 | focal adhesion(GO:0005925) |
5.6 | 16.8 | GO:0090498 | extrinsic component of Golgi membrane(GO:0090498) |
5.6 | 27.9 | GO:0045202 | synapse(GO:0045202) |
5.5 | 27.7 | GO:0031264 | death-inducing signaling complex(GO:0031264) |
5.5 | 22.2 | GO:0035061 | interchromatin granule(GO:0035061) |
5.5 | 16.6 | GO:0036513 | Derlin-1 retrotranslocation complex(GO:0036513) |
5.5 | 77.3 | GO:0000178 | exosome (RNase complex)(GO:0000178) |
5.5 | 43.7 | GO:0070652 | HAUS complex(GO:0070652) |
5.4 | 16.3 | GO:0031010 | ISWI-type complex(GO:0031010) |
5.4 | 10.8 | GO:0097452 | GAIT complex(GO:0097452) |
5.3 | 37.4 | GO:0030121 | AP-1 adaptor complex(GO:0030121) |
5.3 | 21.1 | GO:0005863 | striated muscle myosin thick filament(GO:0005863) |
5.2 | 41.7 | GO:0000109 | nucleotide-excision repair complex(GO:0000109) |
5.2 | 31.2 | GO:0005915 | zonula adherens(GO:0005915) |
5.2 | 31.1 | GO:0030014 | CCR4-NOT complex(GO:0030014) |
5.1 | 154.2 | GO:0005876 | spindle microtubule(GO:0005876) |
5.0 | 20.1 | GO:0044611 | nuclear pore inner ring(GO:0044611) |
5.0 | 44.6 | GO:0097550 | transcriptional preinitiation complex(GO:0097550) |
4.9 | 19.7 | GO:0031414 | N-terminal protein acetyltransferase complex(GO:0031414) |
4.9 | 157.0 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
4.9 | 77.8 | GO:0070822 | Sin3-type complex(GO:0070822) |
4.8 | 184.0 | GO:0000307 | cyclin-dependent protein kinase holoenzyme complex(GO:0000307) |
4.8 | 77.0 | GO:0000812 | Swr1 complex(GO:0000812) |
4.8 | 687.0 | GO:0005681 | spliceosomal complex(GO:0005681) |
4.8 | 23.9 | GO:0046581 | intercellular canaliculus(GO:0046581) |
4.7 | 37.5 | GO:0097431 | mitotic spindle pole(GO:0097431) |
4.7 | 14.1 | GO:0030532 | small nuclear ribonucleoprotein complex(GO:0030532) |
4.7 | 27.9 | GO:0035749 | myelin sheath adaxonal region(GO:0035749) |
4.6 | 18.5 | GO:0031467 | Cul7-RING ubiquitin ligase complex(GO:0031467) |
4.6 | 23.1 | GO:0071148 | TEAD-1-YAP complex(GO:0071148) |
4.6 | 13.8 | GO:0005958 | DNA-dependent protein kinase-DNA ligase 4 complex(GO:0005958) |
4.6 | 41.0 | GO:0030027 | lamellipodium(GO:0030027) |
4.5 | 36.3 | GO:0031931 | TORC1 complex(GO:0031931) |
4.5 | 40.6 | GO:0005955 | calcineurin complex(GO:0005955) |
4.4 | 253.4 | GO:0031970 | organelle envelope lumen(GO:0031970) |
4.4 | 8.9 | GO:0043260 | laminin-11 complex(GO:0043260) |
4.4 | 22.0 | GO:0001739 | sex chromatin(GO:0001739) |
4.4 | 30.7 | GO:0005854 | nascent polypeptide-associated complex(GO:0005854) |
4.4 | 13.1 | GO:0035032 | phosphatidylinositol 3-kinase complex, class III(GO:0035032) |
4.3 | 121.4 | GO:0032592 | integral component of mitochondrial membrane(GO:0032592) |
4.3 | 17.3 | GO:0048237 | rough endoplasmic reticulum lumen(GO:0048237) |
4.3 | 42.8 | GO:0031209 | SCAR complex(GO:0031209) |
4.2 | 8.4 | GO:0043202 | lysosomal lumen(GO:0043202) |
4.2 | 25.1 | GO:1990131 | EGO complex(GO:0034448) Gtr1-Gtr2 GTPase complex(GO:1990131) |
4.1 | 20.7 | GO:0031301 | integral component of organelle membrane(GO:0031301) |
4.1 | 37.1 | GO:0005614 | interstitial matrix(GO:0005614) |
4.1 | 24.5 | GO:1902560 | GMP reductase complex(GO:1902560) |
4.1 | 12.3 | GO:0031166 | integral component of vacuolar membrane(GO:0031166) |
3.9 | 39.4 | GO:0030140 | trans-Golgi network transport vesicle(GO:0030140) |
3.9 | 263.9 | GO:0035578 | azurophil granule lumen(GO:0035578) |
3.9 | 38.7 | GO:0030127 | COPII vesicle coat(GO:0030127) |
3.9 | 7.7 | GO:0031252 | cell leading edge(GO:0031252) |
3.8 | 38.4 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
3.8 | 61.4 | GO:0030867 | rough endoplasmic reticulum membrane(GO:0030867) |
3.8 | 3.8 | GO:1990462 | omegasome(GO:1990462) |
3.8 | 19.2 | GO:0005903 | brush border(GO:0005903) |
3.8 | 11.4 | GO:0031088 | platelet dense granule membrane(GO:0031088) |
3.8 | 7.6 | GO:0070939 | Dsl1p complex(GO:0070939) |
3.7 | 15.0 | GO:0034518 | mRNA cap binding complex(GO:0005845) RNA cap binding complex(GO:0034518) |
3.6 | 39.7 | GO:0035577 | azurophil granule membrane(GO:0035577) |
3.6 | 7.2 | GO:0043527 | tRNA methyltransferase complex(GO:0043527) |
3.6 | 10.7 | GO:0070195 | growth hormone receptor complex(GO:0070195) |
3.6 | 32.1 | GO:0030904 | retromer complex(GO:0030904) |
3.5 | 14.2 | GO:0098554 | cytoplasmic side of endoplasmic reticulum membrane(GO:0098554) |
3.5 | 7.0 | GO:0044327 | dendritic spine head(GO:0044327) |
3.5 | 66.3 | GO:0005868 | cytoplasmic dynein complex(GO:0005868) |
3.5 | 3.5 | GO:1990316 | ATG1/ULK1 kinase complex(GO:1990316) |
3.4 | 10.3 | GO:0044295 | axonal growth cone(GO:0044295) |
3.4 | 62.0 | GO:0005640 | nuclear outer membrane(GO:0005640) |
3.4 | 24.0 | GO:0042641 | actomyosin(GO:0042641) |
3.4 | 37.7 | GO:0097346 | INO80-type complex(GO:0097346) |
3.4 | 23.7 | GO:0070554 | synaptobrevin 2-SNAP-25-syntaxin-3-complexin complex(GO:0070554) |
3.4 | 101.5 | GO:0000118 | histone deacetylase complex(GO:0000118) |
3.4 | 16.9 | GO:0071797 | LUBAC complex(GO:0071797) |
3.4 | 6.7 | GO:0005869 | dynactin complex(GO:0005869) |
3.3 | 128.6 | GO:0045095 | keratin filament(GO:0045095) |
3.2 | 3.2 | GO:0044615 | nuclear pore nuclear basket(GO:0044615) |
3.2 | 25.8 | GO:0071144 | SMAD2-SMAD3 protein complex(GO:0071144) |
3.2 | 674.7 | GO:0005743 | mitochondrial inner membrane(GO:0005743) |
3.2 | 19.1 | GO:0032311 | angiogenin-PRI complex(GO:0032311) |
3.1 | 25.1 | GO:0030122 | AP-2 adaptor complex(GO:0030122) |
3.1 | 21.7 | GO:0031932 | TORC2 complex(GO:0031932) TOR complex(GO:0038201) |
3.1 | 36.9 | GO:0045239 | tricarboxylic acid cycle enzyme complex(GO:0045239) |
3.1 | 27.7 | GO:0032059 | bleb(GO:0032059) |
3.1 | 18.4 | GO:0042405 | nuclear inclusion body(GO:0042405) |
3.0 | 12.2 | GO:0000153 | cytoplasmic ubiquitin ligase complex(GO:0000153) |
3.0 | 48.7 | GO:0001527 | microfibril(GO:0001527) fibril(GO:0043205) |
3.0 | 90.4 | GO:0031903 | peroxisomal membrane(GO:0005778) microbody membrane(GO:0031903) |
3.0 | 18.0 | GO:0061574 | ASAP complex(GO:0061574) |
3.0 | 130.3 | GO:0031093 | platelet alpha granule lumen(GO:0031093) |
2.9 | 58.7 | GO:0005779 | integral component of peroxisomal membrane(GO:0005779) intrinsic component of peroxisomal membrane(GO:0031231) |
2.9 | 8.8 | GO:0030125 | clathrin vesicle coat(GO:0030125) |
2.9 | 126.1 | GO:0032580 | Golgi cisterna membrane(GO:0032580) |
2.8 | 5.6 | GO:0051286 | cell tip(GO:0051286) |
2.8 | 27.9 | GO:0017146 | NMDA selective glutamate receptor complex(GO:0017146) |
2.8 | 8.4 | GO:0016938 | kinesin I complex(GO:0016938) |
2.8 | 8.3 | GO:0002081 | outer acrosomal membrane(GO:0002081) |
2.8 | 2.8 | GO:0005606 | laminin-1 complex(GO:0005606) laminin-3 complex(GO:0005608) |
2.7 | 5.5 | GO:0055087 | Ski complex(GO:0055087) |
2.7 | 2.7 | GO:0031306 | intrinsic component of mitochondrial outer membrane(GO:0031306) |
2.7 | 10.8 | GO:0005968 | Rab-protein geranylgeranyltransferase complex(GO:0005968) |
2.7 | 10.6 | GO:0032937 | SREBP-SCAP-Insig complex(GO:0032937) |
2.5 | 76.5 | GO:0045178 | basal part of cell(GO:0045178) |
2.5 | 35.5 | GO:0030669 | clathrin-coated endocytic vesicle membrane(GO:0030669) |
2.5 | 2.5 | GO:0035189 | Rb-E2F complex(GO:0035189) |
2.5 | 7.5 | GO:0071595 | Nem1-Spo7 phosphatase complex(GO:0071595) |
2.5 | 22.2 | GO:0097413 | Lewy body(GO:0097413) |
2.4 | 45.8 | GO:0042629 | mast cell granule(GO:0042629) |
2.4 | 16.9 | GO:0005832 | chaperonin-containing T-complex(GO:0005832) |
2.4 | 23.8 | GO:0005666 | DNA-directed RNA polymerase III complex(GO:0005666) |
2.4 | 2.4 | GO:0030056 | hemidesmosome(GO:0030056) |
2.4 | 61.6 | GO:0000421 | autophagosome membrane(GO:0000421) |
2.3 | 6.9 | GO:0030688 | preribosome, small subunit precursor(GO:0030688) |
2.3 | 27.6 | GO:0000346 | transcription export complex(GO:0000346) |
2.3 | 64.3 | GO:0044391 | ribosomal subunit(GO:0044391) |
2.3 | 43.5 | GO:0001726 | ruffle(GO:0001726) |
2.3 | 13.6 | GO:0016328 | lateral plasma membrane(GO:0016328) |
2.2 | 4.5 | GO:0042827 | platelet dense granule(GO:0042827) |
2.2 | 129.3 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
2.2 | 4.4 | GO:0072558 | NLRP1 inflammasome complex(GO:0072558) |
2.2 | 19.8 | GO:0098645 | network-forming collagen trimer(GO:0098642) collagen network(GO:0098645) |
2.2 | 6.5 | GO:0097447 | dendritic tree(GO:0097447) |
2.2 | 4.3 | GO:0097179 | protease inhibitor complex(GO:0097179) |
2.1 | 2.1 | GO:0042587 | glycogen granule(GO:0042587) |
2.1 | 10.7 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
2.1 | 6.4 | GO:1990393 | 3M complex(GO:1990393) |
2.1 | 6.4 | GO:0032993 | protein-DNA complex(GO:0032993) |
2.1 | 62.8 | GO:0030670 | phagocytic vesicle membrane(GO:0030670) |
2.1 | 104.7 | GO:0005811 | lipid particle(GO:0005811) |
2.1 | 18.5 | GO:0032039 | integrator complex(GO:0032039) |
2.0 | 4.1 | GO:0044308 | axonal spine(GO:0044308) |
2.0 | 8.1 | GO:0032044 | DSIF complex(GO:0032044) |
2.0 | 6.0 | GO:0031362 | anchored component of external side of plasma membrane(GO:0031362) |
2.0 | 5.9 | GO:0042575 | DNA polymerase complex(GO:0042575) |
2.0 | 91.7 | GO:0005637 | nuclear inner membrane(GO:0005637) |
1.9 | 48.5 | GO:0044215 | other organism(GO:0044215) other organism cell(GO:0044216) other organism part(GO:0044217) |
1.9 | 11.6 | GO:0000124 | SAGA complex(GO:0000124) |
1.9 | 3.8 | GO:0005674 | transcription factor TFIIF complex(GO:0005674) |
1.9 | 22.8 | GO:0097025 | MPP7-DLG1-LIN7 complex(GO:0097025) |
1.9 | 104.3 | GO:0035580 | specific granule lumen(GO:0035580) |
1.9 | 3.8 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
1.9 | 5.6 | GO:0070531 | BRCA1-A complex(GO:0070531) |
1.9 | 7.5 | GO:0030936 | collagen type XIII trimer(GO:0005600) transmembrane collagen trimer(GO:0030936) |
1.8 | 25.3 | GO:0033276 | transcription factor TFTC complex(GO:0033276) |
1.8 | 10.7 | GO:1990635 | proximal dendrite(GO:1990635) |
1.8 | 49.6 | GO:0031526 | brush border membrane(GO:0031526) |
1.7 | 70.2 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
1.7 | 4244.5 | GO:0070062 | extracellular exosome(GO:0070062) |
1.7 | 3.3 | GO:0030424 | axon(GO:0030424) |
1.6 | 62.3 | GO:0000784 | nuclear chromosome, telomeric region(GO:0000784) |
1.6 | 22.7 | GO:0030057 | desmosome(GO:0030057) |
1.6 | 1.6 | GO:0031390 | Ctf18 RFC-like complex(GO:0031390) |
1.6 | 14.5 | GO:0016602 | CCAAT-binding factor complex(GO:0016602) |
1.6 | 17.6 | GO:0044666 | MLL3/4 complex(GO:0044666) |
1.6 | 11.0 | GO:0034385 | very-low-density lipoprotein particle(GO:0034361) triglyceride-rich lipoprotein particle(GO:0034385) |
1.6 | 12.4 | GO:0070187 | telosome(GO:0070187) |
1.5 | 4.6 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
1.5 | 3.0 | GO:0005677 | chromatin silencing complex(GO:0005677) |
1.5 | 6.0 | GO:0033553 | rDNA heterochromatin(GO:0033553) |
1.5 | 4.5 | GO:0031466 | Cul5-RING ubiquitin ligase complex(GO:0031466) |
1.5 | 8.7 | GO:1990589 | ATF4-CREB1 transcription factor complex(GO:1990589) |
1.4 | 14.1 | GO:0055038 | recycling endosome membrane(GO:0055038) |
1.4 | 9.7 | GO:0030478 | actin cap(GO:0030478) |
1.4 | 5.4 | GO:0005790 | smooth endoplasmic reticulum(GO:0005790) |
1.3 | 12.0 | GO:0070603 | SWI/SNF superfamily-type complex(GO:0070603) |
1.3 | 21.8 | GO:0005719 | nuclear euchromatin(GO:0005719) |
1.3 | 5.0 | GO:0033257 | Bcl3/NF-kappaB2 complex(GO:0033257) |
1.2 | 5.0 | GO:0072557 | IPAF inflammasome complex(GO:0072557) |
1.2 | 11.0 | GO:0017119 | Golgi transport complex(GO:0017119) |
1.2 | 54.3 | GO:0005913 | cell-cell adherens junction(GO:0005913) |
1.2 | 10.5 | GO:0000808 | origin recognition complex(GO:0000808) nuclear origin of replication recognition complex(GO:0005664) |
1.1 | 26.4 | GO:0005881 | cytoplasmic microtubule(GO:0005881) |
1.1 | 19.2 | GO:0032432 | actin filament bundle(GO:0032432) |
1.1 | 14.3 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
1.1 | 1.1 | GO:0070419 | nonhomologous end joining complex(GO:0070419) |
1.1 | 281.4 | GO:0005635 | nuclear envelope(GO:0005635) |
1.1 | 3.2 | GO:0005905 | clathrin-coated pit(GO:0005905) |
1.0 | 2.1 | GO:0034751 | aryl hydrocarbon receptor complex(GO:0034751) |
1.0 | 10.8 | GO:0000930 | gamma-tubulin complex(GO:0000930) |
0.9 | 0.9 | GO:0097449 | astrocyte projection(GO:0097449) |
0.9 | 19.8 | GO:0000781 | chromosome, telomeric region(GO:0000781) |
0.9 | 2.7 | GO:0032280 | symmetric synapse(GO:0032280) |
0.9 | 17.4 | GO:0030673 | axolemma(GO:0030673) |
0.8 | 114.3 | GO:0005819 | spindle(GO:0005819) |
0.8 | 8.1 | GO:0031258 | lamellipodium membrane(GO:0031258) |
0.7 | 0.7 | GO:0044309 | dendritic spine(GO:0043197) neuron spine(GO:0044309) |
0.7 | 2.2 | GO:0005953 | CAAX-protein geranylgeranyltransferase complex(GO:0005953) |
0.7 | 0.7 | GO:0043256 | laminin complex(GO:0043256) |
0.7 | 0.7 | GO:0032302 | MutSbeta complex(GO:0032302) |
0.6 | 1.2 | GO:0033186 | CAF-1 complex(GO:0033186) |
0.6 | 1.2 | GO:0071438 | invadopodium membrane(GO:0071438) |
0.6 | 39.7 | GO:0005741 | mitochondrial outer membrane(GO:0005741) |
0.6 | 4.5 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
0.6 | 0.6 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
0.5 | 6.4 | GO:0030684 | preribosome(GO:0030684) |
0.5 | 2.1 | GO:0000127 | transcription factor TFIIIC complex(GO:0000127) |
0.5 | 0.5 | GO:0032591 | dendritic spine membrane(GO:0032591) |
0.4 | 3.4 | GO:0035327 | transcriptionally active chromatin(GO:0035327) |
0.4 | 1.3 | GO:0014701 | junctional sarcoplasmic reticulum membrane(GO:0014701) |
0.4 | 2.9 | GO:0005847 | mRNA cleavage and polyadenylation specificity factor complex(GO:0005847) |
0.4 | 1.6 | GO:0072559 | NLRP3 inflammasome complex(GO:0072559) |
0.4 | 2.6 | GO:0034364 | high-density lipoprotein particle(GO:0034364) |
0.4 | 11.8 | GO:0016592 | mediator complex(GO:0016592) |
0.4 | 0.4 | GO:0042406 | extrinsic component of endoplasmic reticulum membrane(GO:0042406) |
0.4 | 44.0 | GO:1990904 | ribonucleoprotein complex(GO:1990904) |
0.4 | 0.4 | GO:0000138 | Golgi trans cisterna(GO:0000138) |
0.3 | 10.5 | GO:0005795 | Golgi stack(GO:0005795) |
0.3 | 4.7 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
0.2 | 0.4 | GO:0097486 | multivesicular body lumen(GO:0097486) |
0.2 | 1.4 | GO:0031941 | filamentous actin(GO:0031941) |
0.1 | 3.0 | GO:0045171 | intercellular bridge(GO:0045171) |
0.1 | 0.1 | GO:0034680 | integrin alpha10-beta1 complex(GO:0034680) |
0.1 | 2.8 | GO:0005802 | trans-Golgi network(GO:0005802) |
0.1 | 0.5 | GO:0005605 | basal lamina(GO:0005605) |
0.1 | 0.1 | GO:0098839 | postsynaptic density membrane(GO:0098839) |
0.1 | 0.6 | GO:0032982 | myosin filament(GO:0032982) |
0.1 | 0.2 | GO:0070436 | Grb2-EGFR complex(GO:0070436) |
0.1 | 0.1 | GO:0016528 | sarcoplasm(GO:0016528) |
0.1 | 0.5 | GO:0044292 | dendrite terminus(GO:0044292) |
0.1 | 0.8 | GO:0019898 | extrinsic component of membrane(GO:0019898) |
0.1 | 36.8 | GO:0005730 | nucleolus(GO:0005730) |
0.0 | 1.5 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
0.0 | 3.3 | GO:0016324 | apical plasma membrane(GO:0016324) |
0.0 | 0.2 | GO:0035631 | CD40 receptor complex(GO:0035631) |
0.0 | 0.1 | GO:0005943 | phosphatidylinositol 3-kinase complex, class IA(GO:0005943) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
49.3 | 344.8 | GO:0047134 | protein-disulfide reductase activity(GO:0047134) |
45.0 | 134.9 | GO:0070320 | inward rectifier potassium channel inhibitor activity(GO:0070320) |
39.8 | 119.3 | GO:0003978 | UDP-N-acetylglucosamine 4-epimerase activity(GO:0003974) UDP-glucose 4-epimerase activity(GO:0003978) |
38.3 | 191.6 | GO:0043023 | ribosomal large subunit binding(GO:0043023) |
38.3 | 153.1 | GO:0016728 | ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor(GO:0004748) oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor(GO:0016728) ribonucleoside-diphosphate reductase activity(GO:0061731) |
38.0 | 152.0 | GO:0004743 | pyruvate kinase activity(GO:0004743) |
35.8 | 143.1 | GO:0033981 | D-dopachrome decarboxylase activity(GO:0033981) |
35.4 | 106.2 | GO:0036317 | tyrosyl-RNA phosphodiesterase activity(GO:0036317) 5'-tyrosyl-DNA phosphodiesterase activity(GO:0070260) |
35.0 | 104.9 | GO:0045155 | electron transporter, transferring electrons from CoQH2-cytochrome c reductase complex and cytochrome c oxidase complex activity(GO:0045155) |
33.8 | 135.1 | GO:0005046 | KDEL sequence binding(GO:0005046) |
32.3 | 32.3 | GO:0015230 | FAD transmembrane transporter activity(GO:0015230) |
31.0 | 155.2 | GO:0071208 | histone pre-mRNA DCP binding(GO:0071208) |
30.8 | 92.5 | GO:0098626 | methylselenol reductase activity(GO:0098625) methylseleninic acid reductase activity(GO:0098626) |
30.7 | 215.2 | GO:0061575 | cyclin-dependent protein serine/threonine kinase activator activity(GO:0061575) |
28.0 | 196.0 | GO:0061133 | endopeptidase activator activity(GO:0061133) |
27.7 | 110.8 | GO:0002060 | purine nucleobase binding(GO:0002060) |
27.7 | 166.0 | GO:0043141 | ATP-dependent 5'-3' DNA helicase activity(GO:0043141) |
27.2 | 299.7 | GO:0036402 | proteasome-activating ATPase activity(GO:0036402) |
27.2 | 81.6 | GO:0004347 | glucose-6-phosphate isomerase activity(GO:0004347) |
27.1 | 81.2 | GO:0004450 | isocitrate dehydrogenase (NADP+) activity(GO:0004450) |
26.8 | 80.3 | GO:0042134 | rRNA primary transcript binding(GO:0042134) |
26.6 | 186.5 | GO:0004849 | uridine kinase activity(GO:0004849) |
26.6 | 106.6 | GO:0005471 | ATP:ADP antiporter activity(GO:0005471) adenine transmembrane transporter activity(GO:0015207) |
26.6 | 79.8 | GO:0008426 | protein kinase C inhibitor activity(GO:0008426) |
26.0 | 468.9 | GO:0001054 | RNA polymerase I activity(GO:0001054) |
26.0 | 104.0 | GO:0032143 | single thymine insertion binding(GO:0032143) |
25.8 | 154.9 | GO:0003960 | NADPH:quinone reductase activity(GO:0003960) |
25.8 | 77.4 | GO:0004814 | arginine-tRNA ligase activity(GO:0004814) |
25.2 | 755.3 | GO:0070003 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
25.1 | 125.7 | GO:0004066 | asparagine synthase (glutamine-hydrolyzing) activity(GO:0004066) |
25.1 | 75.2 | GO:0000033 | alpha-1,3-mannosyltransferase activity(GO:0000033) |
25.1 | 300.7 | GO:0031386 | protein tag(GO:0031386) |
25.0 | 150.1 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
25.0 | 199.7 | GO:0008379 | thioredoxin peroxidase activity(GO:0008379) |
24.9 | 248.8 | GO:0036042 | long-chain fatty acyl-CoA binding(GO:0036042) |
24.3 | 97.3 | GO:0004165 | dodecenoyl-CoA delta-isomerase activity(GO:0004165) |
24.3 | 169.9 | GO:0050815 | phosphoserine binding(GO:0050815) |
23.7 | 94.9 | GO:0030337 | DNA polymerase processivity factor activity(GO:0030337) |
23.0 | 92.1 | GO:0031871 | proteinase activated receptor binding(GO:0031871) |
22.9 | 114.3 | GO:0019798 | procollagen-proline 4-dioxygenase activity(GO:0004656) procollagen-proline dioxygenase activity(GO:0019798) |
22.6 | 22.6 | GO:0003854 | 3-beta-hydroxy-delta5-steroid dehydrogenase activity(GO:0003854) |
22.5 | 315.7 | GO:1990825 | sequence-specific mRNA binding(GO:1990825) |
22.5 | 179.7 | GO:0034604 | pyruvate dehydrogenase activity(GO:0004738) pyruvate dehydrogenase [NAD(P)+] activity(GO:0034603) pyruvate dehydrogenase (NAD+) activity(GO:0034604) |
22.4 | 89.7 | GO:0004774 | succinate-CoA ligase activity(GO:0004774) |
22.0 | 198.0 | GO:0015288 | porin activity(GO:0015288) |
21.8 | 87.1 | GO:0032217 | riboflavin transporter activity(GO:0032217) |
21.5 | 64.6 | GO:0000213 | tRNA-intron endonuclease activity(GO:0000213) |
21.4 | 150.1 | GO:0033170 | DNA clamp loader activity(GO:0003689) protein-DNA loading ATPase activity(GO:0033170) |
21.4 | 106.8 | GO:0047179 | platelet-activating factor acetyltransferase activity(GO:0047179) |
21.3 | 191.3 | GO:1990226 | histone methyltransferase binding(GO:1990226) |
20.9 | 963.3 | GO:0061631 | ubiquitin conjugating enzyme activity(GO:0061631) |
20.9 | 209.2 | GO:0019784 | NEDD8-specific protease activity(GO:0019784) |
20.9 | 83.5 | GO:0043262 | adenosine-diphosphatase activity(GO:0043262) |
20.8 | 62.3 | GO:0004829 | threonine-tRNA ligase activity(GO:0004829) |
20.7 | 82.7 | GO:0044378 | non-sequence-specific DNA binding, bending(GO:0044378) |
20.6 | 103.1 | GO:0098639 | collagen binding involved in cell-matrix adhesion(GO:0098639) |
20.6 | 247.4 | GO:0000774 | adenyl-nucleotide exchange factor activity(GO:0000774) |
20.0 | 20.0 | GO:0008240 | tripeptidyl-peptidase activity(GO:0008240) |
20.0 | 139.9 | GO:0030267 | hydroxypyruvate reductase activity(GO:0016618) glyoxylate reductase (NADP) activity(GO:0030267) |
19.9 | 139.0 | GO:0004459 | lactate dehydrogenase activity(GO:0004457) L-lactate dehydrogenase activity(GO:0004459) |
19.6 | 195.8 | GO:0015450 | P-P-bond-hydrolysis-driven protein transmembrane transporter activity(GO:0015450) |
19.5 | 117.0 | GO:0044388 | small protein activating enzyme binding(GO:0044388) |
19.5 | 58.4 | GO:0048408 | epidermal growth factor binding(GO:0048408) |
19.3 | 57.9 | GO:0005047 | signal recognition particle binding(GO:0005047) |
19.3 | 96.3 | GO:0004523 | RNA-DNA hybrid ribonuclease activity(GO:0004523) |
19.1 | 114.9 | GO:0010858 | calcium-dependent protein kinase regulator activity(GO:0010858) |
19.0 | 57.0 | GO:0005459 | UDP-galactose transmembrane transporter activity(GO:0005459) |
19.0 | 57.0 | GO:0004170 | dUTP diphosphatase activity(GO:0004170) |
18.9 | 113.2 | GO:0034513 | box H/ACA snoRNA binding(GO:0034513) |
18.4 | 165.8 | GO:0033592 | RNA strand annealing activity(GO:0033592) |
18.4 | 92.1 | GO:0046912 | transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer(GO:0046912) |
18.4 | 147.3 | GO:1990446 | U1 snRNP binding(GO:1990446) |
18.4 | 147.1 | GO:0000340 | RNA 7-methylguanosine cap binding(GO:0000340) |
18.3 | 201.8 | GO:0004576 | oligosaccharyl transferase activity(GO:0004576) |
18.3 | 128.1 | GO:0004793 | glycine hydroxymethyltransferase activity(GO:0004372) threonine aldolase activity(GO:0004793) L-allo-threonine aldolase activity(GO:0008732) |
18.2 | 54.6 | GO:0004822 | isoleucine-tRNA ligase activity(GO:0004822) |
18.2 | 145.5 | GO:0016842 | amidine-lyase activity(GO:0016842) |
18.0 | 108.2 | GO:0035402 | histone kinase activity (H3-T11 specific)(GO:0035402) |
18.0 | 107.9 | GO:0010859 | calcium-dependent cysteine-type endopeptidase inhibitor activity(GO:0010859) |
17.7 | 106.0 | GO:0019834 | phospholipase A2 inhibitor activity(GO:0019834) |
17.6 | 17.6 | GO:0017057 | 6-phosphogluconolactonase activity(GO:0017057) |
17.6 | 105.5 | GO:0010997 | anaphase-promoting complex binding(GO:0010997) |
17.6 | 17.6 | GO:0008309 | double-stranded DNA exodeoxyribonuclease activity(GO:0008309) |
17.6 | 123.0 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
17.5 | 70.1 | GO:0000104 | succinate dehydrogenase activity(GO:0000104) |
17.5 | 52.5 | GO:0004514 | nicotinate-nucleotide diphosphorylase (carboxylating) activity(GO:0004514) |
17.4 | 69.7 | GO:0016748 | succinyltransferase activity(GO:0016748) |
17.4 | 69.5 | GO:0008670 | 2,4-dienoyl-CoA reductase (NADPH) activity(GO:0008670) |
17.3 | 51.9 | GO:0004582 | dolichyl-phosphate beta-D-mannosyltransferase activity(GO:0004582) |
17.1 | 188.6 | GO:0004332 | fructose-bisphosphate aldolase activity(GO:0004332) |
17.1 | 34.1 | GO:0003985 | acetyl-CoA C-acetyltransferase activity(GO:0003985) |
17.0 | 34.1 | GO:0070990 | snRNP binding(GO:0070990) |
17.0 | 67.9 | GO:0008508 | bile acid:sodium symporter activity(GO:0008508) |
16.7 | 50.1 | GO:0003881 | CDP-diacylglycerol-inositol 3-phosphatidyltransferase activity(GO:0003881) |
16.5 | 33.0 | GO:0031177 | phosphopantetheine binding(GO:0031177) |
16.4 | 16.4 | GO:0030170 | pyridoxal phosphate binding(GO:0030170) |
16.4 | 98.7 | GO:0043138 | 3'-5' DNA helicase activity(GO:0043138) |
16.4 | 65.5 | GO:0016744 | transferase activity, transferring aldehyde or ketonic groups(GO:0016744) |
16.1 | 64.6 | GO:0005347 | adenine nucleotide transmembrane transporter activity(GO:0000295) purine ribonucleotide transmembrane transporter activity(GO:0005346) ATP transmembrane transporter activity(GO:0005347) purine nucleotide transmembrane transporter activity(GO:0015216) ADP transmembrane transporter activity(GO:0015217) |
16.1 | 96.8 | GO:0019238 | cyclohydrolase activity(GO:0019238) |
16.0 | 79.8 | GO:0030942 | endoplasmic reticulum signal peptide binding(GO:0030942) |
15.9 | 47.8 | GO:0004766 | spermidine synthase activity(GO:0004766) |
15.8 | 31.7 | GO:0004167 | dopachrome isomerase activity(GO:0004167) |
15.8 | 47.4 | GO:0004821 | histidine-tRNA ligase activity(GO:0004821) |
15.7 | 47.2 | GO:0032767 | copper-dependent protein binding(GO:0032767) |
15.7 | 94.0 | GO:0004749 | ribose phosphate diphosphokinase activity(GO:0004749) |
15.5 | 77.7 | GO:0016509 | long-chain-3-hydroxyacyl-CoA dehydrogenase activity(GO:0016509) |
15.5 | 93.1 | GO:0044594 | 3alpha,7alpha,12alpha-trihydroxy-5beta-cholest-24-enoyl-CoA hydratase activity(GO:0033989) 17-beta-hydroxysteroid dehydrogenase (NAD+) activity(GO:0044594) |
15.5 | 46.5 | GO:0003883 | CTP synthase activity(GO:0003883) |
15.4 | 30.8 | GO:0061676 | importin-alpha family protein binding(GO:0061676) |
15.3 | 107.1 | GO:0004704 | NF-kappaB-inducing kinase activity(GO:0004704) |
15.3 | 76.4 | GO:0008934 | inositol monophosphate 1-phosphatase activity(GO:0008934) inositol monophosphate 3-phosphatase activity(GO:0052832) inositol monophosphate 4-phosphatase activity(GO:0052833) inositol monophosphate phosphatase activity(GO:0052834) |
15.2 | 136.5 | GO:0070883 | pre-miRNA binding(GO:0070883) |
15.0 | 44.9 | GO:0004139 | deoxyribose-phosphate aldolase activity(GO:0004139) |
15.0 | 59.9 | GO:0004850 | uridine phosphorylase activity(GO:0004850) |
14.9 | 104.3 | GO:0097506 | uracil DNA N-glycosylase activity(GO:0004844) deaminated base DNA N-glycosylase activity(GO:0097506) |
14.9 | 14.9 | GO:0032551 | pyrimidine nucleoside binding(GO:0001884) UTP binding(GO:0002134) pyrimidine ribonucleoside binding(GO:0032551) |
14.8 | 44.5 | GO:0003983 | UTP:glucose-1-phosphate uridylyltransferase activity(GO:0003983) UTP-monosaccharide-1-phosphate uridylyltransferase activity(GO:0051748) |
14.8 | 88.6 | GO:0003857 | 3-hydroxyacyl-CoA dehydrogenase activity(GO:0003857) |
14.7 | 44.2 | GO:0004719 | protein-L-isoaspartate (D-aspartate) O-methyltransferase activity(GO:0004719) |
14.6 | 58.4 | GO:0050220 | prostaglandin-E synthase activity(GO:0050220) |
14.4 | 748.7 | GO:0008137 | NADH dehydrogenase (ubiquinone) activity(GO:0008137) NADH dehydrogenase (quinone) activity(GO:0050136) |
14.3 | 42.9 | GO:0004492 | methylmalonyl-CoA decarboxylase activity(GO:0004492) |
13.9 | 139.5 | GO:0001094 | TFIID-class transcription factor binding(GO:0001094) |
13.9 | 41.8 | GO:0004853 | uroporphyrinogen decarboxylase activity(GO:0004853) |
13.8 | 41.5 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
13.8 | 179.3 | GO:1990247 | N6-methyladenosine-containing RNA binding(GO:1990247) |
13.8 | 82.6 | GO:0030621 | U4 snRNA binding(GO:0030621) |
13.7 | 41.0 | GO:0070404 | NADH binding(GO:0070404) |
13.7 | 68.3 | GO:0030060 | L-malate dehydrogenase activity(GO:0030060) |
13.6 | 135.9 | GO:1990948 | ligase inhibitor activity(GO:0055104) ubiquitin ligase inhibitor activity(GO:1990948) |
13.5 | 108.2 | GO:0019206 | nucleoside kinase activity(GO:0019206) |
13.4 | 268.1 | GO:0070628 | proteasome binding(GO:0070628) |
13.4 | 26.8 | GO:0051920 | peroxiredoxin activity(GO:0051920) |
13.4 | 40.1 | GO:0070546 | L-phenylalanine aminotransferase activity(GO:0070546) L-phenylalanine:2-oxoglutarate aminotransferase activity(GO:0080130) |
13.3 | 26.5 | GO:0003998 | acylphosphatase activity(GO:0003998) |
13.2 | 39.7 | GO:0008413 | 8-oxo-7,8-dihydroguanosine triphosphate pyrophosphatase activity(GO:0008413) 8-oxo-7,8-dihydrodeoxyguanosine triphosphate pyrophosphatase activity(GO:0035539) |
13.1 | 354.1 | GO:0046933 | proton-transporting ATP synthase activity, rotational mechanism(GO:0046933) |
12.9 | 25.8 | GO:0016531 | copper chaperone activity(GO:0016531) |
12.9 | 38.6 | GO:0030984 | kininogen binding(GO:0030984) |
12.8 | 102.4 | GO:0016679 | oxidoreductase activity, acting on diphenols and related substances as donors(GO:0016679) |
12.8 | 38.3 | GO:0004730 | pseudouridylate synthase activity(GO:0004730) |
12.7 | 50.6 | GO:0004735 | pyrroline-5-carboxylate reductase activity(GO:0004735) |
12.5 | 37.6 | GO:1990404 | protein ADP-ribosylase activity(GO:1990404) |
12.4 | 99.6 | GO:0019237 | centromeric DNA binding(GO:0019237) |
12.4 | 61.8 | GO:0016403 | dimethylargininase activity(GO:0016403) |
12.3 | 172.9 | GO:0016018 | cyclosporin A binding(GO:0016018) |
12.3 | 49.3 | GO:0004310 | farnesyl-diphosphate farnesyltransferase activity(GO:0004310) squalene synthase activity(GO:0051996) |
12.2 | 36.7 | GO:0033149 | FFAT motif binding(GO:0033149) |
12.2 | 48.8 | GO:0043515 | kinetochore binding(GO:0043515) |
12.1 | 48.5 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
12.1 | 48.5 | GO:1990190 | peptide-glutamate-N-acetyltransferase activity(GO:1990190) |
12.1 | 36.3 | GO:0030377 | urokinase plasminogen activator receptor activity(GO:0030377) |
12.1 | 120.6 | GO:0001055 | RNA polymerase II activity(GO:0001055) |
12.1 | 421.9 | GO:0044183 | protein binding involved in protein folding(GO:0044183) |
12.1 | 72.3 | GO:0023025 | MHC class Ib protein complex binding(GO:0023025) MHC class Ib protein binding, via antigen binding groove(GO:0023030) |
12.0 | 168.2 | GO:0000339 | RNA cap binding(GO:0000339) |
11.9 | 47.4 | GO:1904408 | dihydronicotinamide riboside quinone reductase activity(GO:0001512) melatonin binding(GO:1904408) |
11.8 | 94.7 | GO:0016721 | superoxide dismutase activity(GO:0004784) oxidoreductase activity, acting on superoxide radicals as acceptor(GO:0016721) |
11.8 | 47.1 | GO:0004047 | aminomethyltransferase activity(GO:0004047) |
11.7 | 70.4 | GO:0046979 | TAP2 binding(GO:0046979) |
11.7 | 46.9 | GO:0004074 | biliverdin reductase activity(GO:0004074) |
11.6 | 69.7 | GO:0008553 | hydrogen-exporting ATPase activity, phosphorylative mechanism(GO:0008553) |
11.6 | 69.6 | GO:0044020 | histone methyltransferase activity (H4-R3 specific)(GO:0044020) |
11.6 | 69.5 | GO:0000400 | four-way junction DNA binding(GO:0000400) |
11.6 | 92.5 | GO:0016861 | intramolecular oxidoreductase activity, interconverting aldoses and ketoses(GO:0016861) |
11.5 | 69.2 | GO:0003872 | 6-phosphofructokinase activity(GO:0003872) |
11.5 | 46.0 | GO:0016936 | galactoside binding(GO:0016936) |
11.5 | 57.4 | GO:1990460 | leptin receptor binding(GO:1990460) |
11.5 | 23.0 | GO:0005006 | epidermal growth factor-activated receptor activity(GO:0005006) |
11.4 | 102.9 | GO:0046703 | natural killer cell lectin-like receptor binding(GO:0046703) |
11.4 | 216.3 | GO:0003756 | protein disulfide isomerase activity(GO:0003756) intramolecular oxidoreductase activity, transposing S-S bonds(GO:0016864) |
11.3 | 45.3 | GO:0034988 | Fc-gamma receptor I complex binding(GO:0034988) |
11.2 | 44.6 | GO:0003938 | IMP dehydrogenase activity(GO:0003938) |
11.1 | 133.7 | GO:0001075 | transcription factor activity, RNA polymerase II core promoter sequence-specific binding involved in preinitiation complex assembly(GO:0001075) |
11.1 | 55.6 | GO:0050145 | nucleoside phosphate kinase activity(GO:0050145) |
11.0 | 33.0 | GO:0017130 | poly(C) RNA binding(GO:0017130) |
10.9 | 76.6 | GO:0030229 | very-low-density lipoprotein particle receptor activity(GO:0030229) |
10.9 | 240.5 | GO:0048027 | mRNA 5'-UTR binding(GO:0048027) |
10.8 | 32.5 | GO:0008097 | 5S rRNA binding(GO:0008097) |
10.8 | 54.0 | GO:0038064 | collagen receptor activity(GO:0038064) |
10.8 | 32.4 | GO:0033823 | procollagen-lysine 5-dioxygenase activity(GO:0008475) procollagen glucosyltransferase activity(GO:0033823) |
10.7 | 32.2 | GO:0010698 | acetyltransferase activator activity(GO:0010698) |
10.7 | 42.7 | GO:0032137 | guanine/thymine mispair binding(GO:0032137) |
10.6 | 53.1 | GO:0070363 | mitochondrial light strand promoter sense binding(GO:0070363) |
10.6 | 84.4 | GO:0004017 | adenylate kinase activity(GO:0004017) |
10.5 | 42.1 | GO:0016784 | 3-mercaptopyruvate sulfurtransferase activity(GO:0016784) |
10.5 | 42.1 | GO:0004466 | long-chain-acyl-CoA dehydrogenase activity(GO:0004466) |
10.5 | 52.6 | GO:0015140 | malate transmembrane transporter activity(GO:0015140) |
10.5 | 21.0 | GO:0008263 | pyrimidine-specific mismatch base pair DNA N-glycosylase activity(GO:0008263) |
10.4 | 52.0 | GO:0004485 | methylcrotonoyl-CoA carboxylase activity(GO:0004485) |
10.4 | 20.8 | GO:0008312 | 7S RNA binding(GO:0008312) |
10.3 | 2110.9 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
10.3 | 41.1 | GO:0015142 | citrate transmembrane transporter activity(GO:0015137) tricarboxylic acid transmembrane transporter activity(GO:0015142) |
10.3 | 30.8 | GO:0004779 | adenylylsulfate kinase activity(GO:0004020) sulfate adenylyltransferase activity(GO:0004779) sulfate adenylyltransferase (ATP) activity(GO:0004781) |
10.2 | 30.7 | GO:0004611 | phosphoenolpyruvate carboxykinase activity(GO:0004611) phosphoenolpyruvate carboxykinase (GTP) activity(GO:0004613) |
10.2 | 102.1 | GO:0042731 | PH domain binding(GO:0042731) |
10.1 | 30.4 | GO:0004694 | eukaryotic translation initiation factor 2alpha kinase activity(GO:0004694) |
10.1 | 161.7 | GO:0004526 | ribonuclease P activity(GO:0004526) |
10.0 | 40.2 | GO:1903135 | cupric ion binding(GO:1903135) |
10.0 | 110.2 | GO:0017128 | phospholipid scramblase activity(GO:0017128) |
9.9 | 168.4 | GO:0046961 | hydrogen-exporting ATPase activity(GO:0036442) proton-transporting ATPase activity, rotational mechanism(GO:0046961) |
9.8 | 39.3 | GO:0008112 | nicotinamide N-methyltransferase activity(GO:0008112) pyridine N-methyltransferase activity(GO:0030760) |
9.8 | 49.0 | GO:0004830 | tryptophan-tRNA ligase activity(GO:0004830) |
9.8 | 48.9 | GO:0070026 | nitric oxide binding(GO:0070026) |
9.8 | 19.5 | GO:0003923 | GPI-anchor transamidase activity(GO:0003923) |
9.7 | 48.4 | GO:0016717 | oxidoreductase activity, acting on paired donors, with oxidation of a pair of donors resulting in the reduction of molecular oxygen to two molecules of water(GO:0016717) |
9.6 | 19.1 | GO:0016879 | ligase activity, forming carbon-nitrogen bonds(GO:0016879) |
9.5 | 57.2 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
9.5 | 19.0 | GO:0045294 | alpha-catenin binding(GO:0045294) |
9.5 | 37.9 | GO:0004566 | beta-glucuronidase activity(GO:0004566) |
9.5 | 37.9 | GO:0031996 | thioesterase binding(GO:0031996) |
9.4 | 37.8 | GO:0004132 | dCMP deaminase activity(GO:0004132) |
9.4 | 9.4 | GO:0004549 | tRNA-specific ribonuclease activity(GO:0004549) |
9.4 | 56.5 | GO:0043183 | vascular endothelial growth factor receptor 1 binding(GO:0043183) |
9.4 | 28.2 | GO:0004345 | glucose-6-phosphate dehydrogenase activity(GO:0004345) |
9.4 | 46.8 | GO:0047844 | deoxycytidine deaminase activity(GO:0047844) |
9.3 | 64.8 | GO:0030620 | U2 snRNA binding(GO:0030620) |
9.2 | 9.2 | GO:0043812 | phosphatidylinositol-4-phosphate phosphatase activity(GO:0043812) |
9.2 | 229.5 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
9.2 | 91.6 | GO:0098505 | single-stranded telomeric DNA binding(GO:0043047) G-rich strand telomeric DNA binding(GO:0098505) |
9.1 | 27.4 | GO:0048030 | disaccharide binding(GO:0048030) |
9.1 | 45.7 | GO:0004883 | glucocorticoid receptor activity(GO:0004883) glucocorticoid-activated RNA polymerase II transcription factor binding transcription factor activity(GO:0038051) |
9.1 | 45.7 | GO:0015129 | lactate transmembrane transporter activity(GO:0015129) |
9.1 | 9.1 | GO:0051734 | ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity(GO:0046404) polydeoxyribonucleotide kinase activity(GO:0051733) ATP-dependent polynucleotide kinase activity(GO:0051734) |
9.1 | 27.3 | GO:0004819 | glutamine-tRNA ligase activity(GO:0004819) |
9.0 | 18.1 | GO:0035529 | NADH pyrophosphatase activity(GO:0035529) |
9.0 | 72.1 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
8.9 | 44.7 | GO:0004161 | dimethylallyltranstransferase activity(GO:0004161) geranyltranstransferase activity(GO:0004337) |
8.9 | 26.7 | GO:0017150 | tRNA dihydrouridine synthase activity(GO:0017150) |
8.9 | 292.4 | GO:0051059 | NF-kappaB binding(GO:0051059) |
8.8 | 35.3 | GO:0050509 | N-acetylglucosaminyl-proteoglycan 4-beta-glucuronosyltransferase activity(GO:0050509) |
8.8 | 70.5 | GO:0005497 | androgen binding(GO:0005497) |
8.8 | 52.8 | GO:0047429 | nucleoside-triphosphate diphosphatase activity(GO:0047429) |
8.8 | 79.2 | GO:0086083 | cell adhesive protein binding involved in bundle of His cell-Purkinje myocyte communication(GO:0086083) |
8.7 | 35.0 | GO:0055077 | gap junction hemi-channel activity(GO:0055077) |
8.7 | 26.2 | GO:0032427 | GBD domain binding(GO:0032427) |
8.7 | 61.0 | GO:0030911 | TPR domain binding(GO:0030911) |
8.7 | 470.1 | GO:0003743 | translation initiation factor activity(GO:0003743) |
8.7 | 77.9 | GO:0055131 | C3HC4-type RING finger domain binding(GO:0055131) |
8.5 | 17.1 | GO:0043532 | angiostatin binding(GO:0043532) |
8.5 | 102.1 | GO:0050786 | RAGE receptor binding(GO:0050786) |
8.5 | 25.4 | GO:0004817 | cysteine-tRNA ligase activity(GO:0004817) |
8.5 | 25.4 | GO:0000773 | phosphatidyl-N-methylethanolamine N-methyltransferase activity(GO:0000773) phosphatidylethanolamine N-methyltransferase activity(GO:0004608) phosphatidyl-N-dimethylethanolamine N-methyltransferase activity(GO:0080101) |
8.4 | 573.9 | GO:0019003 | GDP binding(GO:0019003) |
8.4 | 75.9 | GO:1901612 | cardiolipin binding(GO:1901612) |
8.4 | 244.3 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
8.4 | 201.5 | GO:0034236 | protein kinase A catalytic subunit binding(GO:0034236) |
8.3 | 25.0 | GO:0061505 | DNA topoisomerase type II (ATP-hydrolyzing) activity(GO:0003918) DNA topoisomerase II activity(GO:0061505) |
8.3 | 33.3 | GO:0008823 | cupric reductase activity(GO:0008823) ferric-chelate reductase (NADPH) activity(GO:0052851) |
8.3 | 82.7 | GO:0017176 | phosphatidylinositol N-acetylglucosaminyltransferase activity(GO:0017176) |
8.3 | 24.8 | GO:0034511 | U3 snoRNA binding(GO:0034511) |
8.3 | 24.8 | GO:0016454 | serine C-palmitoyltransferase activity(GO:0004758) C-palmitoyltransferase activity(GO:0016454) |
8.2 | 74.0 | GO:0016884 | carbon-nitrogen ligase activity, with glutamine as amido-N-donor(GO:0016884) |
8.2 | 24.6 | GO:0004756 | selenide, water dikinase activity(GO:0004756) phosphotransferase activity, paired acceptors(GO:0016781) |
8.2 | 155.4 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
8.2 | 146.8 | GO:0098748 | clathrin adaptor activity(GO:0035615) endocytic adaptor activity(GO:0098748) |
8.1 | 105.7 | GO:0035256 | G-protein coupled glutamate receptor binding(GO:0035256) |
8.1 | 8.1 | GO:0004652 | polynucleotide adenylyltransferase activity(GO:0004652) |
8.1 | 16.2 | GO:0043398 | HLH domain binding(GO:0043398) |
8.1 | 193.4 | GO:0098641 | cadherin binding involved in cell-cell adhesion(GO:0098641) |
8.1 | 3084.6 | GO:0045296 | cadherin binding(GO:0045296) |
8.0 | 279.8 | GO:0004003 | ATP-dependent DNA helicase activity(GO:0004003) |
7.9 | 94.8 | GO:0017049 | GTP-Rho binding(GO:0017049) |
7.9 | 15.8 | GO:0017089 | glycolipid transporter activity(GO:0017089) |
7.9 | 23.6 | GO:0047726 | nitric oxide dioxygenase activity(GO:0008941) oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of two atoms of oxygen into one donor(GO:0016708) iron-cytochrome-c reductase activity(GO:0047726) |
7.9 | 23.6 | GO:0030366 | molybdopterin synthase activity(GO:0030366) |
7.8 | 311.2 | GO:0031492 | nucleosomal DNA binding(GO:0031492) |
7.7 | 15.4 | GO:0034046 | poly(G) binding(GO:0034046) |
7.7 | 30.8 | GO:0004335 | galactokinase activity(GO:0004335) |
7.7 | 53.9 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
7.7 | 15.4 | GO:0033743 | peptide-methionine (R)-S-oxide reductase activity(GO:0033743) |
7.6 | 61.0 | GO:0008432 | JUN kinase binding(GO:0008432) |
7.6 | 30.4 | GO:0016823 | hydrolase activity, acting on acid carbon-carbon bonds(GO:0016822) hydrolase activity, acting on acid carbon-carbon bonds, in ketonic substances(GO:0016823) |
7.6 | 15.1 | GO:0001165 | RNA polymerase I upstream control element sequence-specific DNA binding(GO:0001165) |
7.6 | 90.7 | GO:0089720 | caspase binding(GO:0089720) |
7.5 | 22.5 | GO:0016426 | tRNA (adenine) methyltransferase activity(GO:0016426) tRNA (adenine-N1-)-methyltransferase activity(GO:0016429) |
7.5 | 209.5 | GO:0016676 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
7.5 | 22.4 | GO:0000253 | 3-keto sterol reductase activity(GO:0000253) |
7.4 | 22.3 | GO:0034038 | deoxyhypusine synthase activity(GO:0034038) |
7.4 | 29.6 | GO:0004307 | ethanolaminephosphotransferase activity(GO:0004307) |
7.3 | 44.1 | GO:0016997 | exo-alpha-sialidase activity(GO:0004308) alpha-sialidase activity(GO:0016997) |
7.3 | 29.3 | GO:0004826 | phenylalanine-tRNA ligase activity(GO:0004826) |
7.3 | 43.6 | GO:0016802 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
7.2 | 28.9 | GO:0097100 | supercoiled DNA binding(GO:0097100) |
7.2 | 36.0 | GO:0000014 | single-stranded DNA endodeoxyribonuclease activity(GO:0000014) |
7.1 | 278.6 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
7.1 | 64.1 | GO:0003876 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
7.1 | 21.3 | GO:0016603 | glutaminyl-peptide cyclotransferase activity(GO:0016603) |
7.1 | 141.7 | GO:0070064 | proline-rich region binding(GO:0070064) |
7.1 | 77.7 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
7.0 | 28.2 | GO:0034186 | apolipoprotein A-I binding(GO:0034186) |
7.0 | 7.0 | GO:0051539 | 4 iron, 4 sulfur cluster binding(GO:0051539) |
7.0 | 63.3 | GO:0070878 | primary miRNA binding(GO:0070878) |
7.0 | 161.3 | GO:0004812 | aminoacyl-tRNA ligase activity(GO:0004812) ligase activity, forming carbon-oxygen bonds(GO:0016875) ligase activity, forming aminoacyl-tRNA and related compounds(GO:0016876) |
7.0 | 14.0 | GO:0016774 | phosphotransferase activity, carboxyl group as acceptor(GO:0016774) |
7.0 | 7.0 | GO:1990189 | peptide-serine-N-acetyltransferase activity(GO:1990189) |
6.9 | 55.4 | GO:0015349 | thyroid hormone transmembrane transporter activity(GO:0015349) |
6.9 | 62.2 | GO:0004032 | alditol:NADP+ 1-oxidoreductase activity(GO:0004032) |
6.9 | 41.5 | GO:0016814 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines(GO:0016814) |
6.9 | 61.7 | GO:0010314 | phosphatidylinositol-5-phosphate binding(GO:0010314) |
6.9 | 6.9 | GO:0004312 | fatty acid synthase activity(GO:0004312) |
6.8 | 20.5 | GO:0045127 | N-acetylglucosamine kinase activity(GO:0045127) |
6.8 | 20.5 | GO:0003976 | UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity(GO:0003976) |
6.8 | 306.3 | GO:0004864 | protein phosphatase inhibitor activity(GO:0004864) |
6.7 | 67.0 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
6.7 | 13.4 | GO:0046976 | histone methyltransferase activity (H3-K27 specific)(GO:0046976) |
6.7 | 13.4 | GO:0051021 | GDP-dissociation inhibitor binding(GO:0051021) Rho GDP-dissociation inhibitor binding(GO:0051022) |
6.7 | 6.7 | GO:0048038 | quinone binding(GO:0048038) |
6.6 | 33.2 | GO:1990254 | keratin filament binding(GO:1990254) |
6.6 | 184.7 | GO:0001671 | ATPase activator activity(GO:0001671) |
6.6 | 288.3 | GO:0050699 | WW domain binding(GO:0050699) |
6.5 | 196.4 | GO:0008574 | ATP-dependent microtubule motor activity, plus-end-directed(GO:0008574) |
6.5 | 32.7 | GO:0015165 | pyrimidine nucleotide-sugar transmembrane transporter activity(GO:0015165) |
6.5 | 19.6 | GO:0004362 | glutathione-disulfide reductase activity(GO:0004362) |
6.5 | 58.8 | GO:1990381 | ubiquitin-specific protease binding(GO:1990381) |
6.5 | 6.5 | GO:0005000 | vasopressin receptor activity(GO:0005000) |
6.5 | 32.6 | GO:0015266 | protein channel activity(GO:0015266) |
6.5 | 26.1 | GO:0036033 | mediator complex binding(GO:0036033) |
6.5 | 32.5 | GO:0031962 | mineralocorticoid receptor binding(GO:0031962) |
6.5 | 77.9 | GO:0051537 | 2 iron, 2 sulfur cluster binding(GO:0051537) |
6.5 | 19.4 | GO:0016838 | carbon-oxygen lyase activity, acting on phosphates(GO:0016838) |
6.4 | 19.2 | GO:0046921 | glycoprotein 6-alpha-L-fucosyltransferase activity(GO:0008424) alpha-(1->6)-fucosyltransferase activity(GO:0046921) |
6.4 | 25.6 | GO:0016655 | oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor(GO:0016655) |
6.4 | 12.7 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) |
6.4 | 120.7 | GO:0008353 | RNA polymerase II carboxy-terminal domain kinase activity(GO:0008353) |
6.3 | 37.8 | GO:0102337 | fatty acid elongase activity(GO:0009922) 3-oxo-arachidoyl-CoA synthase activity(GO:0102336) 3-oxo-cerotoyl-CoA synthase activity(GO:0102337) 3-oxo-lignoceronyl-CoA synthase activity(GO:0102338) |
6.3 | 50.3 | GO:0019788 | NEDD8 transferase activity(GO:0019788) |
6.3 | 118.9 | GO:0051400 | BH domain binding(GO:0051400) |
6.2 | 18.7 | GO:0034452 | dynactin binding(GO:0034452) |
6.2 | 43.6 | GO:0070087 | chromo shadow domain binding(GO:0070087) |
6.2 | 6.2 | GO:0038049 | transcription factor activity, ligand-activated RNA polymerase II transcription factor binding(GO:0038049) |
6.2 | 68.2 | GO:0034450 | ubiquitin-ubiquitin ligase activity(GO:0034450) |
6.2 | 6.2 | GO:0046923 | ER retention sequence binding(GO:0046923) |
6.2 | 30.8 | GO:0015307 | drug:proton antiporter activity(GO:0015307) |
6.1 | 30.7 | GO:0032050 | clathrin heavy chain binding(GO:0032050) |
6.1 | 171.5 | GO:0000993 | RNA polymerase II core binding(GO:0000993) |
6.1 | 30.5 | GO:0032795 | heterotrimeric G-protein binding(GO:0032795) |
6.1 | 24.3 | GO:0030292 | protein tyrosine kinase inhibitor activity(GO:0030292) |
6.1 | 60.7 | GO:0016273 | arginine N-methyltransferase activity(GO:0016273) protein-arginine N-methyltransferase activity(GO:0016274) |
6.1 | 91.1 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
6.1 | 12.1 | GO:0016832 | aldehyde-lyase activity(GO:0016832) |
6.0 | 36.1 | GO:0004470 | malic enzyme activity(GO:0004470) |
6.0 | 24.0 | GO:0035650 | AP-1 adaptor complex binding(GO:0035650) |
6.0 | 6.0 | GO:0016312 | inositol bisphosphate phosphatase activity(GO:0016312) |
5.9 | 11.8 | GO:0010340 | carboxyl-O-methyltransferase activity(GO:0010340) protein carboxyl O-methyltransferase activity(GO:0051998) |
5.9 | 29.4 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
5.8 | 210.2 | GO:0003755 | peptidyl-prolyl cis-trans isomerase activity(GO:0003755) |
5.8 | 11.7 | GO:0004609 | phosphatidylserine decarboxylase activity(GO:0004609) |
5.8 | 23.1 | GO:0004082 | bisphosphoglycerate mutase activity(GO:0004082) phosphoglycerate mutase activity(GO:0004619) 2,3-bisphosphoglycerate-dependent phosphoglycerate mutase activity(GO:0046538) |
5.8 | 28.8 | GO:0008073 | ornithine decarboxylase inhibitor activity(GO:0008073) |
5.7 | 34.5 | GO:0019776 | Atg8 ligase activity(GO:0019776) |
5.7 | 11.5 | GO:0047237 | glucuronylgalactosylproteoglycan 4-beta-N-acetylgalactosaminyltransferase activity(GO:0047237) |
5.7 | 74.6 | GO:0005337 | nucleoside transmembrane transporter activity(GO:0005337) |
5.7 | 80.4 | GO:0019707 | protein-cysteine S-palmitoyltransferase activity(GO:0019706) protein-cysteine S-acyltransferase activity(GO:0019707) |
5.7 | 740.0 | GO:0005200 | structural constituent of cytoskeleton(GO:0005200) |
5.7 | 131.1 | GO:0017166 | vinculin binding(GO:0017166) |
5.6 | 90.3 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
5.6 | 22.5 | GO:0043295 | glutathione binding(GO:0043295) |
5.6 | 56.2 | GO:0008428 | ribonuclease inhibitor activity(GO:0008428) |
5.6 | 84.2 | GO:0080025 | phosphatidylinositol-3,5-bisphosphate binding(GO:0080025) |
5.6 | 39.2 | GO:0031491 | nucleosome binding(GO:0031491) |
5.5 | 155.2 | GO:0005123 | death receptor binding(GO:0005123) |
5.5 | 38.7 | GO:0019212 | phosphatase inhibitor activity(GO:0019212) |
5.5 | 175.5 | GO:0046966 | thyroid hormone receptor binding(GO:0046966) |
5.5 | 27.3 | GO:0004910 | interleukin-1, Type II, blocking receptor activity(GO:0004910) |
5.4 | 21.8 | GO:0004663 | Rab geranylgeranyltransferase activity(GO:0004663) |
5.4 | 16.3 | GO:0044549 | GTP cyclohydrolase binding(GO:0044549) |
5.4 | 32.6 | GO:0015186 | L-glutamine transmembrane transporter activity(GO:0015186) |
5.4 | 21.6 | GO:0048256 | flap endonuclease activity(GO:0048256) |
5.4 | 75.7 | GO:0015035 | protein disulfide oxidoreductase activity(GO:0015035) |
5.4 | 128.7 | GO:0070410 | co-SMAD binding(GO:0070410) |
5.3 | 16.0 | GO:0004392 | heme oxygenase (decyclizing) activity(GO:0004392) |
5.3 | 26.6 | GO:0042974 | retinoic acid receptor binding(GO:0042974) |
5.3 | 37.2 | GO:0042975 | peroxisome proliferator activated receptor binding(GO:0042975) |
5.3 | 63.7 | GO:0001222 | transcription corepressor binding(GO:0001222) |
5.3 | 31.7 | GO:0004614 | phosphoglucomutase activity(GO:0004614) |
5.3 | 15.8 | GO:0046573 | lactonohydrolase activity(GO:0046573) acyl-L-homoserine-lactone lactonohydrolase activity(GO:0102007) |
5.2 | 52.1 | GO:0019869 | chloride channel inhibitor activity(GO:0019869) |
5.2 | 72.7 | GO:0003688 | DNA replication origin binding(GO:0003688) |
5.2 | 20.7 | GO:0004809 | tRNA (guanine-N2-)-methyltransferase activity(GO:0004809) |
5.2 | 82.6 | GO:0008483 | transaminase activity(GO:0008483) |
5.1 | 40.9 | GO:0047144 | 2-acylglycerol-3-phosphate O-acyltransferase activity(GO:0047144) |
5.1 | 15.3 | GO:0001069 | regulatory region RNA binding(GO:0001069) |
5.1 | 71.0 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
5.1 | 136.8 | GO:0070717 | poly-purine tract binding(GO:0070717) |
5.0 | 10.1 | GO:0043813 | phosphatidylinositol-3,5-bisphosphate 5-phosphatase activity(GO:0043813) |
5.0 | 20.1 | GO:0050309 | glucose-6-phosphatase activity(GO:0004346) sugar-terminal-phosphatase activity(GO:0050309) |
5.0 | 40.0 | GO:0070273 | phosphatidylinositol-4-phosphate binding(GO:0070273) |
5.0 | 39.9 | GO:0005049 | nuclear export signal receptor activity(GO:0005049) |
5.0 | 34.8 | GO:0070492 | oligosaccharide binding(GO:0070492) |
5.0 | 129.2 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
4.9 | 14.7 | GO:0005169 | neurotrophin TRKB receptor binding(GO:0005169) |
4.9 | 346.4 | GO:0003697 | single-stranded DNA binding(GO:0003697) |
4.8 | 150.0 | GO:0000175 | 3'-5'-exoribonuclease activity(GO:0000175) |
4.8 | 67.3 | GO:0031014 | troponin T binding(GO:0031014) |
4.7 | 66.5 | GO:0070182 | DNA polymerase binding(GO:0070182) |
4.7 | 23.7 | GO:0030345 | extracellular matrix structural constituent conferring compression resistance(GO:0030021) structural constituent of tooth enamel(GO:0030345) |
4.7 | 52.2 | GO:0003831 | beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity(GO:0003831) |
4.7 | 9.4 | GO:0032422 | purine-rich negative regulatory element binding(GO:0032422) |
4.7 | 18.7 | GO:0098518 | polynucleotide phosphatase activity(GO:0098518) |
4.7 | 9.4 | GO:0004731 | purine-nucleoside phosphorylase activity(GO:0004731) |
4.7 | 14.0 | GO:0050510 | N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity(GO:0050510) |
4.7 | 14.0 | GO:0032089 | NACHT domain binding(GO:0032089) |
4.6 | 9.2 | GO:0035373 | chondroitin sulfate proteoglycan binding(GO:0035373) |
4.6 | 23.1 | GO:0004064 | arylesterase activity(GO:0004064) |
4.6 | 60.1 | GO:0003993 | acid phosphatase activity(GO:0003993) |
4.6 | 124.4 | GO:0070577 | lysine-acetylated histone binding(GO:0070577) |
4.6 | 73.5 | GO:0097602 | cullin family protein binding(GO:0097602) |
4.6 | 23.0 | GO:0052740 | 1-acyl-2-lysophosphatidylserine acylhydrolase activity(GO:0052740) |
4.6 | 13.8 | GO:0071566 | UFM1 activating enzyme activity(GO:0071566) |
4.6 | 13.7 | GO:0099602 | acetylcholine receptor regulator activity(GO:0030548) neurotransmitter receptor regulator activity(GO:0099602) |
4.5 | 18.1 | GO:0004966 | galanin receptor activity(GO:0004966) |
4.5 | 18.0 | GO:0004348 | glucosylceramidase activity(GO:0004348) |
4.5 | 22.5 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
4.5 | 35.9 | GO:0050833 | pyruvate transmembrane transporter activity(GO:0050833) |
4.5 | 13.4 | GO:0003858 | 3-hydroxybutyrate dehydrogenase activity(GO:0003858) |
4.4 | 17.7 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
4.4 | 43.9 | GO:0042609 | CD4 receptor binding(GO:0042609) |
4.4 | 43.7 | GO:0070053 | thrombospondin receptor activity(GO:0070053) |
4.3 | 17.4 | GO:0072542 | protein phosphatase activator activity(GO:0072542) |
4.3 | 234.2 | GO:0050681 | androgen receptor binding(GO:0050681) |
4.3 | 13.0 | GO:0004769 | steroid delta-isomerase activity(GO:0004769) |
4.3 | 21.4 | GO:0015556 | C4-dicarboxylate transmembrane transporter activity(GO:0015556) |
4.3 | 29.9 | GO:0051425 | PTB domain binding(GO:0051425) |
4.2 | 25.4 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
4.2 | 16.6 | GO:0002046 | opsin binding(GO:0002046) |
4.2 | 74.9 | GO:0035497 | cAMP response element binding(GO:0035497) |
4.2 | 16.6 | GO:0070576 | vitamin D 24-hydroxylase activity(GO:0070576) |
4.1 | 16.6 | GO:0008336 | gamma-butyrobetaine dioxygenase activity(GO:0008336) |
4.1 | 8.3 | GO:0016863 | intramolecular oxidoreductase activity, transposing C=C bonds(GO:0016863) |
4.1 | 4.1 | GO:0043142 | single-stranded DNA-dependent ATPase activity(GO:0043142) |
4.1 | 20.6 | GO:0004647 | phosphoserine phosphatase activity(GO:0004647) |
4.1 | 4.1 | GO:0016421 | CoA carboxylase activity(GO:0016421) |
4.1 | 12.3 | GO:0004727 | prenylated protein tyrosine phosphatase activity(GO:0004727) |
4.1 | 20.5 | GO:0004839 | ubiquitin activating enzyme activity(GO:0004839) |
4.1 | 16.4 | GO:0047057 | oxidoreductase activity, acting on the CH-OH group of donors, disulfide as acceptor(GO:0016900) vitamin-K-epoxide reductase (warfarin-sensitive) activity(GO:0047057) |
4.1 | 24.5 | GO:0003920 | GMP reductase activity(GO:0003920) oxidoreductase activity, acting on NAD(P)H, nitrogenous group as acceptor(GO:0016657) |
4.1 | 28.4 | GO:0042301 | phosphate ion binding(GO:0042301) |
4.0 | 8.1 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
4.0 | 20.1 | GO:0004532 | exoribonuclease activity(GO:0004532) |
4.0 | 27.9 | GO:0038085 | vascular endothelial growth factor binding(GO:0038085) |
4.0 | 55.7 | GO:0003746 | translation elongation factor activity(GO:0003746) |
4.0 | 11.9 | GO:0000150 | recombinase activity(GO:0000150) |
4.0 | 27.8 | GO:0019870 | potassium channel inhibitor activity(GO:0019870) |
4.0 | 135.1 | GO:0004407 | histone deacetylase activity(GO:0004407) |
3.9 | 11.8 | GO:0001609 | G-protein coupled adenosine receptor activity(GO:0001609) |
3.9 | 54.8 | GO:0003841 | 1-acylglycerol-3-phosphate O-acyltransferase activity(GO:0003841) lysophosphatidic acid acyltransferase activity(GO:0042171) lysophospholipid acyltransferase activity(GO:0071617) |
3.9 | 7.8 | GO:0008184 | glycogen phosphorylase activity(GO:0008184) |
3.9 | 81.4 | GO:0016538 | cyclin-dependent protein serine/threonine kinase regulator activity(GO:0016538) |
3.9 | 15.4 | GO:0004046 | aminoacylase activity(GO:0004046) |
3.8 | 22.8 | GO:0017080 | sodium channel regulator activity(GO:0017080) |
3.8 | 129.1 | GO:0008536 | Ran GTPase binding(GO:0008536) |
3.8 | 26.5 | GO:0042979 | ornithine decarboxylase activator activity(GO:0042978) ornithine decarboxylase regulator activity(GO:0042979) |
3.8 | 3.8 | GO:0047718 | indanol dehydrogenase activity(GO:0047718) |
3.8 | 22.5 | GO:0008266 | poly(U) RNA binding(GO:0008266) |
3.7 | 18.6 | GO:1904264 | ubiquitin protein ligase activity involved in ERAD pathway(GO:1904264) |
3.7 | 133.7 | GO:0005154 | epidermal growth factor receptor binding(GO:0005154) |
3.7 | 233.3 | GO:0004177 | aminopeptidase activity(GO:0004177) |
3.7 | 14.7 | GO:0005105 | type 1 fibroblast growth factor receptor binding(GO:0005105) |
3.7 | 11.0 | GO:0034714 | type III transforming growth factor beta receptor binding(GO:0034714) |
3.6 | 14.6 | GO:0003989 | acetyl-CoA carboxylase activity(GO:0003989) |
3.6 | 7.3 | GO:0000386 | second spliceosomal transesterification activity(GO:0000386) |
3.6 | 57.6 | GO:0097200 | cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:0097200) |
3.6 | 10.8 | GO:0046848 | hydroxyapatite binding(GO:0046848) |
3.6 | 35.8 | GO:0017070 | U6 snRNA binding(GO:0017070) |
3.5 | 38.7 | GO:0031852 | mu-type opioid receptor binding(GO:0031852) |
3.5 | 31.6 | GO:0038132 | neuregulin binding(GO:0038132) |
3.5 | 17.5 | GO:0004906 | interferon-gamma receptor activity(GO:0004906) |
3.5 | 20.9 | GO:0048156 | tau protein binding(GO:0048156) |
3.5 | 31.4 | GO:0050544 | icosanoid binding(GO:0050542) arachidonic acid binding(GO:0050544) fatty acid derivative binding(GO:1901567) |
3.5 | 10.5 | GO:0046790 | virion binding(GO:0046790) |
3.5 | 10.4 | GO:0033867 | Fas-activated serine/threonine kinase activity(GO:0033867) |
3.4 | 6.9 | GO:0050211 | procollagen galactosyltransferase activity(GO:0050211) |
3.4 | 30.9 | GO:0008603 | cAMP-dependent protein kinase regulator activity(GO:0008603) |
3.4 | 6.8 | GO:0005026 | transforming growth factor beta receptor activity, type II(GO:0005026) |
3.4 | 204.6 | GO:0032947 | protein complex scaffold(GO:0032947) |
3.4 | 20.4 | GO:0000182 | rDNA binding(GO:0000182) |
3.4 | 10.2 | GO:0008523 | sodium-dependent multivitamin transmembrane transporter activity(GO:0008523) |
3.4 | 3.4 | GO:0016417 | S-acyltransferase activity(GO:0016417) |
3.4 | 47.4 | GO:0005095 | GTPase inhibitor activity(GO:0005095) |
3.4 | 6.8 | GO:0000829 | inositol-1,3,4,5,6-pentakisphosphate kinase activity(GO:0000827) inositol hexakisphosphate kinase activity(GO:0000828) inositol heptakisphosphate kinase activity(GO:0000829) inositol hexakisphosphate 5-kinase activity(GO:0000832) inositol hexakisphosphate 1-kinase activity(GO:0052723) inositol hexakisphosphate 3-kinase activity(GO:0052724) |
3.4 | 3.4 | GO:0008192 | RNA guanylyltransferase activity(GO:0008192) |
3.4 | 16.8 | GO:0036310 | annealing helicase activity(GO:0036310) |
3.4 | 47.0 | GO:0008527 | taste receptor activity(GO:0008527) |
3.3 | 3.3 | GO:0019166 | trans-2-enoyl-CoA reductase (NADPH) activity(GO:0019166) |
3.3 | 53.2 | GO:0043531 | ADP binding(GO:0043531) |
3.3 | 49.6 | GO:0010485 | H4 histone acetyltransferase activity(GO:0010485) |
3.3 | 6.6 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
3.3 | 42.8 | GO:0031957 | very long-chain fatty acid-CoA ligase activity(GO:0031957) |
3.3 | 82.2 | GO:0016790 | thiolester hydrolase activity(GO:0016790) |
3.3 | 196.0 | GO:0016765 | transferase activity, transferring alkyl or aryl (other than methyl) groups(GO:0016765) |
3.3 | 287.3 | GO:0043130 | ubiquitin binding(GO:0043130) |
3.3 | 9.8 | GO:0004379 | glycylpeptide N-tetradecanoyltransferase activity(GO:0004379) myristoyltransferase activity(GO:0019107) |
3.2 | 25.9 | GO:0004322 | ferroxidase activity(GO:0004322) oxidoreductase activity, oxidizing metal ions, oxygen as acceptor(GO:0016724) |
3.2 | 249.2 | GO:0047485 | protein N-terminus binding(GO:0047485) |
3.2 | 19.4 | GO:1904929 | coreceptor activity involved in Wnt signaling pathway, planar cell polarity pathway(GO:1904929) |
3.2 | 99.4 | GO:0004386 | helicase activity(GO:0004386) |
3.2 | 15.9 | GO:0030348 | syntaxin-3 binding(GO:0030348) |
3.2 | 9.5 | GO:0004958 | prostaglandin F receptor activity(GO:0004958) |
3.2 | 123.2 | GO:0008138 | protein tyrosine/serine/threonine phosphatase activity(GO:0008138) |
3.2 | 15.8 | GO:0008079 | translation release factor activity(GO:0003747) translation termination factor activity(GO:0008079) |
3.1 | 22.0 | GO:0070402 | NADPH binding(GO:0070402) |
3.1 | 21.9 | GO:0017134 | fibroblast growth factor binding(GO:0017134) |
3.1 | 6.2 | GO:0070653 | high-density lipoprotein particle receptor binding(GO:0070653) |
3.1 | 15.4 | GO:0070513 | death domain binding(GO:0070513) |
3.1 | 9.2 | GO:0102008 | cytosolic dipeptidase activity(GO:0102008) |
3.1 | 15.3 | GO:0046870 | cadmium ion binding(GO:0046870) |
3.0 | 21.0 | GO:0016846 | carbon-sulfur lyase activity(GO:0016846) |
3.0 | 9.0 | GO:0035473 | lipase binding(GO:0035473) |
3.0 | 35.8 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
2.9 | 5.9 | GO:0030552 | cAMP binding(GO:0030552) |
2.9 | 5.8 | GO:0016401 | palmitoyl-CoA oxidase activity(GO:0016401) |
2.9 | 20.3 | GO:0004550 | nucleoside diphosphate kinase activity(GO:0004550) |
2.9 | 11.6 | GO:0008466 | glycogenin glucosyltransferase activity(GO:0008466) |
2.9 | 60.2 | GO:0008242 | omega peptidase activity(GO:0008242) |
2.9 | 5.7 | GO:0016868 | intramolecular transferase activity, phosphotransferases(GO:0016868) |
2.8 | 28.5 | GO:0008301 | DNA binding, bending(GO:0008301) |
2.8 | 19.7 | GO:0005324 | long-chain fatty acid transporter activity(GO:0005324) |
2.8 | 522.5 | GO:0003924 | GTPase activity(GO:0003924) |
2.8 | 22.3 | GO:0005005 | transmembrane-ephrin receptor activity(GO:0005005) |
2.8 | 30.7 | GO:0055103 | ligase regulator activity(GO:0055103) |
2.8 | 8.4 | GO:0097158 | pre-mRNA intronic pyrimidine-rich binding(GO:0097158) |
2.8 | 13.9 | GO:0009982 | pseudouridine synthase activity(GO:0009982) |
2.7 | 5.5 | GO:0032564 | adenyl deoxyribonucleotide binding(GO:0032558) dATP binding(GO:0032564) |
2.7 | 2.7 | GO:0034041 | sterol-transporting ATPase activity(GO:0034041) |
2.7 | 8.2 | GO:1902122 | chenodeoxycholic acid binding(GO:1902122) |
2.7 | 29.9 | GO:0004033 | aldo-keto reductase (NADP) activity(GO:0004033) |
2.7 | 75.6 | GO:0003785 | actin monomer binding(GO:0003785) |
2.7 | 26.9 | GO:0031730 | CCR5 chemokine receptor binding(GO:0031730) |
2.7 | 8.0 | GO:0071535 | RING-like zinc finger domain binding(GO:0071535) |
2.7 | 42.5 | GO:0005537 | mannose binding(GO:0005537) |
2.6 | 2.6 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
2.6 | 79.0 | GO:0005547 | phosphatidylinositol-3,4,5-trisphosphate binding(GO:0005547) |
2.6 | 7.9 | GO:0015315 | hexose phosphate transmembrane transporter activity(GO:0015119) organophosphate:inorganic phosphate antiporter activity(GO:0015315) hexose-phosphate:inorganic phosphate antiporter activity(GO:0015526) glucose 6-phosphate:inorganic phosphate antiporter activity(GO:0061513) |
2.6 | 21.1 | GO:0070569 | uridylyltransferase activity(GO:0070569) |
2.6 | 7.9 | GO:0005384 | manganese ion transmembrane transporter activity(GO:0005384) |
2.6 | 7.9 | GO:0004531 | deoxyribonuclease II activity(GO:0004531) |
2.6 | 7.8 | GO:0008479 | queuine tRNA-ribosyltransferase activity(GO:0008479) |
2.6 | 13.0 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
2.6 | 10.4 | GO:0018479 | benzaldehyde dehydrogenase (NAD+) activity(GO:0018479) |
2.6 | 2834.7 | GO:0003723 | RNA binding(GO:0003723) |
2.6 | 7.8 | GO:0008199 | ferric iron binding(GO:0008199) |
2.6 | 18.0 | GO:1990459 | transferrin receptor binding(GO:1990459) |
2.6 | 7.7 | GO:0004157 | dihydropyrimidinase activity(GO:0004157) |
2.6 | 12.8 | GO:0034596 | phosphatidylinositol phosphate 4-phosphatase activity(GO:0034596) |
2.5 | 25.2 | GO:0031995 | insulin-like growth factor II binding(GO:0031995) |
2.5 | 15.0 | GO:0070324 | thyroid hormone binding(GO:0070324) |
2.5 | 5.0 | GO:0004998 | transferrin receptor activity(GO:0004998) |
2.5 | 9.9 | GO:0042379 | chemokine receptor binding(GO:0042379) |
2.4 | 9.8 | GO:0008518 | reduced folate carrier activity(GO:0008518) methotrexate transporter activity(GO:0015350) |
2.4 | 4.9 | GO:0019239 | deaminase activity(GO:0019239) |
2.4 | 19.5 | GO:0044548 | S100 protein binding(GO:0044548) |
2.4 | 17.0 | GO:0016701 | oxidoreductase activity, acting on single donors with incorporation of molecular oxygen(GO:0016701) |
2.4 | 4.8 | GO:0016778 | diphosphotransferase activity(GO:0016778) |
2.4 | 14.5 | GO:0005134 | interleukin-2 receptor binding(GO:0005134) |
2.4 | 118.1 | GO:0016616 | oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor(GO:0016616) |
2.4 | 19.2 | GO:0004340 | glucokinase activity(GO:0004340) hexokinase activity(GO:0004396) fructokinase activity(GO:0008865) mannokinase activity(GO:0019158) |
2.4 | 4.8 | GO:0016715 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen(GO:0016715) |
2.4 | 4.7 | GO:0000995 | transcription factor activity, core RNA polymerase III binding(GO:0000995) |
2.3 | 21.1 | GO:0035174 | histone serine kinase activity(GO:0035174) |
2.3 | 30.2 | GO:0016628 | oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor(GO:0016628) |
2.3 | 7.0 | GO:0008476 | protein-tyrosine sulfotransferase activity(GO:0008476) |
2.3 | 11.6 | GO:0097016 | L27 domain binding(GO:0097016) |
2.3 | 43.1 | GO:0043021 | ribonucleoprotein complex binding(GO:0043021) |
2.2 | 4.5 | GO:0008641 | small protein activating enzyme activity(GO:0008641) |
2.2 | 11.2 | GO:0070644 | vitamin D response element binding(GO:0070644) |
2.2 | 8.8 | GO:0008449 | N-acetylglucosamine-6-sulfatase activity(GO:0008449) |
2.2 | 312.1 | GO:0005178 | integrin binding(GO:0005178) |
2.2 | 17.3 | GO:0004111 | creatine kinase activity(GO:0004111) |
2.2 | 47.6 | GO:0015248 | sterol transporter activity(GO:0015248) |
2.1 | 17.2 | GO:0016667 | oxidoreductase activity, acting on a sulfur group of donors(GO:0016667) |
2.1 | 4.2 | GO:0071987 | WD40-repeat domain binding(GO:0071987) |
2.1 | 6.4 | GO:1901505 | carbohydrate derivative transporter activity(GO:1901505) |
2.1 | 6.4 | GO:0005338 | nucleotide-sugar transmembrane transporter activity(GO:0005338) |
2.1 | 2.1 | GO:0032810 | sterol response element binding(GO:0032810) |
2.0 | 4.1 | GO:0030296 | protein tyrosine kinase activator activity(GO:0030296) |
2.0 | 16.1 | GO:0030346 | protein phosphatase 2B binding(GO:0030346) |
2.0 | 9.9 | GO:0016502 | purinergic nucleotide receptor activity(GO:0001614) extracellular ATP-gated cation channel activity(GO:0004931) nucleotide receptor activity(GO:0016502) ATP-gated ion channel activity(GO:0035381) |
2.0 | 23.6 | GO:0045295 | gamma-catenin binding(GO:0045295) |
2.0 | 19.5 | GO:0001135 | transcription factor activity, RNA polymerase II transcription factor recruiting(GO:0001135) |
1.9 | 17.3 | GO:0008525 | phosphatidylcholine transporter activity(GO:0008525) |
1.9 | 36.5 | GO:0003899 | DNA-directed RNA polymerase activity(GO:0003899) |
1.9 | 1.9 | GO:0008174 | mRNA methyltransferase activity(GO:0008174) |
1.9 | 70.7 | GO:0005507 | copper ion binding(GO:0005507) |
1.9 | 115.6 | GO:0008565 | protein transporter activity(GO:0008565) |
1.9 | 105.8 | GO:0017048 | Rho GTPase binding(GO:0017048) |
1.8 | 80.7 | GO:0003777 | microtubule motor activity(GO:0003777) |
1.8 | 14.5 | GO:0004873 | asialoglycoprotein receptor activity(GO:0004873) |
1.8 | 12.7 | GO:0005375 | copper ion transmembrane transporter activity(GO:0005375) |
1.8 | 1.8 | GO:0050656 | 3'-phosphoadenosine 5'-phosphosulfate binding(GO:0050656) |
1.8 | 16.0 | GO:0016755 | transferase activity, transferring amino-acyl groups(GO:0016755) |
1.7 | 10.3 | GO:0051183 | vitamin transporter activity(GO:0051183) |
1.7 | 10.0 | GO:0047685 | amine sulfotransferase activity(GO:0047685) |
1.7 | 23.2 | GO:0031404 | chloride ion binding(GO:0031404) |
1.7 | 6.6 | GO:0016230 | sphingomyelin phosphodiesterase activator activity(GO:0016230) |
1.6 | 3.1 | GO:0031727 | CCR2 chemokine receptor binding(GO:0031727) |
1.5 | 4.6 | GO:0050308 | carbohydrate phosphatase activity(GO:0019203) sugar-phosphatase activity(GO:0050308) |
1.5 | 6.0 | GO:0004666 | prostaglandin-endoperoxide synthase activity(GO:0004666) |
1.5 | 5.9 | GO:0098821 | BMP receptor activity(GO:0098821) |
1.4 | 14.4 | GO:0035259 | glucocorticoid receptor binding(GO:0035259) |
1.4 | 47.4 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
1.4 | 26.9 | GO:0016500 | protein-hormone receptor activity(GO:0016500) |
1.4 | 1.4 | GO:0015187 | glycine transmembrane transporter activity(GO:0015187) |
1.4 | 5.6 | GO:0005499 | vitamin D binding(GO:0005499) |
1.4 | 30.4 | GO:0005416 | cation:amino acid symporter activity(GO:0005416) |
1.4 | 2.7 | GO:0044323 | retinoic acid-responsive element binding(GO:0044323) |
1.4 | 5.4 | GO:0004887 | thyroid hormone receptor activity(GO:0004887) |
1.4 | 5.4 | GO:0016520 | growth hormone-releasing hormone receptor activity(GO:0016520) |
1.3 | 6.7 | GO:0030023 | extracellular matrix constituent conferring elasticity(GO:0030023) |
1.3 | 6.7 | GO:0005544 | calcium-dependent phospholipid binding(GO:0005544) |
1.3 | 2.7 | GO:0051429 | corticotropin-releasing hormone receptor binding(GO:0051429) corticotropin-releasing hormone receptor 1 binding(GO:0051430) |
1.3 | 34.0 | GO:0015078 | hydrogen ion transmembrane transporter activity(GO:0015078) |
1.3 | 6.5 | GO:0043120 | tumor necrosis factor binding(GO:0043120) |
1.3 | 3.9 | GO:0015235 | cobalamin transporter activity(GO:0015235) |
1.3 | 1.3 | GO:0019966 | interleukin-1 binding(GO:0019966) |
1.3 | 5.1 | GO:0031208 | POZ domain binding(GO:0031208) |
1.3 | 2.5 | GO:0070697 | activin receptor binding(GO:0070697) type II activin receptor binding(GO:0070699) |
1.3 | 5.1 | GO:0004359 | glutaminase activity(GO:0004359) |
1.3 | 12.6 | GO:0019534 | toxin transporter activity(GO:0019534) |
1.2 | 35.8 | GO:0001105 | RNA polymerase II transcription coactivator activity(GO:0001105) |
1.2 | 3.6 | GO:0004711 | ribosomal protein S6 kinase activity(GO:0004711) |
1.2 | 62.0 | GO:0008307 | structural constituent of muscle(GO:0008307) |
1.2 | 2.4 | GO:0034648 | histone demethylase activity (H3-dimethyl-K4 specific)(GO:0034648) |
1.2 | 7.0 | GO:0017018 | myosin phosphatase activity(GO:0017018) |
1.1 | 8.0 | GO:0008109 | N-acetyllactosaminide beta-1,6-N-acetylglucosaminyltransferase activity(GO:0008109) |
1.1 | 1.1 | GO:0016406 | carnitine O-palmitoyltransferase activity(GO:0004095) carnitine O-acyltransferase activity(GO:0016406) |
1.1 | 7.8 | GO:0001727 | lipid kinase activity(GO:0001727) |
1.1 | 4.4 | GO:0005172 | vascular endothelial growth factor receptor binding(GO:0005172) |
1.1 | 7.6 | GO:0047894 | flavonol 3-sulfotransferase activity(GO:0047894) |
1.1 | 6.5 | GO:0039706 | co-receptor binding(GO:0039706) |
1.1 | 8.6 | GO:0016505 | peptidase activator activity involved in apoptotic process(GO:0016505) |
1.1 | 5.3 | GO:0045545 | syndecan binding(GO:0045545) |
1.0 | 3.1 | GO:0005124 | scavenger receptor binding(GO:0005124) |
1.0 | 3.1 | GO:0004924 | oncostatin-M receptor activity(GO:0004924) |
1.0 | 6.0 | GO:0022833 | mechanically-gated ion channel activity(GO:0008381) mechanically gated channel activity(GO:0022833) |
1.0 | 3.0 | GO:0031726 | CCR1 chemokine receptor binding(GO:0031726) |
1.0 | 24.4 | GO:0003887 | DNA-directed DNA polymerase activity(GO:0003887) |
1.0 | 13.7 | GO:0005132 | type I interferon receptor binding(GO:0005132) |
1.0 | 1.0 | GO:0019215 | intermediate filament binding(GO:0019215) |
1.0 | 7.7 | GO:0016634 | oxidoreductase activity, acting on the CH-CH group of donors, oxygen as acceptor(GO:0016634) |
0.9 | 18.8 | GO:0046875 | ephrin receptor binding(GO:0046875) |
0.9 | 2.7 | GO:0005254 | chloride channel activity(GO:0005254) |
0.9 | 3.5 | GO:0003990 | acetylcholinesterase activity(GO:0003990) |
0.9 | 0.9 | GO:0016262 | protein N-acetylglucosaminyltransferase activity(GO:0016262) |
0.9 | 5.2 | GO:0031543 | peptidyl-proline dioxygenase activity(GO:0031543) |
0.9 | 3.4 | GO:0005412 | glucose:sodium symporter activity(GO:0005412) |
0.9 | 0.9 | GO:0016623 | oxidoreductase activity, acting on the aldehyde or oxo group of donors, oxygen as acceptor(GO:0016623) |
0.8 | 5.0 | GO:0005351 | sugar:proton symporter activity(GO:0005351) cation:sugar symporter activity(GO:0005402) |
0.8 | 2.5 | GO:0031731 | CCR6 chemokine receptor binding(GO:0031731) |
0.8 | 4.8 | GO:0008158 | hedgehog receptor activity(GO:0008158) |
0.8 | 5.6 | GO:0019213 | deacetylase activity(GO:0019213) |
0.8 | 3.2 | GO:0061649 | ubiquitinated histone binding(GO:0061649) |
0.8 | 0.8 | GO:0004461 | lactose synthase activity(GO:0004461) |
0.8 | 2.3 | GO:0005549 | odorant binding(GO:0005549) |
0.7 | 23.2 | GO:0015020 | glucuronosyltransferase activity(GO:0015020) |
0.7 | 26.9 | GO:0097472 | cyclin-dependent protein kinase activity(GO:0097472) |
0.7 | 1.4 | GO:0004605 | phosphatidate cytidylyltransferase activity(GO:0004605) |
0.7 | 2.1 | GO:0004603 | phenylethanolamine N-methyltransferase activity(GO:0004603) |
0.7 | 5.0 | GO:0016167 | glial cell-derived neurotrophic factor receptor activity(GO:0016167) |
0.7 | 113.1 | GO:0003714 | transcription corepressor activity(GO:0003714) |
0.7 | 1.4 | GO:0034875 | oxidoreductase activity, acting on CH or CH2 groups, quinone or similar compound as acceptor(GO:0033695) caffeine oxidase activity(GO:0034875) |
0.7 | 0.7 | GO:0030274 | LIM domain binding(GO:0030274) |
0.7 | 1.3 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
0.6 | 1.9 | GO:0099580 | ion antiporter activity involved in regulation of postsynaptic membrane potential(GO:0099580) |
0.6 | 4.4 | GO:0035251 | UDP-glucosyltransferase activity(GO:0035251) |
0.6 | 15.3 | GO:0016776 | phosphotransferase activity, phosphate group as acceptor(GO:0016776) |
0.6 | 1.2 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
0.6 | 1.8 | GO:0046527 | glucosyltransferase activity(GO:0046527) |
0.6 | 15.0 | GO:0001965 | G-protein alpha-subunit binding(GO:0001965) |
0.6 | 2.9 | GO:0016015 | morphogen activity(GO:0016015) |
0.6 | 1.1 | GO:0005219 | ryanodine-sensitive calcium-release channel activity(GO:0005219) |
0.6 | 4.0 | GO:0016929 | SUMO-specific protease activity(GO:0016929) |
0.6 | 7.5 | GO:0015125 | bile acid transmembrane transporter activity(GO:0015125) |
0.6 | 5.7 | GO:0001104 | RNA polymerase II transcription cofactor activity(GO:0001104) |
0.5 | 0.5 | GO:0008431 | vitamin E binding(GO:0008431) |
0.5 | 42.2 | GO:0042393 | histone binding(GO:0042393) |
0.5 | 23.9 | GO:0008238 | exopeptidase activity(GO:0008238) |
0.5 | 4.4 | GO:0005112 | Notch binding(GO:0005112) |
0.5 | 1.9 | GO:0008142 | oxysterol binding(GO:0008142) |
0.5 | 5.7 | GO:0009881 | photoreceptor activity(GO:0009881) |
0.5 | 2.3 | GO:0001540 | beta-amyloid binding(GO:0001540) |
0.4 | 1.6 | GO:0003827 | alpha-1,3-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity(GO:0003827) |
0.4 | 9.0 | GO:0032934 | sterol binding(GO:0032934) |
0.4 | 9.7 | GO:0005109 | frizzled binding(GO:0005109) |
0.4 | 6.9 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
0.4 | 1.1 | GO:0002113 | interleukin-33 binding(GO:0002113) |
0.4 | 2.1 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
0.3 | 1.6 | GO:0060230 | lipoprotein lipase activator activity(GO:0060230) |
0.3 | 0.3 | GO:0004886 | 9-cis retinoic acid receptor activity(GO:0004886) |
0.3 | 1.5 | GO:0035005 | 1-phosphatidylinositol-4-phosphate 3-kinase activity(GO:0035005) |
0.3 | 2.4 | GO:0004708 | MAP kinase kinase activity(GO:0004708) |
0.3 | 6.7 | GO:0030374 | ligand-dependent nuclear receptor transcription coactivator activity(GO:0030374) |
0.3 | 0.3 | GO:0004951 | cholecystokinin receptor activity(GO:0004951) |
0.3 | 8.4 | GO:0005160 | transforming growth factor beta receptor binding(GO:0005160) |
0.3 | 1.1 | GO:0016888 | endodeoxyribonuclease activity, producing 5'-phosphomonoesters(GO:0016888) |
0.3 | 2.2 | GO:0008970 | phosphatidylcholine 1-acylhydrolase activity(GO:0008970) |
0.3 | 1.9 | GO:0070061 | fructose binding(GO:0070061) |
0.2 | 0.2 | GO:0004833 | tryptophan 2,3-dioxygenase activity(GO:0004833) |
0.2 | 0.7 | GO:0002114 | interleukin-33 receptor activity(GO:0002114) |
0.2 | 2.3 | GO:0005225 | volume-sensitive anion channel activity(GO:0005225) |
0.2 | 0.7 | GO:0031748 | D1 dopamine receptor binding(GO:0031748) |
0.2 | 1.1 | GO:0042834 | peptidoglycan binding(GO:0042834) |
0.2 | 0.7 | GO:0043008 | ATP-dependent protein binding(GO:0043008) |
0.2 | 0.6 | GO:0005148 | prolactin receptor binding(GO:0005148) |
0.2 | 2.2 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
0.1 | 0.1 | GO:0034056 | estrogen response element binding(GO:0034056) |
0.1 | 5.1 | GO:0097110 | scaffold protein binding(GO:0097110) |
0.1 | 0.5 | GO:0033192 | calmodulin-dependent protein phosphatase activity(GO:0033192) |
0.1 | 0.1 | GO:0008252 | nucleotidase activity(GO:0008252) |
0.1 | 0.7 | GO:0030228 | low-density lipoprotein receptor activity(GO:0005041) lipoprotein particle receptor activity(GO:0030228) |
0.1 | 0.7 | GO:0019208 | phosphatase regulator activity(GO:0019208) |
0.1 | 0.2 | GO:0004862 | cAMP-dependent protein kinase inhibitor activity(GO:0004862) |
0.0 | 0.7 | GO:0050431 | transforming growth factor beta binding(GO:0050431) |
0.0 | 0.1 | GO:0051525 | NFAT protein binding(GO:0051525) |
0.0 | 0.2 | GO:0031419 | cobalamin binding(GO:0031419) |
0.0 | 0.1 | GO:0019828 | aspartic-type endopeptidase inhibitor activity(GO:0019828) |
0.0 | 0.2 | GO:0016829 | lyase activity(GO:0016829) |
0.0 | 0.0 | GO:0023024 | MHC class I protein complex binding(GO:0023024) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
17.0 | 238.1 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
13.8 | 593.2 | PID BARD1 PATHWAY | BARD1 signaling events |
12.9 | 724.8 | PID ATR PATHWAY | ATR signaling pathway |
12.9 | 411.2 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
12.8 | 676.7 | PID PLK1 PATHWAY | PLK1 signaling events |
11.5 | 573.5 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
11.0 | 562.1 | PID AURORA B PATHWAY | Aurora B signaling |
11.0 | 1401.7 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
9.2 | 210.8 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
8.1 | 8.1 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
8.1 | 24.4 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
8.1 | 494.0 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
7.6 | 196.5 | PID FOXM1 PATHWAY | FOXM1 transcription factor network |
7.4 | 171.2 | PID ARF 3PATHWAY | Arf1 pathway |
7.2 | 129.7 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
7.2 | 86.0 | PID RANBP2 PATHWAY | Sumoylation by RanBP2 regulates transcriptional repression |
7.0 | 468.8 | PID ILK PATHWAY | Integrin-linked kinase signaling |
6.9 | 20.6 | ST T CELL SIGNAL TRANSDUCTION | T Cell Signal Transduction |
6.0 | 18.1 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
6.0 | 257.7 | PID ALK1 PATHWAY | ALK1 signaling events |
6.0 | 149.6 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
5.9 | 271.4 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
5.6 | 452.0 | PID E2F PATHWAY | E2F transcription factor network |
5.6 | 39.4 | PID FAS PATHWAY | FAS (CD95) signaling pathway |
5.4 | 274.0 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
5.3 | 89.7 | PID AURORA A PATHWAY | Aurora A signaling |
5.2 | 134.5 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
5.1 | 123.4 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
5.1 | 61.2 | PID AVB3 OPN PATHWAY | Osteopontin-mediated events |
5.0 | 181.6 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
4.9 | 351.2 | PID CERAMIDE PATHWAY | Ceramide signaling pathway |
4.8 | 290.4 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
4.8 | 235.0 | PID RAC1 PATHWAY | RAC1 signaling pathway |
4.7 | 281.1 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
4.6 | 196.9 | PID IL1 PATHWAY | IL1-mediated signaling events |
4.6 | 237.8 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
4.5 | 67.7 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
4.3 | 112.5 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
4.3 | 379.7 | PID AR PATHWAY | Coregulation of Androgen receptor activity |
4.1 | 65.4 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
4.1 | 117.9 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
4.0 | 20.0 | PID IFNG PATHWAY | IFN-gamma pathway |
4.0 | 7.9 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
3.5 | 53.2 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
3.2 | 114.6 | PID PS1 PATHWAY | Presenilin action in Notch and Wnt signaling |
3.1 | 52.9 | PID BETA CATENIN DEG PATHWAY | Degradation of beta catenin |
3.0 | 143.2 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
2.9 | 126.6 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
2.9 | 374.8 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
2.9 | 20.3 | ST PHOSPHOINOSITIDE 3 KINASE PATHWAY | PI3K Pathway |
2.9 | 80.8 | PID CDC42 PATHWAY | CDC42 signaling events |
2.9 | 23.1 | SA B CELL RECEPTOR COMPLEXES | Antigen binding to B cell receptors activates protein tyrosine kinases, such as the Src family, which ultimate activate MAP kinases. |
2.9 | 20.0 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
2.8 | 71.7 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
2.7 | 38.0 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt |
2.5 | 30.5 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
2.5 | 27.8 | PID S1P S1P1 PATHWAY | S1P1 pathway |
2.5 | 57.5 | PID RHOA PATHWAY | RhoA signaling pathway |
2.5 | 39.7 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
2.4 | 135.1 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
2.4 | 26.4 | ST INTEGRIN SIGNALING PATHWAY | Integrin Signaling Pathway |
2.4 | 12.0 | ST INTERLEUKIN 4 PATHWAY | Interleukin 4 (IL-4) Pathway |
2.4 | 47.2 | PID FANCONI PATHWAY | Fanconi anemia pathway |
2.1 | 67.8 | PID ATF2 PATHWAY | ATF-2 transcription factor network |
2.1 | 48.3 | PID FOXO PATHWAY | FoxO family signaling |
2.1 | 20.9 | PID TRAIL PATHWAY | TRAIL signaling pathway |
2.0 | 30.7 | PID CD40 PATHWAY | CD40/CD40L signaling |
2.0 | 7.8 | ST IL 13 PATHWAY | Interleukin 13 (IL-13) Pathway |
2.0 | 76.5 | PID NOTCH PATHWAY | Notch signaling pathway |
1.9 | 39.8 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
1.9 | 64.4 | PID DELTA NP63 PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
1.9 | 90.4 | PID TELOMERASE PATHWAY | Regulation of Telomerase |
1.9 | 26.1 | PID INSULIN PATHWAY | Insulin Pathway |
1.8 | 48.0 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
1.8 | 143.3 | PID CMYB PATHWAY | C-MYB transcription factor network |
1.7 | 59.0 | PID P73PATHWAY | p73 transcription factor network |
1.7 | 109.9 | PID ERA GENOMIC PATHWAY | Validated nuclear estrogen receptor alpha network |
1.6 | 60.9 | ST FAS SIGNALING PATHWAY | Fas Signaling Pathway |
1.6 | 43.6 | SIG INSULIN RECEPTOR PATHWAY IN CARDIAC MYOCYTES | Genes related to the insulin receptor pathway |
1.5 | 26.2 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
1.5 | 11.7 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
1.5 | 7.3 | NABA COLLAGENS | Genes encoding collagen proteins |
1.4 | 46.2 | PID P75 NTR PATHWAY | p75(NTR)-mediated signaling |
1.3 | 28.1 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
1.1 | 20.3 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
1.0 | 7.7 | PID ECADHERIN NASCENT AJ PATHWAY | E-cadherin signaling in the nascent adherens junction |
0.9 | 17.8 | PID THROMBIN PAR1 PATHWAY | PAR1-mediated thrombin signaling events |
0.9 | 13.0 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
0.9 | 8.6 | PID ATM PATHWAY | ATM pathway |
0.8 | 16.8 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
0.8 | 3.4 | PID TCPTP PATHWAY | Signaling events mediated by TCPTP |
0.8 | 19.0 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
0.7 | 23.8 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.6 | 5.3 | PID IL3 PATHWAY | IL3-mediated signaling events |
0.6 | 3.3 | ST JNK MAPK PATHWAY | JNK MAPK Pathway |
0.4 | 7.2 | ST ERK1 ERK2 MAPK PATHWAY | ERK1/ERK2 MAPK Pathway |
0.4 | 12.8 | PID PTP1B PATHWAY | Signaling events mediated by PTP1B |
0.3 | 0.6 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
0.2 | 0.5 | ST JAK STAT PATHWAY | Jak-STAT Pathway |
0.2 | 3.0 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
0.2 | 4.2 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
0.1 | 1.4 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.1 | 0.1 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
0.1 | 3.2 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
0.1 | 0.3 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
30.7 | 123.0 | REACTOME PHOSPHORYLATION OF THE APC C | Genes involved in Phosphorylation of the APC/C |
25.6 | 872.0 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
23.7 | 403.2 | REACTOME PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |
23.2 | 720.5 | REACTOME FORMATION OF TUBULIN FOLDING INTERMEDIATES BY CCT TRIC | Genes involved in Formation of tubulin folding intermediates by CCT/TriC |
22.8 | 1782.3 | REACTOME REGULATION OF ORNITHINE DECARBOXYLASE ODC | Genes involved in Regulation of ornithine decarboxylase (ODC) |
21.4 | 493.2 | REACTOME RNA POL III CHAIN ELONGATION | Genes involved in RNA Polymerase III Chain Elongation |
21.0 | 189.0 | REACTOME PREFOLDIN MEDIATED TRANSFER OF SUBSTRATE TO CCT TRIC | Genes involved in Prefoldin mediated transfer of substrate to CCT/TriC |
20.1 | 321.8 | REACTOME SLBP DEPENDENT PROCESSING OF REPLICATION DEPENDENT HISTONE PRE MRNAS | Genes involved in SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs |
20.1 | 281.1 | REACTOME RAF MAP KINASE CASCADE | Genes involved in RAF/MAP kinase cascade |
19.2 | 327.1 | REACTOME REPAIR SYNTHESIS FOR GAP FILLING BY DNA POL IN TC NER | Genes involved in Repair synthesis for gap-filling by DNA polymerase in TC-NER |
18.4 | 18.4 | REACTOME APC CDC20 MEDIATED DEGRADATION OF NEK2A | Genes involved in APC-Cdc20 mediated degradation of Nek2A |
18.1 | 163.2 | REACTOME APOBEC3G MEDIATED RESISTANCE TO HIV1 INFECTION | Genes involved in APOBEC3G mediated resistance to HIV-1 infection |
17.6 | 632.1 | REACTOME CYTOSOLIC TRNA AMINOACYLATION | Genes involved in Cytosolic tRNA aminoacylation |
16.9 | 491.5 | REACTOME INHIBITION OF THE PROTEOLYTIC ACTIVITY OF APC C REQUIRED FOR THE ONSET OF ANAPHASE BY MITOTIC SPINDLE CHECKPOINT COMPONENTS | Genes involved in Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components |
16.5 | 148.7 | REACTOME POST CHAPERONIN TUBULIN FOLDING PATHWAY | Genes involved in Post-chaperonin tubulin folding pathway |
16.5 | 263.3 | REACTOME UNWINDING OF DNA | Genes involved in Unwinding of DNA |
16.2 | 194.9 | REACTOME APC C CDH1 MEDIATED DEGRADATION OF CDC20 AND OTHER APC C CDH1 TARGETED PROTEINS IN LATE MITOSIS EARLY G1 | Genes involved in APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 |
16.2 | 32.4 | REACTOME NEP NS2 INTERACTS WITH THE CELLULAR EXPORT MACHINERY | Genes involved in NEP/NS2 Interacts with the Cellular Export Machinery |
15.8 | 94.5 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
15.6 | 406.4 | REACTOME KINESINS | Genes involved in Kinesins |
15.6 | 249.0 | REACTOME CITRIC ACID CYCLE TCA CYCLE | Genes involved in Citric acid cycle (TCA cycle) |
14.9 | 388.1 | REACTOME DESTABILIZATION OF MRNA BY KSRP | Genes involved in Destabilization of mRNA by KSRP |
14.8 | 1259.5 | REACTOME RESPIRATORY ELECTRON TRANSPORT | Genes involved in Respiratory electron transport |
14.6 | 511.1 | REACTOME PYRIMIDINE METABOLISM | Genes involved in Pyrimidine metabolism |
14.4 | 332.0 | REACTOME FORMATION OF ATP BY CHEMIOSMOTIC COUPLING | Genes involved in Formation of ATP by chemiosmotic coupling |
14.4 | 303.1 | REACTOME TETRAHYDROBIOPTERIN BH4 SYNTHESIS RECYCLING SALVAGE AND REGULATION | Genes involved in Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation |
14.1 | 155.2 | REACTOME ENOS ACTIVATION AND REGULATION | Genes involved in eNOS activation and regulation |
13.7 | 259.8 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
13.4 | 684.2 | REACTOME GLYCOLYSIS | Genes involved in Glycolysis |
13.4 | 280.7 | REACTOME EXTENSION OF TELOMERES | Genes involved in Extension of Telomeres |
13.3 | 173.4 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION IN TLR7 8 OR 9 SIGNALING | Genes involved in TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling |
12.9 | 501.2 | REACTOME INTERACTIONS OF VPR WITH HOST CELLULAR PROTEINS | Genes involved in Interactions of Vpr with host cellular proteins |
12.8 | 63.8 | REACTOME CYCLIN E ASSOCIATED EVENTS DURING G1 S TRANSITION | Genes involved in Cyclin E associated events during G1/S transition |
12.8 | 548.4 | REACTOME DOWNREGULATION OF SMAD2 3 SMAD4 TRANSCRIPTIONAL ACTIVITY | Genes involved in Downregulation of SMAD2/3:SMAD4 transcriptional activity |
12.7 | 685.3 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
12.7 | 126.6 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
12.5 | 349.5 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
12.4 | 12.4 | REACTOME MRNA DECAY BY 3 TO 5 EXORIBONUCLEASE | Genes involved in mRNA Decay by 3' to 5' Exoribonuclease |
12.2 | 121.8 | REACTOME DESTABILIZATION OF MRNA BY AUF1 HNRNP D0 | Genes involved in Destabilization of mRNA by AUF1 (hnRNP D0) |
12.0 | 96.1 | REACTOME INFLUENZA VIRAL RNA TRANSCRIPTION AND REPLICATION | Genes involved in Influenza Viral RNA Transcription and Replication |
11.8 | 58.9 | REACTOME INFLUENZA LIFE CYCLE | Genes involved in Influenza Life Cycle |
11.5 | 219.2 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
11.1 | 400.8 | REACTOME MRNA SPLICING MINOR PATHWAY | Genes involved in mRNA Splicing - Minor Pathway |
11.0 | 219.9 | REACTOME ER PHAGOSOME PATHWAY | Genes involved in ER-Phagosome pathway |
10.8 | 258.7 | REACTOME FORMATION OF INCISION COMPLEX IN GG NER | Genes involved in Formation of incision complex in GG-NER |
10.6 | 328.6 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
10.6 | 338.3 | REACTOME TRANSFERRIN ENDOCYTOSIS AND RECYCLING | Genes involved in Transferrin endocytosis and recycling |
10.2 | 214.7 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
10.2 | 234.0 | REACTOME PURINE METABOLISM | Genes involved in Purine metabolism |
10.1 | 141.1 | REACTOME VITAMIN B5 PANTOTHENATE METABOLISM | Genes involved in Vitamin B5 (pantothenate) metabolism |
10.0 | 289.1 | REACTOME PYRUVATE METABOLISM AND CITRIC ACID TCA CYCLE | Genes involved in Pyruvate metabolism and Citric Acid (TCA) cycle |
9.9 | 179.0 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
9.9 | 178.4 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
9.6 | 478.5 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
9.5 | 654.5 | REACTOME MITOTIC PROMETAPHASE | Genes involved in Mitotic Prometaphase |
9.4 | 149.8 | REACTOME METABOLISM OF NON CODING RNA | Genes involved in Metabolism of non-coding RNA |
9.3 | 2294.1 | REACTOME TRANSLATION | Genes involved in Translation |
9.1 | 90.5 | REACTOME CYCLIN A B1 ASSOCIATED EVENTS DURING G2 M TRANSITION | Genes involved in Cyclin A/B1 associated events during G2/M transition |
8.8 | 185.5 | REACTOME ACTIVATION OF BH3 ONLY PROTEINS | Genes involved in Activation of BH3-only proteins |
8.5 | 399.7 | REACTOME G1 PHASE | Genes involved in G1 Phase |
8.5 | 126.8 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
8.4 | 33.8 | REACTOME P130CAS LINKAGE TO MAPK SIGNALING FOR INTEGRINS | Genes involved in p130Cas linkage to MAPK signaling for integrins |
8.3 | 233.2 | REACTOME NEF MEDIATES DOWN MODULATION OF CELL SURFACE RECEPTORS BY RECRUITING THEM TO CLATHRIN ADAPTERS | Genes involved in Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters |
8.2 | 220.1 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
7.9 | 127.1 | REACTOME DEADENYLATION OF MRNA | Genes involved in Deadenylation of mRNA |
7.9 | 142.7 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
7.8 | 209.4 | REACTOME FATTY ACYL COA BIOSYNTHESIS | Genes involved in Fatty Acyl-CoA Biosynthesis |
7.7 | 69.2 | REACTOME RNA POL III TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase III Transcription Termination |
7.7 | 230.6 | REACTOME TGF BETA RECEPTOR SIGNALING ACTIVATES SMADS | Genes involved in TGF-beta receptor signaling activates SMADs |
7.6 | 122.0 | REACTOME ZINC TRANSPORTERS | Genes involved in Zinc transporters |
7.5 | 97.1 | REACTOME DEADENYLATION DEPENDENT MRNA DECAY | Genes involved in Deadenylation-dependent mRNA decay |
7.2 | 166.6 | REACTOME HS GAG DEGRADATION | Genes involved in HS-GAG degradation |
7.2 | 115.0 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
7.1 | 92.6 | REACTOME G0 AND EARLY G1 | Genes involved in G0 and Early G1 |
6.9 | 69.0 | REACTOME P53 INDEPENDENT G1 S DNA DAMAGE CHECKPOINT | Genes involved in p53-Independent G1/S DNA damage checkpoint |
6.6 | 425.5 | REACTOME ACTIVATION OF CHAPERONE GENES BY XBP1S | Genes involved in Activation of Chaperone Genes by XBP1(S) |
6.6 | 638.1 | REACTOME MRNA SPLICING | Genes involved in mRNA Splicing |
6.6 | 131.5 | REACTOME LYSOSOME VESICLE BIOGENESIS | Genes involved in Lysosome Vesicle Biogenesis |
6.6 | 137.6 | REACTOME MITOTIC M M G1 PHASES | Genes involved in Mitotic M-M/G1 phases |
6.4 | 262.5 | REACTOME ANTIVIRAL MECHANISM BY IFN STIMULATED GENES | Genes involved in Antiviral mechanism by IFN-stimulated genes |
6.2 | 49.9 | REACTOME MTORC1 MEDIATED SIGNALLING | Genes involved in mTORC1-mediated signalling |
6.1 | 919.9 | REACTOME ANTIGEN PROCESSING UBIQUITINATION PROTEASOME DEGRADATION | Genes involved in Antigen processing: Ubiquitination & Proteasome degradation |
5.8 | 163.8 | REACTOME RECYCLING PATHWAY OF L1 | Genes involved in Recycling pathway of L1 |
5.8 | 81.9 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
5.8 | 110.3 | REACTOME SYNTHESIS OF PIPS AT THE GOLGI MEMBRANE | Genes involved in Synthesis of PIPs at the Golgi membrane |
5.7 | 107.4 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
5.6 | 112.5 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
5.6 | 157.0 | REACTOME AMINO ACID SYNTHESIS AND INTERCONVERSION TRANSAMINATION | Genes involved in Amino acid synthesis and interconversion (transamination) |
5.5 | 114.6 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
5.5 | 349.1 | REACTOME APOPTOTIC EXECUTION PHASE | Genes involved in Apoptotic execution phase |
5.3 | 127.8 | REACTOME ADP SIGNALLING THROUGH P2RY12 | Genes involved in ADP signalling through P2Y purinoceptor 12 |
5.3 | 101.1 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
5.3 | 53.0 | REACTOME INTEGRATION OF PROVIRUS | Genes involved in Integration of provirus |
5.1 | 168.8 | REACTOME POST TRANSLATIONAL MODIFICATION SYNTHESIS OF GPI ANCHORED PROTEINS | Genes involved in Post-translational modification: synthesis of GPI-anchored proteins |
4.9 | 59.2 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
4.8 | 72.2 | REACTOME SIGNALING BY NOTCH2 | Genes involved in Signaling by NOTCH2 |
4.8 | 196.3 | REACTOME GOLGI ASSOCIATED VESICLE BIOGENESIS | Genes involved in Golgi Associated Vesicle Biogenesis |
4.7 | 178.2 | REACTOME SULFUR AMINO ACID METABOLISM | Genes involved in Sulfur amino acid metabolism |
4.6 | 120.5 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
4.6 | 32.4 | REACTOME NEGATIVE REGULATION OF THE PI3K AKT NETWORK | Genes involved in Negative regulation of the PI3K/AKT network |
4.6 | 258.5 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
4.6 | 82.5 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
4.6 | 32.0 | REACTOME MICRORNA MIRNA BIOGENESIS | Genes involved in MicroRNA (miRNA) Biogenesis |
4.5 | 81.5 | REACTOME DOUBLE STRAND BREAK REPAIR | Genes involved in Double-Strand Break Repair |
4.4 | 8.8 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
4.4 | 26.4 | REACTOME PD1 SIGNALING | Genes involved in PD-1 signaling |
4.3 | 133.9 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
4.3 | 17.2 | REACTOME FORMATION OF TRANSCRIPTION COUPLED NER TC NER REPAIR COMPLEX | Genes involved in Formation of transcription-coupled NER (TC-NER) repair complex |
4.1 | 24.6 | REACTOME DESTABILIZATION OF MRNA BY TRISTETRAPROLIN TTP | Genes involved in Destabilization of mRNA by Tristetraprolin (TTP) |
4.0 | 71.5 | REACTOME MITOCHONDRIAL TRNA AMINOACYLATION | Genes involved in Mitochondrial tRNA aminoacylation |
4.0 | 189.6 | REACTOME DEPOSITION OF NEW CENPA CONTAINING NUCLEOSOMES AT THE CENTROMERE | Genes involved in Deposition of New CENPA-containing Nucleosomes at the Centromere |
3.8 | 3.8 | REACTOME G2 M DNA DAMAGE CHECKPOINT | Genes involved in G2/M DNA damage checkpoint |
3.8 | 134.1 | REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
3.8 | 52.7 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
3.7 | 293.6 | REACTOME P75 NTR RECEPTOR MEDIATED SIGNALLING | Genes involved in p75 NTR receptor-mediated signalling |
3.6 | 43.0 | REACTOME PECAM1 INTERACTIONS | Genes involved in PECAM1 interactions |
3.6 | 21.4 | REACTOME SYNTHESIS OF PIPS AT THE EARLY ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the early endosome membrane |
3.5 | 88.6 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
3.4 | 27.0 | REACTOME PROSTACYCLIN SIGNALLING THROUGH PROSTACYCLIN RECEPTOR | Genes involved in Prostacyclin signalling through prostacyclin receptor |
3.3 | 29.6 | REACTOME ACTIVATION OF CHAPERONE GENES BY ATF6 ALPHA | Genes involved in Activation of Chaperone Genes by ATF6-alpha |
3.2 | 13.0 | REACTOME TRANS GOLGI NETWORK VESICLE BUDDING | Genes involved in trans-Golgi Network Vesicle Budding |
3.1 | 34.3 | REACTOME INTRINSIC PATHWAY | Genes involved in Intrinsic Pathway |
3.0 | 136.1 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
3.0 | 45.0 | REACTOME ACYL CHAIN REMODELLING OF PG | Genes involved in Acyl chain remodelling of PG |
3.0 | 39.0 | REACTOME SEMA3A PAK DEPENDENT AXON REPULSION | Genes involved in Sema3A PAK dependent Axon repulsion |
2.8 | 110.0 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
2.7 | 103.4 | REACTOME GLUCOSE METABOLISM | Genes involved in Glucose metabolism |
2.7 | 70.2 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
2.7 | 5.4 | REACTOME ACTIVATED TAK1 MEDIATES P38 MAPK ACTIVATION | Genes involved in activated TAK1 mediates p38 MAPK activation |
2.7 | 61.5 | REACTOME BIOSYNTHESIS OF THE N GLYCAN PRECURSOR DOLICHOL LIPID LINKED OLIGOSACCHARIDE LLO AND TRANSFER TO A NASCENT PROTEIN | Genes involved in Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein |
2.6 | 2.6 | REACTOME GLUCAGON SIGNALING IN METABOLIC REGULATION | Genes involved in Glucagon signaling in metabolic regulation |
2.6 | 35.8 | REACTOME TRANSCRIPTIONAL ACTIVITY OF SMAD2 SMAD3 SMAD4 HETEROTRIMER | Genes involved in Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer |
2.5 | 35.6 | REACTOME GAMMA CARBOXYLATION TRANSPORT AND AMINO TERMINAL CLEAVAGE OF PROTEINS | Genes involved in Gamma-carboxylation, transport, and amino-terminal cleavage of proteins |
2.4 | 24.3 | REACTOME DCC MEDIATED ATTRACTIVE SIGNALING | Genes involved in DCC mediated attractive signaling |
2.4 | 57.0 | REACTOME RNA POL II TRANSCRIPTION PRE INITIATION AND PROMOTER OPENING | Genes involved in RNA Polymerase II Transcription Pre-Initiation And Promoter Opening |
2.3 | 25.7 | REACTOME ACTIVATION OF IRF3 IRF7 MEDIATED BY TBK1 IKK EPSILON | Genes involved in Activation of IRF3/IRF7 mediated by TBK1/IKK epsilon |
2.3 | 105.8 | REACTOME TRANSPORT TO THE GOLGI AND SUBSEQUENT MODIFICATION | Genes involved in Transport to the Golgi and subsequent modification |
2.2 | 20.1 | REACTOME RECYCLING OF BILE ACIDS AND SALTS | Genes involved in Recycling of bile acids and salts |
2.0 | 20.1 | REACTOME REGULATION OF MRNA STABILITY BY PROTEINS THAT BIND AU RICH ELEMENTS | Genes involved in Regulation of mRNA Stability by Proteins that Bind AU-rich Elements |
2.0 | 29.9 | REACTOME ASPARAGINE N LINKED GLYCOSYLATION | Genes involved in Asparagine N-linked glycosylation |
2.0 | 9.9 | REACTOME ERKS ARE INACTIVATED | Genes involved in ERKs are inactivated |
2.0 | 27.3 | REACTOME REGULATION OF IFNG SIGNALING | Genes involved in Regulation of IFNG signaling |
1.9 | 7.8 | REACTOME ADENYLATE CYCLASE INHIBITORY PATHWAY | Genes involved in Adenylate cyclase inhibitory pathway |
1.9 | 196.8 | REACTOME PPARA ACTIVATES GENE EXPRESSION | Genes involved in PPARA Activates Gene Expression |
1.9 | 32.3 | REACTOME SYNTHESIS OF PA | Genes involved in Synthesis of PA |
1.9 | 11.2 | REACTOME SEMA4D IN SEMAPHORIN SIGNALING | Genes involved in Sema4D in semaphorin signaling |
1.8 | 33.3 | REACTOME BASE FREE SUGAR PHOSPHATE REMOVAL VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Base-free sugar-phosphate removal via the single-nucleotide replacement pathway |
1.8 | 113.0 | REACTOME LOSS OF NLP FROM MITOTIC CENTROSOMES | Genes involved in Loss of Nlp from mitotic centrosomes |
1.8 | 33.9 | REACTOME SIGNAL TRANSDUCTION BY L1 | Genes involved in Signal transduction by L1 |
1.8 | 166.2 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
1.7 | 138.2 | REACTOME CELL JUNCTION ORGANIZATION | Genes involved in Cell junction organization |
1.6 | 103.8 | REACTOME PHASE II CONJUGATION | Genes involved in Phase II conjugation |
1.6 | 28.9 | REACTOME ABCA TRANSPORTERS IN LIPID HOMEOSTASIS | Genes involved in ABCA transporters in lipid homeostasis |
1.6 | 20.3 | REACTOME METABOLISM OF POLYAMINES | Genes involved in Metabolism of polyamines |
1.5 | 9.2 | REACTOME SOS MEDIATED SIGNALLING | Genes involved in SOS-mediated signalling |
1.5 | 6.1 | REACTOME ACYL CHAIN REMODELLING OF PS | Genes involved in Acyl chain remodelling of PS |
1.5 | 59.8 | REACTOME GLYCOSPHINGOLIPID METABOLISM | Genes involved in Glycosphingolipid metabolism |
1.5 | 8.7 | REACTOME PKA MEDIATED PHOSPHORYLATION OF CREB | Genes involved in PKA-mediated phosphorylation of CREB |
1.4 | 12.8 | REACTOME HDL MEDIATED LIPID TRANSPORT | Genes involved in HDL-mediated lipid transport |
1.4 | 23.2 | REACTOME GLUCOSE TRANSPORT | Genes involved in Glucose transport |
1.4 | 10.8 | REACTOME SIGNALLING TO P38 VIA RIT AND RIN | Genes involved in Signalling to p38 via RIT and RIN |
1.3 | 89.4 | REACTOME DIABETES PATHWAYS | Genes involved in Diabetes pathways |
1.2 | 7.2 | REACTOME NOD1 2 SIGNALING PATHWAY | Genes involved in NOD1/2 Signaling Pathway |
1.2 | 28.9 | REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | Genes involved in Amino acid transport across the plasma membrane |
1.1 | 69.8 | REACTOME RNA POL I RNA POL III AND MITOCHONDRIAL TRANSCRIPTION | Genes involved in RNA Polymerase I, RNA Polymerase III, and Mitochondrial Transcription |
1.1 | 24.8 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
1.1 | 15.1 | REACTOME CLASS I MHC MEDIATED ANTIGEN PROCESSING PRESENTATION | Genes involved in Class I MHC mediated antigen processing & presentation |
1.1 | 60.6 | REACTOME L1CAM INTERACTIONS | Genes involved in L1CAM interactions |
1.0 | 16.3 | REACTOME P38MAPK EVENTS | Genes involved in p38MAPK events |
0.9 | 34.3 | REACTOME O LINKED GLYCOSYLATION OF MUCINS | Genes involved in O-linked glycosylation of mucins |
0.8 | 98.0 | REACTOME METABOLISM OF CARBOHYDRATES | Genes involved in Metabolism of carbohydrates |
0.8 | 20.8 | REACTOME NETRIN1 SIGNALING | Genes involved in Netrin-1 signaling |
0.7 | 2.1 | REACTOME IKK COMPLEX RECRUITMENT MEDIATED BY RIP1 | Genes involved in IKK complex recruitment mediated by RIP1 |
0.7 | 6.4 | REACTOME GAP JUNCTION DEGRADATION | Genes involved in Gap junction degradation |
0.7 | 13.1 | REACTOME INFLAMMASOMES | Genes involved in Inflammasomes |
0.6 | 9.0 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
0.6 | 1.9 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
0.6 | 9.7 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
0.6 | 8.4 | REACTOME FGFR4 LIGAND BINDING AND ACTIVATION | Genes involved in FGFR4 ligand binding and activation |
0.6 | 0.6 | REACTOME SIGNALING BY FGFR1 MUTANTS | Genes involved in Signaling by FGFR1 mutants |
0.5 | 5.5 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
0.4 | 4.9 | REACTOME TELOMERE MAINTENANCE | Genes involved in Telomere Maintenance |
0.4 | 6.3 | REACTOME G ALPHA Z SIGNALLING EVENTS | Genes involved in G alpha (z) signalling events |
0.4 | 0.8 | REACTOME PROCESSING OF CAPPED INTRON CONTAINING PRE MRNA | Genes involved in Processing of Capped Intron-Containing Pre-mRNA |
0.4 | 1.9 | REACTOME GRB2 EVENTS IN ERBB2 SIGNALING | Genes involved in GRB2 events in ERBB2 signaling |
0.4 | 5.6 | REACTOME INTERFERON GAMMA SIGNALING | Genes involved in Interferon gamma signaling |
0.4 | 7.6 | REACTOME REGULATION OF WATER BALANCE BY RENAL AQUAPORINS | Genes involved in Regulation of Water Balance by Renal Aquaporins |
0.3 | 1.1 | REACTOME G BETA GAMMA SIGNALLING THROUGH PLC BETA | Genes involved in G beta:gamma signalling through PLC beta |
0.2 | 1.8 | REACTOME NOTCH HLH TRANSCRIPTION PATHWAY | Genes involved in Notch-HLH transcription pathway |
0.2 | 2.2 | REACTOME METABOLISM OF PROTEINS | Genes involved in Metabolism of proteins |
0.1 | 1.4 | REACTOME NUCLEOTIDE LIKE PURINERGIC RECEPTORS | Genes involved in Nucleotide-like (purinergic) receptors |
0.0 | 1.8 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |